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Transposable elements (TEs), or mobile genetic elements, are major components 
of eukaryotic genomes. TEs became of great interest over the last few decades because of 
their significant impact on gene and genome evolution. My dissertation encompasses five 
different studies that are linked by a common theme – the investigation of TE 
contributions to eukaryotic gene sequences. The studies focus on two types of gene 
sequences: protein coding genes and non-coding regulatory genes. The instances, causes, 
and consequences of TE integration into human protein coding genes have been studied 
previously. However, the precise extent of TE contribution to host protein coding 
sequences and the coding potential of such TE-derived sequences remain a matter of 
controversy. The first objective of this dissertation is to investigate the extent, evolution, 
and coding property of TE-derived protein-coding sequences in human genes as well as 
the ascertainment bias of methods used to detect such sequences.  
Small noncoding regulatory RNAs, such as microRNAs (miRNAs) and short 
interfering RNAs (siRNAs), are a class of genes which was recently discovered. 
Accordingly, a number of open questions regarding their evolutionary origins remain. 
siRNAs are known to originate from and regulate TEs, whereas miRNAs are encoded 
from distinct genetic loci and thought to be dedicated to the regulation of host genes. The 
second objective of my dissertation research objective is to explore the extent of TE 
contributions to the origin and evolution of miRNA genes including the possible 
evolutionary connection between the origin of both siRNAs and miRNAs.   
 xix
The results from my research provide the following five major advances to the 
study of TE-gene evolution:  
Research advance1: The first detailed analysis of exonization events of one 
particular class of TE, long terminal repeat (LTR) containing elements, in the human 
genome indicates that 5.8% of human genes are associated with LTR elements and 50 
distinct protein coding exons were comprised exclusively of LTR retrotransposon 
sequences. A detailed scenario of the exonization process of an alternatively spliced exon 
of the alpha 2 gene of the Interleukin 22 receptor (IL22RA2) was supported by new 
experimental data generated in this research. As a result of a single mutation in the proto-
splice site, recruitment of the part of MaLR LTR as a novel exon in great ape species 
occurred prior to the divergence of orangutans and humans from a common ancestor (∼ 
14 MYA). The majority of human LTR exonization events involve non-coding exon 
sequences in the 5’ and 3’ untranslated regions. 
Research advance2: Differences in the extent of TEs found in experimentally 
characterized protein sequences (CDS) caused by the specific bias of each search method 
are emphasized by the comparison of the results from three sequence similarity search 
approaches: 1-a profile-based approach, 2-BLAST methods and 3-RepeatMasker. Profile 
based methods show a valuable combination of sensitivity, measured by their ability to 
detect well-characterized cases of TE-derived CDS, and selectivity compared to the other 
methods evaluated. The non-overlap of hits and difference in the ability of each approach 
to recover known cases of TE-derived CDS indicates the need to use these 
complementary methods together for more accurate detection of CDS that evolved from 
TEs. On average, TE-derived exon sequences have low protein coding potential. In 
 xx
particular, non-coding TEs, such as Alu elements, are frequently exonized but unlikely to 
encode protein sequences. I hypothesize that many of these non-coding exonized TEs are 
involved in gene regulation via the formation of double stranded RNA (dsRNA) 
complexes with complementary TE-derived exons.      
Research advance3: The investigation of the relationship between human 
miRNAs and TEs shows that 55 experimentally verified human miRNA genes (~12%) 
originated from TEs. Sequence comparisons among vertebrate genomes revealed that, on 
average, TE-derived human miRNAs are significantly less conserved than non TE-
derived miRNAs. However, there are TE-derived miRNAs that are relatively conserved, 
and most are related to the ancient L2 and MIR families. In addition to the known human 
miRNAs that were shown to be derived from TE sequences, an additional 85 novel TE-
derived miRNA genes were predicted in this study. The dispersed repetitive nature of TE 
sequences provides for the emergence of multiple novel miRNA genes as well as 
numerous homologous target sites throughout the genome. Thus, TEs may represent a 
mechanism for the rapid deployment of miRNA based regulatory networks in the human 
genome.  
Research advance4: A group of seven closely related miRNA genes (hsa-mir-
548) was found to be derived from the Made1 family of MITEs. These Made1 elements 
are nearly perfect palindromes which are able to form highly stable hairpin-loops, 
resembling pre-miRNA structures. The analysis of their expression profiles and 
functional affinities suggests cancer-related regulatory roles for hsa-mir-548. 
Research advance5: An original model for a siRNA-to-miRNA evolutionary 
transition mediated by DNA-type TEs is proposed. This model is supported by the 
 xxi
presence of evolutionary intermediate TE sequences that encode both siRNAs and 
miRNAs in the Arabidopsis and rice genomes. These dual coding TEs can be expressed 
as read-through transcripts from the intronic regions of spliced RNA messages. The 
results indicate that ancestral miRNAs could have evolved from TEs prior to the full 
elaboration of the miRNA biogenesis pathway. The siRNA-to-miRNA evolutionary 
transition is representative of a number of other regulatory mechanisms that evolved to 






INTRODUCTION AND LITERATURE REVIEW 
 
Overview of Transposable Elements (TEs) 
 Transposable elements (TEs) are mobile DNA sequences that have ability to 
move (transpose) from one location to another within genomes of their host organisms 
and often make duplicate copies of themselves in the process. Since their first discovery 
by Barbara McClintock about 60 years ago (MCCLINTOCK 1948), TEs have been found to 
be the largest component of the genetic material of most eukaryotes. Eukayotic species 
vary considerably in the distribution and the content of their TE sequences which can 
account for the main differences in genome size among species (BIEMONT and VIEIRA 
2005; BIEMONT and VIEIRA 2006; KIDWELL 2002) (Table 1.1). Of all eukaryotic genomes 
sequenced to date, only Plasmodium falciparum genome was found not to host any active 
TEs (GARDNER et al. 2002).  
TEs can be classified into two major classes based on modes of transposition 
(FINNEGAN 1989; FINNEGAN 1992). Class I elements (retrotransposons) transpose through 
RNA intermediates. They are transcribed into RNA, and then reverse transcribed back to 
DNA and reintegrated into the genome, thereby duplicating the element (“copy and 
paste” mechanism). Reverse transcription and integration are catalyzed by reverse 
transcriptase (RT) and endonuclease/integrase (EN/INT), which are encoded by 
autonomous elements. Retrotransposons can be further divided into two subclasses based 
on the presence/absence of long terminal repeats (LTRs). 
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Table 1.1: Genome sizes and transposable element proportions for eukaryotic 
species 
 
Table 1.1 continued     






Lilium Lilies 36,000 95-99 (BENNETZEN 2000; 
FLAVELL et al. 1994; 
FLAVELL et al. 1974) 
Zea Mays Maize 2,500 60-80 (SANMIGUEL et al. 
1996) 
Hordeum vulgare Barley 4,800 55 (KUMAR and 
BENNETZEN 1999; 
VICIENT et al. 1999) 
Macaca mulatta Rhesus 
monkey 
3,100 50 (HAN et al. 2007) 
Homo sapiens Human 3,200 45 (LANDER et al. 2001) 
Pan troglodytes Chimpanzee 3,000 45 (MIKKELSEN et al. 
2005) 
Bos taurus Cow 3,200 40 (LARKIN et al. 2003) 
Rattus norvegicus Rat 2,500 40 (GIBBS et al. 2004) 
Mus musculus Mouse 3,000 38 (WATERSTON et al. 
2002) 
Xenopus laevis African 
clawed 
frogs 
3,100 37 (CARROLL et al. 1989) 
Canis Familiaris Dog 2,400 34 (LINDBLAD-TOH et al. 
2005) 
Oryza sativa Rice 430 20 (TURCOTTE et al. 
2001) 
Anopheles gambiae Mosquito 278 16 (HOLT et al. 2002) 
Drosophila 
melanogaster 
Fruit fly 180 15-22 (ADAMS et al. 2000; 
VIEIRA et al. 1999) 





Slime mold 34 10 (GLOCKNER et al. 
2001) 






Worm 103 6 (THEC.ELEGANSSEQU
ENCINGCONSORTIUM 
1998) 
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Table 1.1 continued     











12 3-5 (KIM et al. 1998) 
Fugu rubripes Japanese 
pufferfish 











342 0.14  (CROLLIUS et al. 




LTR retrotransposons contain direct repeats at both ends and are related, in 
sequence and genomic structure, to retroviruses; they both contain gag and pol genes that 
encode all necessary proteins to provide enzymatic activities for transposition process 
(Figure 1.1). They differ in that retroviruses encode an envelope protein, whereas LTR 
retrotransposons either lack or contain a remnant of an env gene.  
Non-LTR retrotransposons lack LTRs and possess a polyadenylate sequences at 
their 3’ termini. They are divided into two super-families, LINEs (Long Interspersed 
Nuclear Elements) and SINEs (Short Interspersed Nuclear Elements). LINEs are 
autonomous retroelements encoding two ORFs, ORF1 encoding an RNA binding protein 
and ORF2 encoding endonuclease and reverse transcriptase activities (Figure 1.1). SINEs 
are non-autonomous retroelements which lack coding capacity and are dependent on the 
reverse transcriptase machinery encoded by LINEs for their mobility (DEWANNIEUX et al. 
2003).  
Class II elements (DNA transposons) transpose directly as DNA sequence. These 
elements are generally excised from one genomic site and integrated into another by a 
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conservative “cut and paste” mechanism catalyzed by the enzyme transposase. They have 
terminal inverted repeats (TIRs) flanking an ORF encoding a transposase (Figure 1.1). 
Non-autonomous DNA elements containing only TIRs may be transposed in trans by 
related full length autonomous elements. 
  
 
Figure 1.1: Classes of TEs found in human genome and their characteristics  
 
 
Transposable elements: “junk DNA” or “genetic treasure” 
Eukaryotic genomes are very complex and dynamic systems. Only a small 
fraction of eukaryotic genomes consists of protein coding exons, while a far more 
substantial part is constituted by TEs. For human, TEs contribute more than 45% of the 
whole genome (JASINSKA and KRZYZOSIAK 2004; LANDER et al. 2001). An interesting 
question is whether the abundance and persistence of TEs in eukaryotic genomes rest 
primarily on their ability to out-replicate their host genome or on the contributions they 
make to the evolution and genetic plasticity of their hosts (CHARLESWORTH et al. 1994; 
MCDONALD 1995). TEs have long been considered as “junk” or “selfish” DNA 
parasitizing the genome of living organisms (DOOLITTLE and SAPIENZA 1980; HICKEY 
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1982; OHNO 1972; ORGEL and CRICK 1980). The selfish DNA theory (DOOLITTLE and 
SAPIENZA 1980; ORGEL and CRICK 1980) describes that TEs serve only to survive and 
increase their number even at the expense of their host genomes. They are maintained in 
the host genomes by natural selection for their ability to propagate themselves without 
providing any function or benefit to their hosts. According to the selfish DNA theory, 
TEs make no positive contribution to host function, phenotype or evolution, and the 
effects that TEs have on their hosts are harmful and selected against. For instance, TEs 
can insert into host genes or gene regulatory elements and this will lead to deleterious 
effects including hereditary diseases induced by insertion mutations. The ability to cause 
such insertional mutations has been cited as a possible role for TEs in certain types of 
cancer (SAUTER et al. 1995; WANG-JOHANNING et al. 2003). Approximately 0.5–1% of 
human illnesses were believed to be associated with gene dysfunction or misregulation by 
TEs (KAZAZIAN 1998). TEs can also affect stability of the genome by introducing 
recombination hot spots (MIGHELL et al. 1997; SCHWARTZ et al. 1998).  
Although TEs are considered to be harmful and are expected to be removed by the 
force of natural selection, they cannot be easily eliminated and their endurance in the host 
may be attributable to some evolutionary advantages they provide. The idea that TEs are 
beneficial to the host was proposed before (BROSIUS 1991; HARTL et al. 1983; KIDWELL 
and LISCH 2001; MCCLINTOCK 1984). As a source of genomic variation, TEs have 
potential to play a major role in the evolution of host genomes. TEs frequently donate 
regulatory and coding sequences to host genes (JORDAN et al. 2003; NEKRUTENKO and LI 
2001; VAN DE LAGEMAAT et al. 2003; VOLFF 2006). TEs are also considered as the 
driving force in the evolution of epigenetic regulation (LIPPMAN et al. 2004) and in 
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speciation (ROSE and DOOLITTLE 1983). The preservation of TEs in the host genome is 
enhanced by some mechanisms that TE have evolved to alleviate the harmful effects 
caused by transposition. For example, the restriction of expression of some TEs to 
germline tissue (TRELOGAN and MARTIN 1995) decreases the detrimental effects of 
somatic mutations. Another example is a repressor protein of P-elements in Drosophila 
that blocks transposition in already infected genomes (ROBERTSON and ENGELS 1989).  
More and more evidence regarding the role of TEs in host genomes has 
accumulated in recent years and enhanced our understanding about the impact of these 
elements on genome evolution (BIEMONT and VIEIRA 2006; JURKA et al. 2007; 
KAZAZIAN 2004; KIDWELL and LISCH 2001). However, an ongoing debate still exists 
regarding whether TEs actually confer a benefit to the host organism. A precise 
delineation of underlying mechanisms responsible for TE-host co-evolution remains 
elusive and needs to be clarified.  
Contribution of transposable elements to host protein coding sequences 
One of the many ways that TEs participate in the function and evolution of the 
resident genomes is through the donation of host protein coding sequences (CDSs). A 
specific kind of exaptation termed ‘molecular domestication’ has been observed for both 
major classes of TEs, the retrotransposons and the DNA transposons. Exaptation is a 
general term that describes an evolutionary event whereby any organismic feature takes 
on a functional role that is distinct from the function to which it was originally adapted 
(GOULD and VRBA 1982). Molecular domestication is defined as the process whereby a 
formerly selfish or parasitic TE is co-opted (exapted) to perform a function that benefits 
its host genome (MILLER et al. 1992). Approximately 50–100 protein-coding genes in 
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mammalian genomes evolved from coding sequences of TEs through these processes 
(BRANDT et al. 2005b; CAMPILLOS et al. 2006; KAPITONOV and JURKA 2004; KAPITONOV 
and JURKA 2005; KAPITONOV et al. 2004; LANDER et al. 2001; VOLFF 2006) (Table 1.2).  
Interestingly, most of these genes were derived from TE transposases.  
There are several well known cases of TE-derived CDS. The RAG1, which 
catalyzes the V(D)J recombination necessary for the assembly of immunoglobulin and T-
cell-receptor genes in developing lymphocytes (SCHATZ et al. 1989; TONEGAWA 1983), is 
probably the most ancient known host protein derived from a transposase of DNA-type 
elements (KAPITONOV and JURKA 2004; KAPITONOV and JURKA 2005). The telomerase 
enzyme, a reverse transcriptase involved in the replication of telomeres had its origin 
from the reverse transcriptase of a retrotransposable element (EICKBUSH 1997; 
NAKAMURA et al. 1997). Other well-characterized examples include the centromere 
binding protein CENP-B, which is related to pogo-like DNA transposases (KIPLING and 
WARBURTON 1997).   
TEs insert into an ORF by two possible mechanisms: directly by transposition 
into an exon or indirectly by recruiting an intronic TE. It appears that the latter scenario 
of splice-mediated insertion of an intronic element is the major mechanism by which TEs 
are introduced into CDS (NEKRUTENKO and LI 2001). The underlying mechanisms of the 
TE insertion into the ORF of a host gene were discussed in detail previously 
(MAKALOWSKI 1995; MAKALOWSKI et al. 1994). The exonization process is facilitated by 
sequence motifs that resemble splice sites (pseudo splice sites), mostly found in the 
minus strand of Alu elements (MAKALOWSKI 2000; MAKALOWSKI et al. 1994; SOREK et 
al. 2002).  
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Although a number of TE sequences that have been domesticated to provide host 
CDSs have been identified, the actual proportion of host CDSs that were derived from 
TEs is still a matter of controversy. A number of large-scale analyses have been made in 
an attempt to exhaustively characterize instances of TE-derived host CDS (BRITTEN 
2006; JURKA and KAPITONOV 1999; LANDER et al. 2001; NEKRUTENKO and LI 2001; 
SMIT 1999). Before the availability of complete human genome sequence, 20 cases of 
human CDSs derived from TEs were identified (JURKA and KAPITONOV 1999; SMIT 
1999). Later, investigation of the draft sequence of the human genome found 47 cases 
including previously discovered ones, accounting for a total of 0.16% of human genes 
(LANDER et al. 2001). In the same year, Nekrutenko and Li, analyzed about 14,000 
protein coding genes using similar techniques and reported that ~4% of analyzed human 
genes had a TE sequence present within a CDS (NEKRUTENKO and LI 2001). However, 
no evidence of TE-derived sequences was found when the same detection program was 
applied to a more reliable data set with supported evidence of protein expression and 
function based on 3D structures (PAVLICEK et al. 2002). Although a more sensitive 
technique did found some cases of TE-derived CDS, but none of these were from Alu 
elements, which lack protein coding capacity. Indeed, the actual protein coding potential 
of these non-coding TE sequences is still a matter of speculation. Most of well-supported 
cases of TE-derived host CDSs come from TEs that already encode proteins. Recently, 
protein sequence comparisons have been shown to be more sensitive than DNA 
comparison used in previous studies for detection of TE-derived host CDSs.  For 
instance, protein sequence similarity searches were shown to detect more than twice as 
many cases of TE-derived CDS than DNA sequence similarity based search techniques in 
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one recent study (BRITTEN 2006). In general, the contradictory results obtained from 
these previous studies emphasize the differences in sensitivity and specificity for each of 
the search methods used. In any case, an exhaustive elucidation of the extent and 
significance of TE-derived host CDSs will be important for better understanding of the 
evolutionary dynamic between TEs and their host genomes.  
 
 
Table 1.2: Protein-coding host genes domesticated from TEs [information from 
(VOLFF 2006)] 
 
Table 1.2 continued    
Gene  Protein  functions TE gene Organisms References 
Syncytin-1 membrane glycoprotein, 
cell fusion, placenta 
formation 
envelope human (MI et al. 2000) 
Syncytin-2 membrane glycoprotein, 
cell fusion, placenta 
formation 
envelope human (BLAISE et al. 
2003) 
Syncytin-A/B membrane glycoprotein, 
cell fusion, placenta 
formation 




unknown envelope mammals (BLAISE et al. 
2005) 
Iris defence against viruses? envelope Drosophila (MALIK and 
HENIKOFF 2005) 
Iris-like defence against viruses? envelope mosquitoes (MALIK and 
HENIKOFF 2005) 
Peg10/ Mart2 cell proliferation, 
transcription factor?, 
placenta formation 
gag mammals (ONO et al. 2006) 
Ldoc1/ Mart7 inhibition of NF-kappaB 
activation, induction of 
apoptosis 




unknown gag mammals (BRANDT et al. 




SEITZ et al. 2003; 
YOUNGSON et al. 
2005) 
Map-1/ Ma1 Bax-associating protein, 
induction of apoptosis 
gag mammals (DALMAU et al. 




neuronal autoantigens in 
paraneoplastic neurological 
diseases 
gag mammals (SCHULLER et al. 
2005; WILLS et al. 
2006) 
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Table 1.2 continued    
Gene  Protein  functions TE gene Organisms References 
Fv1 murine leukemia virus 
restriction 
gag mouse (BEST et al. 1996) 
Gin-1 unknown integrase mammals (LLORENS and 
MARIN 2001) 
c-integrase unknown integrase/ 
transposase 
mammals (FESCHOTTE and 
PRITHAM 2005; 
GAO and VOYTAS 
2005) 
Fob1p replication terminator 
protein, rDNA metabolism 
integrase/ 
transposase 
baker’s yeast (DLAKIC 2002; 
FESCHOTTE and 
PRITHAM 2005; 
GAO and VOYTAS 
2005) 





eukaryotes (LINGNER et al. 
1997; NAKAMURA 
et al. 1997) 
Rag1 nuclease, V(D)J 
recombination, adaptive 
immune system 
transposase vertebrates (AGRAWAL et al. 
1998; HIOM et al. 
1998; KAPITONOV 
and JURKA 2005; 
ZHOU et al. 2004) 
Daysleeper DNA binding protein, gene 
regulation, plant 
development 
transposase Arabidopsis (BUNDOCK and 
HOOYKAAS 2005) 
Gary unknown transposase cereal grasses (MUEHLBAUER et 
al. 2006) 
Tram unknown transposase mammals (ESPOSITO et al. 
1999) 
Zbed4 unknown transposase mammals (SMIT 1999) 
KIAA0543 unknown transposase mammals (SMIT 1999) 
P52rIPK binding to inhibitor of 
interferon-induced protein 
kinase PKR 
transposase mammals (GALE et al. 1998) 
Buster1-3 unknown transposase mammals (SMIT 1999) 
Dref transcription factor, 
regulation of DNA 
replication 
transposase Drosophila (ROBERTSON 2002) 
Lin-15B regulator of vulval 
development 
transposase Caenorhabditis (ROBERTSON 2002) 
Cenp-b DNA binding protein, 
centromere function 
transposase eukaryotes (SMIT and RIGGS 
1996) 
Pdc2/Rag3 transcription factor, 
regulation of pyruvate 
utilization 
transposase yeast (HOHMANN 1993) 
Jerky neuron mRNA-binding 
protein, mutated in 
epilepsy syndromes 
transposase mammals (TOTH et al. 1995) 
Jerky-like unknown transposase mammals (ZENG et al. 1997) 
KIAA0461 unknown transposase mammals (SMIT 1999) 
Tigger-derived unknown transposase mammals (ROBERTSON 2002) 
Metnase DNA integration, radiation 
resistance, DNA break 
repair 
transposase human (LEE et al. 2005) 
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Table 1.2 continued    
Gene  Protein  functions TE gene Organisms References 
P-derived DNA binding protein transposase Drosophila (PINSKER et al. 
2001; REISS et al. 
2005) 
Phsa/Pgga unknown transposase mammals, birds (HAMMER et al. 
2005) 
Pgbd1-4 unknown transposase human (SARKAR et al. 
2003) 
Pgbd5 unknown transposase bony 
vertebrates 
(SARKAR et al. 
2003) 




Fhy3, Far1 transcription factors, 
sensitivity to far-red light 
transposase Arabidopsis (HUDSON et al. 
2003) 
Mustang unknown transposase flowering 
plants 




Impact of transposable elements on the evolution of host gene regulation 
The ability of TEs to alter the regulation and expression patterns of host genes is 
well-documented (BI et al. 1997; DUNN et al. 2003; JORDAN et al. 2003; LANDRY et al. 
2002; MEDSTRAND et al. 2001; VAN DE LAGEMAAT et al. 2003) and has been discussed in 
a number of reviews (BROSIUS 1999; HAMDI et al. 2000; KIDWELL and LISCH 1997; 
KIDWELL and LISCH 2001; TOMILIN 1999). TE sequences are saturated by transcription 
factor binding sites and serve as transcriptional promoters, enhancers or silencers for 
nearby genes (BANVILLE and BOIE 1989; BRITTEN 1997; BROSIUS 1999; FRIESEN et al. 
1986; HEWITT et al. 1995; KAZAKOV and TOMILIN 1996; YANG et al. 1998) (Table 1.3). 
Retroelements can also act as alternative promoters (MEDSTRAND et al. 2001), 
bidirectional promoters (DOMANSKY et al. 2000) or may compete with gene promoters 
for the binding of transcription factors (CONTE et al. 2002). Many intriguing cases where 
TE-derived promoters contribute to tissue-specific gene expression were shown (VAN DE 
LAGEMAAT et al. 2003). For instance, many LTR promoters and enhancers are active 
primarily in the placenta (BANVILLE and BOIE 1989; BI et al. 1997; BIECHE et al. 2003; 
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CHANG-YEH et al. 1991; LANDRY et al. 2002; MEDSTRAND et al. 2001; SCHULTE et al. 
1996). In addition to 3’ UTR AU-rich elements that regulate mRNA stability (BRITTEN 
2006), retroposons such as Alu can provide polyadenylation signals to host genes. Some 
Alu insertions contain transcriptional regulatory sequences, such as a retinoic-acid-
response element (VANSANT and REYNOLDS 1995). Both LTR and other TEs contain 
potential hormone-responsive sites (BABICH et al. 1999; RAMAKRISHNAN and ROBINS 
1997) which have been implicated in hormone-dependent regulation of several human 
genes (NORRIS et al. 1995; VANSANT and REYNOLDS 1995). Furthermore, TEs can 
control genes epigenetically when inserted within or very close to the genes (LIPPMAN et 
al. 2004) by two mechanisms: directly by inducing the methylation (and therefore 
silencing) of neighboring DNA and indirectly by disrupting the normal epigenetic state of 
a nearby gene.   
 
Table 1.3: Vertebrate regulatory elements generated by TEs [information from 
(BROSIUS 1999; MEDSTRAND et al. 2005)] 
 
Table 1.3 continued    
TE Gene Organism Function References 
Alu θ1 globin Higher 
primates 
CCAAT box of 
promoter 
(KIM et al. 
1989) 





























(ARONOW et al. 
1992) 
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Table 1.3 continued    







Alu SV40 origin Human Transcriptional 
enhancer 
(SAEGUSA et al. 
1993) 
Alu CD8α Human Transcriptional 
enhancer 
(HAMBOR et al. 
1993) 





















Alu ε-globin Human Transcriptional 
modulation 
(WU et al. 1990)
Alu c-myc Human Transcriptional 
modulation 
(TOMILIN et al. 
1990) 














(OEI et al. 1997; 
SCHWEIGER et 
al. 1995) 
Alu FcεRI-γ Human Transcriptional 
regulation (positive 
and negative) 
(BRINI et al. 
1993) 





(SELL et al. 
1992) 





(HEWITT et al. 
1995) 




Alu PAX6 Human Transcription factor 
binding site 
(ZHOU et al. 
2002) 
B1 Immunoglobulin 
κ light chain 
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Table 1.3 continued    
TE Gene Organism Function References 
B2 MOK-2 zinc-
finger protein 
Mouse Exerts a negative cis-
acting effect on 
MOK-2 promoter 
activity 







Mouse Reduces expression 
rate to 1/10 of non-
H-2k mice 
(ZHENG et al. 
1992) 




(KRESS et al. 
1984) 
B2 B2+ mRNAx Mouse Polyadenylation 
signal 























Human Promoter (EMI et al. 1988; 
SAMUELSON et 
al. 1990; TING 

















(YANG et al. 
1998) 
L1 Insulin I gene Rat Transcriptional 
silencer 
(LAIMINS et al. 
1986) 








LTR Leptin Human Placental enhancer (BI et al. 1997) 
LTR cDNA 7, cDNAγ Human Polyadenylation 
signal 
(PAULSON et al. 
1987) 




LTR cH-6 Human Polyadenylation 
signal 
(MAGER 1989) 
          
                                                                                                                                                                        
 15
Table 1.3 continued    
TE Gene Organism Function References 
LTR cH-7 Human Polyadenylation 
signal 
(MAGER 1989) 
LTR cPB-3 Human Polyadenylation 
signal 
(MAGER 1989)  
LTR carbonic 








Human  Trophoblast-specific  
promoter  




LTR Mid1 Human Tissue-specific 
promoter (fetal 
kidney and placenta) 
(LANDRY et al. 
2002) 
LTR pleiotrophin Human Tissue-specific 
promoter (placenta) 






(BIECHE et al. 
2003) 
LTR Oncomodulin Rat Promoter (BANVILLE and 
BOIE 1989) 
LTR MIPP Mouse Promoter (CHANG-YEH et 
al. 1991) 
LTR AF-3 Human Promoter (FEUCHTER et 
al. 1992) 
LTR AF-4 (CDC4L 
homology) 






MURTHY et al. 
1993) 
LTR Calibindin D28K Human Promoter (LIU and 
ABRAHAM 
1991) 
LTR ZNF80 zinc 
finger gene 
Human Promoter (DI CRISTOFANO 
et al. 1995) 






Human Promoter (DUNN et al. 
2003) 
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Table 1.3 continued    
TE Gene Organism Function References 
LTR Sex-limited 
protein (slp) 
Mouse Promoter  (RAMAKRISHNA
















Human cis-acting element (CHEN et al. 
2002) 





Human Promoter  (VAN DE 
LAGEMAAT et 
al. 2003) 
LTR locus control 
region in the 
human ß-globin 
gene cluster 
Human Promoter (PLANT et al. 
2001) 





























Two recent studies have estimated the impact of TEs on host gene regulation on a 
genome-wide scale. 25% of all known human genes (JORDAN et al. 2003; VAN DE 
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LAGEMAAT et al. 2003) and mouse genes (VAN DE LAGEMAAT et al. 2003) contain TEs 
within their UTR and/or promoter regions. Approximately 8% of all proximal promoter 
regions and 2.5% of known transcription factor binding sites of human genes were 
located within a TE (JORDAN et al. 2003). Besides these cis-regulating effects, more than 
50% of scaffold/matrix attachment regions (S/MARs) are made up of TEs (JORDAN et al. 
2003). These results suggested that TEs may have a substantial impact on the evolution 
of human gene regulation, as was first hypothesized by Britten and Davidson (BRITTEN 
and DAVIDSON 1969), before the connection between TEs and repetitive DNA was 
established. 
 Due to the variety of TE functions related to gene regulation, there is a large 
possibility that more are still uncovered. As recently emphasized, the majority of human 
transcripts do not encode proteins (CLAVERIE 2005). These non-coding RNA (ncRNA) 
can function directly as structural, catalytic or regulatory RNAs (MATTICK and MAKUNIN 
2006). Several different systematic investigations have recently identified an 
unexpectedly large number of ncRNA genes which can potentially be the large source of 
novel gene regulators (HUTTENHOFER and VOGEL 2006; MARKER et al. 2002; STORZ 
2002; WASHIETL et al. 2005a; WASHIETL et al. 2005b; WASSARMAN et al. 2001). The 
availability of these new data opens the opportunity for exploring the relationship 
between non-coding regulatory genes and TEs. 
Introduction to microRNAs (miRNAs) and small interfering RNAs (siRNAs) 
 Currently, considerable evidence indicates that small noncoding RNAs can play a 
major role in regulating gene expression in eukaryotes (CULLEN 2002; HUTVAGNER and 
ZAMORE 2002b). Of particular interest are a class of ~22-nt RNAs that can be divided 
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into small interfering RNAs (siRNAs) and microRNAs (miRNAs) (AMBROS et al. 2003). 
siRNAs are derived from long, double-stranded RNAs which are processed into shorter 
duplexes by Dicer ribonuclease (BERNSTEIN et al. 2001; KNIGHT and BASS 2001), and 
then one strand of the duplex is incorporated into RNA induced silencing complex 
(RISC) (AMBROS et al. 2003; MARTINEZ et al. 2002; SCHWARZ et al. 2002). The siRNA 
component guides RISC to mRNA molecules containing a homologous antisense 
sequence, resulting in degradation of that mRNA (MARTINEZ et al. 2002; SCHWARZ et al. 
2002). This process is termed RNA interference (RNAi) (FIRE et al. 1998) which is 
thought to have originally evolved to silence viruses and TEs (BUCHON and VAURY 
2006). 
Similar to siRNAs, miRNAs are ~22nt single-stranded noncoding RNAs that 
regulate the expression of complementary mRNAs (BARTEL 2004). In contrast to 
siRNAs, miRNAs are derived by processing of a ~70-nt RNA stem–loop (hairpin) 
structure termed a pre-miRNAs (AMBROS et al. 2003; LAGOS-QUINTANA et al. 2001; LAU 
et al. 2001; LEE and AMBROS 2001). In animals, pre-miRNAs are transcribed as longer 
primary transcripts (pri-miRNAs) that are processed by Drosha in the nucleus into 
compact, folded structures (pre-miRNAs), then exported to the cytoplasm, where they are 
cleaved by Dicer to yield mature miRNAs (LEE et al. 2002) and are incorporated into a 
ribonucleoprotein complex (MOURELATOS et al. 2002). 
As regulators of gene expression, miRNAs can work by basically two modes 
(DOENCH et al. 2003; HUTVAGNER and ZAMORE 2002a; RHOADES et al. 2002; TANG et 
al. 2003; ZENG et al. 2003). miRNAs can act through translational repression of their 
target mRNAs and may also cause mRNA degradation of their target genes via an RNAi-
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like mechanism (HUTVAGNER and ZAMORE 2002a; LLAVE et al. 2002; YEKTA et al. 2004; 
ZENG et al. 2003). Recently, anti-correlated expression patterns between miRNA 
sequences and their target mRNAs have provided evidence in favor of the mRNA 
degradation model (HUANG et al. 2006). Hundreds of miRNA genes have been found in 
animals, and the majority of these are phylogenetically conserved (AMBROS 2004). Their 
importance is supported by the many biological processes in which they are participated, 
including developmental timing, cell proliferation, apoptosis, metabolism, cell 
differentiation, and morphogenesis (ALVAREZ-GARCIA and MISKA 2005; AMBROS 2004). 
One previously recognized distinction between miRNAs and siRNAs is that 
miRNAs are usually found in introns and intergenic regions (BARTEL 2004), while 
siRNAs originate from within genes and TEs (MATZKE et al. 2000; SLOTKIN et al. 2005; 
VASTENHOUW and PLASTERK 2004). Interestingly, the relationship to TEs has been 
pointed out as a discrepancy between miRNAs and siRNAs, which are closely related in 
terms of structure, function, and biogenesis. A major goal of my dissertation research was 
to address whether or not the TE-based distinction between siRNAs and miRNAs was 
justified and valid. miRNAs are estimated to comprise 1%–5% of animal genes (BARTEL 
2004; BENTWICH et al. 2005; BEREZIKOV et al. 2005), making them one of the most 
abundant classes of regulators. The growing number of annotated miRNA genes, 
enhanced by advanced experimental techniques and new detection programs, has 
provided an opportunity to explore the relationship between TEs and evolution of these 
new regulatory elements as well as the possibility of an evolutionary connection between 
siRNAs and miRNAs through TEs.   
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Analysis of origin and evolution of gene sequences derived from TEs 
This dissertation focuses exclusively on eukaryotic TEs, with an emphasis on 
human TEs that have contributed to the evolution of protein coding sequences 
(CHAPTER 2 and 3) and non-coding regulatory RNAs (CHAPTER 4, 5 and 6). 
CHAPTER 2 presents a detailed analysis of exonization events of LTR elements 
in the human genome. The distribution patterns of LTR retrotransposon sequences in 
human exons were determined. Using new experimental data, the evolutionary history of 
the exonization process of an alternatively spliced exon of IL22RA2 was reconstructed.  
CHAPTER 3 illustrates the ability of different classes of sequence similarity 
search methods to detect TE-derived sequences in experimentally characterized proteins. 
The ascertainment biases related to these search methods were evaluated. The 
probabilistic analysis of TE-derived exon sequences was applied to determine the 
potential of TEs, particularly non-coding TEs, to contribute protein coding sequences to 
human genome.  
CHAPTER 4 determines the extent of TE contributions to human miRNA genes 
along with the evolutionary dynamics of TE-derived human miRNAs. The potential 
regulatory and functional significance of TE-derived miRNAs was explored by 
combining information on miRNA target site prediction, expression data for miRNA-
mRNApairs, and gene functional annotations. An ab initio prediction algorithm I 
developed was used to discover putative cases of novel TE-derived miRNA genes.  
CHAPTER 5 demonstrates the investigation of a recently discovered family of 
human miRNA genes, hsa-mir-548, which was found in this study to be derived from 
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Made1 TEs. The analysis of hsa-mir-548 target genes in terms of gene expression and 
functional affinities indicates a potential role for this miRNA family in cancer. 
CHAPTER 6 proposes a specific model whereby miRNAs encoded from short 
non-autonomous DNA-type TEs, known as MITEs, evolved from corresponding 
ancestral autonomous elements that originally encoded siRNAs. A computational 
analysis of genome sequences, annotation and expression data from the plants 
Arabidopsis thaliana and Oryza sativa (rice) was performed to predict the dual coding 
siRNA-miRNA TEs, which represent evolutionary intermediates in the transition from 
siRNAs to miRNAs.  
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CHAPTER 2 
EXONIZATION OF THE LTR TRANSPOSABLE ELEMENTS  




Retrotransposons have been shown to contribute to evolution of both structure 
and regulation of protein coding genes. It has been postulated that the primary 
mechanism by which retrotransposons contribute to structural gene evolution is through 
insertion into an intron or a gene flanking region, and subsequent incorporation into an 
exon.  
Results 
We found that Long Terminal Repeat (LTR) retrotransposons are associated with 
1,057 human genes (5.8%). In 256 cases LTR retrotransposons were observed in protein-
coding regions, while 50 distinct protein coding exons in 45 genes were comprised 
exclusively of LTR RetroTransposon Sequence (LRTS). We go on to reconstruct the 
evolutionary history of an alternatively spliced exon of the Interleukin 22 receptor, alpha 
2 gene (IL22RA2) derived from a sequence of retrotransposon of the Mammalian 
apparent LTR retrotransposons (MaLR) family. Sequencing and analysis of the 
homologous regions of genomes of several primates indicate that the LTR 
retrotransposon was inserted into the IL22RA2 gene at least prior to the divergence of 
Apes and Old World monkeys from a common ancestor (∼ 25 MYA). We hypothesize 
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that the recruitment of the part of LTR as a novel exon in great ape species occurred prior 
to the divergence of orangutans and humans from a common ancestor (∼ 14 MYA) as a 
result of a single mutation in the proto-splice site. 
Conclusions 
Our analysis of LRTS exonization events has shown that the patterns of LRTS 
distribution in human exons support the hypothesis that LRTS played a significant role in 
human gene evolution by providing cis-regulatory sequences; direct incorporation of 
LTR sequences into protein coding regions was observed less frequently. Combination of 
computational and experimental approaches used for tracing the history of the LTR 
exonization process of IL22RA2 gene presents a promising strategy that could facilitate 
further studies of transposon initiated gene evolution. 
INTRODUCTION 
Retrotransposon sequences comprise more than 40 % of the human genome 
(JASINSKA and KRZYZOSIAK 2004; LANDER et al. 2001). Once dismissed as “junk DNA” 
of little or no adaptive significance (DOOLITTLE and SAPIENZA 1980; OHNO 1972), 
retrotransposons and other classes of transposable elements (TEs) are now generally 
considered as significant contributors to gene and genome evolution (BROSIUS 1999; 
BROSIUS and GOULD 1992; KAZAZIAN 2004; KIDWELL and LISCH 2001; MAKALOWSKI 
2003). Of particular interest has been the ability of TEs to contribute to exon evolution by 
“exonization”, i.e., an insertion of a TE into an intron and subsequent recruitment of this 
sequence or its part into a new protein-coding exon (NEKRUTENKO and LI 2001). For 
example, it has been estimated that 5% of all alternatively spliced human exons had been 
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derived from the exonization of Alu elements (DAGAN et al. 2004; MAKALOWSKI et al. 
1994; SOREK et al. 2002).   
LTR transposable elements comprise nearly one-tenth of the human genome and 
have been implicated in the cis-regulatory evolution of a number of human genes (BI et 
al. 1997; BROSIUS 1999; BROSIUS and GOULD 1992; DUNN et al. 2003; LANDRY et al. 
2002; MEDSTRAND et al. 2001; VAN DE LAGEMAAT et al. 2003). The structure of a 
complete LTR retrotransposon (autonomous mobile element) comprises two copies of 
long terminal directed repeats (LTRs) flanking an internal region containing gag and pol 
genes, which encode a protease, reverse transcriptase, RNase H and integrase. These 
protein products are necessary for the formation of virus-like particles (VLPs) wherein 
replication of the element takes place. Some elements evolved from retroviruses have 
additional open reading frames (ORFs), e.g. env gene (LANDER et al. 2001; SEMIN and 
IL'IN IU 2005). Flanking LTRs contain all the necessary transcriptional regulatory 
elements.   
Although global database screens have been conducted to examine the 
contribution of TEs to human protein-coding regions (BRITTEN 2006; LORENC and 
MAKALOWSKI 2003; NEKRUTENKO and LI 2001), none have concentrated specifically on 
the prevalence of the LRTS-derived protein-coding exons of human genes. Here we 
report the results of computational analysis of the LRTS exonization in human genome. 
Also we describe the plausible scenario of the exonization process of an alternatively 
spliced exon of the alpha 2 gene of the Interleukin 22 receptor (IL22RA2) supported by 
new experimental data. 
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RESULTS AND DISCUSSION 
Updated list of LRTS-associated genes 
 To identify incidences of LRTS exonization, the annotation of human exons 
given in the UCSC genome browser was compared with the annotation of transposable 
elements available in the same source. We detected LRTS associations in 1,057 out of 
18,241 genes (5.8 %). These associations include 1,249 distinct exons participating in 
1,287 transcripts (note that a particular exon is counted once though it may participate in 
several alternative transcripts). It was reported earlier (NEKRUTENKO and LI 2001) that 
130 out of 13,799 human genes (0.9 %) were found to contain LRTS in protein coding 
regions. In comparison, in our data set (18,241 genes/23,821 transcripts) we observed 
LRTS associations with protein-coding exons in 256 genes (1.4 %). Current LRTS search 
done at the DNA instead of mRNA level helped detect several short LRTS-exon overlaps 
that could be missed at mRNA level. Interestingly, only 53 of the previously reported 130 
cases were found in current analysis using the updated RefSeq gene data. Many 
previously identified cases (61 cases) did not show up in our data set as the earlier 
sequences were removed, suppressed, or replaced. Several cases appear to be possible 
false positives. In one case, LRTS was detected in UTR instead of in CDS. No LRTS was 
detected in other two cases when the RepeatMasker program was run separately on each 
mRNA sequence using its specific G+C content, which gives a slightly more accurate 
result, as opposed to input of multiple sequences with averaged G+C content used in the 
program (http://biowulf.nih.gov/apps/repeatmasker/repeatmasker_help.txt). 
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Distribution of LRTS in human exons 
We found that human gene exons (either protein-coding or non-coding) overlap 
with LTR flanks of LTR elements more frequently (1,074 cases) than with internal 
sequences (242 cases; note that exons overlaped with both regions were counted twice). 
This observation could be related to the fact that most (85%) of the LTR retroposon-
derived sequences in human genome consist only of a solo LTR, with the internal 
sequence lost due to homologous recombination between the flanking LTRs (LANDER et 
al. 2001). Upon checking by BLASTX of 242 exons overlapping with the internal 
sequences, 61 exons were found to contain a section or even a whole viral gene (i.e. gag, 
pol, and env). However, only 20 of these 61 exons were protein-coding exons. Moreover, 
only in 10 cases was the reading frame of a human gene the same as the one of the viral 
gene. Seven out of these ten cases were observed in hypothetical genes. The remaining 
three cases represented a gene for endogenous retroviral protein, syncytin (ERVWE1), a 
gene for Krueppel-related zinc finger protein (H-plk) and a placenta-specific gene 
(PLAC4) which protein products contain the envelope, envelope and gag viral protein 
domain, respectively. All three genes are preferentially expressed in the placenta (BLOND 
et al. 1999; KATO et al. 1990; KIDO et al. 1993). This observation indicates that the 
invasion of the Human Endogenous Retrovirus (HERV) may contribute to molecular 
mechanisms involved in human reproduction (MUIR et al. 2004). 
The majority of exons overlapping with LRTS (1,123 of 1,249) contain sequences 
homologous to only one LRTS. Exons overlapping with more than one LRTS were 
observed as well (Table 2.1). Overall, we have found 1,395 associations (overlaps) 
between an LRTS and an exonic sequence. These 1,395 observations were classified 
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further according to the extent of LRTS overlap with an exon (Table 2.2), type of exon 
(Table 2.3), and LRTS class/family (Table 2.4). The majority of LRTS associations with 
genes (586/1395 or 42 %) constitute an apparent extension of original exon due to 
activation of alternative splice site located inside LRTS. On the other hand, in 22.9% 
(319/1395) of these associations LRTS was recruited as an entirely novel exon (Table 
2.2).  
Regarding the distribution of LRTS within a complete gene structure (5’UTR, 
first CDS exon, internal protein coding exons, last CDS exon, 3’UTR), the LRTS 
fragments were found in untranslated regions (UTRs), mainly in 3’UTRs, much more 
frequently than in protein-coding (CDS) regions. This observation is consistent with the 
previous study (JORDAN et al. 2003) and indicates the putative role of LRTS in resident 
gene regulation by providing sequence material for emerging regulatory sequences 
(BROSIUS 1999; MEDSTRAND et al. 2001). In comparison, insertion of LRTS in a protein 
coding region may interfere with gene function, and in many cases such a modification is 
likely to be eliminated by negative selection. Note that an LRTS was found more 
frequently in the last CDS exon, especially in the exon untranslated region, and less 
frequently in internal coding exons (Table 2.3). 
 
 
Table 2.1: The distribution of the number of LTR elements (either partial or full 
elements) containing in an exon 
 
number of LTR elements 
overlaps with an exon 
number of exons number of 
associations 
1 1123 1123 
2   108   216 
3    16     48 
4      2      8 
Total 1249 1395 
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Table 2.2: The distribution of the extent of overlap between an exon and an LTR 
element 
 
extent of LRTS overlap number of 
associations 
An LRTS completely covers an exon  319 
An LRTS partially overlaps (5’ or 3’ boundaries) with an exon 586 
An LRTS is situated within an exon 490 
Total            1395  
    
 
 
Table 2.3: The distribution of type of exons containing LRTS                                  
exon type number of associations 
5’UTR exon 245 
3’UTR exon 196 




(41 in the 5’UTR, 8 in the CDS region 
and 78 span both regions) 
Last CDS exon  571 
(484 in the 3’UTR, 16 in the CDS 
region and 71 span both regions) 
Single protein coding exon 152 
(17 in the 5’UTR, 97 in the 3’UTR, 
11 in the CDS region and 27 span 
both UTR and CDS regions) 
Internal protein coding exon 72 
More than one type of exon (for a 
particular exonic sequence) 
32 




Table 2.4: The distribution of class/family of LRTS containing in an exon 
LRTS class/ family number of associations 
ERV1 513 
ERVK   58 
ERVL  249 
MaLR  575 
Total                    1395 
 
 
          
                                                                                                                                                                        
 29
LRTS-derived protein coding exons 
We have found 50 protein coding exons completely derived from LRTS (41 
internal, 2 initial, 4 terminal coding exons and 3 single coding exons (Table A.1). Most of 
LRTS-derived exons (36/50) were comprised exclusively of LTR flanking regions. 
Eleven exons were derived from LTR element internal sequences and 3 exons contained 
both types of regions. Of the 50 exons, 38 were components of well characterized protein 
coding genes (i.e., genes with the corresponding mRNAs available in GenBank and with 
encoded proteins listed in SWISS-PROT, TrEMBL, and TrEMBL-NEW).   
The low frequency of protein coding exons fully derived from LRTS indicates 
that the chance of a successful recruitment of a whole coding exon from the LTR 
transposable element is rather small. The exonization of originally intronic LRTS 
requires the presence of a pair of potential splice sites, enclosing a sequence with no stop 
codon in the appropriate reading frame. Also, the amino acids contributed by a mobile 
element should not disrupt the structure of a protein encoded by the original gene, 
particularly, the addition of a new exon should not change the coding frame for the 
remaining part of a gene.  
Interestingly, most of the protein coding exons derived entirely from the LTR 
flanking regions originated from the MaLR family (24 out of 36). This could be 
explained by several factors. First of all, MaLR elements make up about 50% of the LTR 
retroelements in the human genome (LANDER et al. 2001), and this high frequency alone 
may relate to their over-representation in protein coding exons. MaLRs are also relatively 
ancient elements, which have probably been exposed to more opportunities for 
exonizations over time. Note that the age factor has been implicated for proliferation of 
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Alu-derived exons as well (SOREK et al. 2002). Finally, it is a formal possibility that 
nucleotide sequences of the MaLR family are better amenable for derivation of protein 
coding exons. The internal sequence of MaLR is rarely found retained in the human 
genomic sequence (SMIT 1993). Particularly, among exons derived from the internal parts 
of LRTS only one was from the MaLR family. 
Contribution of LRTS to gene transcripts 
We further analyzed the abundance of LRTS-derived exons in gene transcripts. 
Most of the 275 genes containing at least one exon completely derived from LRTS (201 
out of 275) are single transcript genes while the remaining 74 generate more than one 
transcript per gene. Note that about 60% (121/201) of single transcript genes encode zinc 
finger proteins (25%) or hypothetical proteins (35%). Apparently for the single transcript 
gene the LRTS insertion either has not disrupted the host gene function or possibly 
provided some beneficial modulation of the initial function and thus has been tolerated by 
natural selection.  
In 55 out of 74 genes (74.3%) with multiple transcripts, LRTS-derived exons 
were present in some transcript variants, but not in all of them. This observation 
corresponds to the scenario whereby recruiting of LRTS into alternatively spliced exon 
allows the main transcript to maintain the function while the LRTS-associated exons are 
“examined” by natural selection, which may lead to emergence of transcripts with new 
functions.  
We also found that most of the LRTS-derived protein coding exons (48/50) were 
either alternatively spliced ones or the components of single transcript genes. In contrast, 
most of LRTS derived constitutive exons (those that are present in all alternative 
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transcripts) are found in 5’ UTR sequences. This observation indicates that novel cis-
regulatory sequences supplied by LTR elements to human genes are more likely to be 
fixed in evolution than sequences supplying protein coding domain which are used as 
alternative ways to create protein variability.  
Reconstruction of evolution of IL22RA2 gene (transcript variant 1) 
The IL22RA2 gene has an internal protein coding exon derived from an LTR 
flanking sequence. This gene encodes the only soluble receptor (WEISS et al. 2004) in the 
class II cytokine receptor family (CRF2). IL22RA2 protein specifically binds to 
interleukin 22 (IL22) and by preventing the interaction of IL22 with its cell surface 
receptor, neutralizes IL22 activity (DUMOUTIER et al. 2001; KOTENKO et al. 2001; XU et 
al. 2001). Three alternatively spliced transcripts of the IL22RA2 human gene encoding 
three protein variants (263, 231 and 130 amino acids in length) have been described 
earlier (KOTENKO et al. 2001). The longest transcript (variant 1) is generated (Figure 2.1) 
by addition of the 96 nt exon (exon 3/4) to splice variant 2 between exon 3 and exon 4 
(DUMOUTIER et al. 2001; GRUENBERG et al. 2001; KOTENKO et al. 2001).   
In the current study, we provide experimental data and computational analysis 
that show evolutionary evidence of exonization of LRTS invaded the human IL22RA2 
gene. The exon 3/4 of the IL22RA2 gene (transcript variant 1) is situated within the LTR 
sequence of MSTB2 subfamily of MaLR family (found in the same orientation as the 
coding sequence (Figure 2.1)). The sequence alignment of the particular LTR and the 
MSTB2 LTR consensus sequence shows 82.8 % identity (for ungapped part of the 431 nt 
long alignment). The exon 3/4 contributes 32 amino acids to the IL22RA2 protein 
product without changing reading frame for the rest of the protein. A homologous exon 
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was not found either in the mouse or in the rat orthologous gene. Weiss et al. 2004 
(WEISS et al. 2004) also indicated that a counterpart of this exon was absent in mouse and 
rat. The functionality of the LTR exonization is corroborated by the existence of the 
mRNA sequences containing the exon 3/4 [RefSeq: NM_052962, GenBank: AY040567, 
AY358737, EMBL: AJ313162]. The data available at the UCSC genome browser show 
that the MSTB2 derived sequence is conserved in chimpanzee and rhesus monkey while 
is absent in other vertebrates. To extract the sequences homologous to the exon 3/4 in 
seven primates: human, chimpanzee, bonobo, gorilla, orangutan, crab-eating macaque 
and rhesus monkey, we have performed the PCRs with human DNA derived primers (see 
methods), which generated well interpretable PCR products for all species (Figure 2.2). 
We used newly determined PCR product sequences as well as publicly available genomic 
sequences of human, chimpanzee and rhesus monkey to construct the multiple sequence 
alignment. We observed that the splice sites flanking the target exon in all species but the 
crab-eating macaque and the rhesus monkey followed the GT/AG rule. In the other two 
species, we observed AT instead of GT at the donor site (Figure 2.3). Therefore, 
emergence of this exon was likely to occur in ape lineage earlier than the divergence of 
orangutans and humans (Figure 2.4). This event was mediated by the single transition 
from A to G yielding canonical donor splice site consensus. Note that AT (or GT in other 
cases) is positioned in the predicted LTR polyadenylation site AATAAA (Figure 2.3). 
Contrary to the acceptor site, the strength of the donor site depends on the presence of 
just a few specific nucleotides around GT consensus. Therefore, a single mutation might 
create a functional donor splice site. The canonical dinucleotide (AG) of the acceptor site 
appeared in all primates we have studied. However, this dinucleotide is different from 
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dinucleotide (GC) situated in the same position in MSTB2 consensus sequence (Figure 
2.3). One possibility is that the mutation of GC to AG could happen earlier in the primate 
lineage. However, the sequence logo generated from the multiple sequence alignment of 
the 880 MSTB2 sequences existing in the human genome shows low degree of 
conservation in the vicinity of acceptor site. Therefore, the dinucleotide predecessor of 
AG should not necessarily be the consensus GC dinucleotide.  
 
 
Figure 2.1: Exon-intron organization of human IL22RA2 gene. Exon and intron 
sequences are represented by boxes and angular lines, respectively, with lengths indicated 
in base pairs. Coding and untranslated regions are represented by filled boxes and open 
boxes, respectively while the blue dashed boxes demonstrate the absence of the exon 
sequences on mRNA level. The region showing homology with MSTB2 is labeled in red 




Several coincidences must have been involved in creation of the exon 3/4. The 
viable structural elements of the splice sites (GT/AG) were created by mutations. With 
the upstream intron in phase 2, the exon 3/4 emerged in the frame which had no stop 
codons inside, while the other two possible phases of intron would cause premature 
termination of translation. The new exon 3/4 (with length divisible by three) did not 
disrupt the global reading frame and therefore did not change the downstream amino acid 
sequence known to be important for ligand binding (GRUENBERG et al. 2001). Our 
236 
 Splice variant 1 
(NM_052962) 
 Splice variant 2 
(NM_181309) 
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findings show that the exon 3/4 of IL22RA2 might be active and be expressed in the Great 
Apes, while we have not confirmed its expression in the Old World monkeys. This 
observation indicates that the exon 3/4 is likely to possess functional properties and it is 
an alternatively spliced exon. We have evaluated the possibility that the exon 3/4 is the 
subject for positive selection by the standard test based on non-synonymous Ka to 
synonymous Ks divergence rates ratio. There are three nonsynonymous substitutions 
between human and orangutan homologous exonic sequences, while there are no 
synonymous substitutions. The use of the Laplace pseudocounts produces (Ka+1)/(Ks+1) 




Figure 2.2: PCR-sequencing. Agarose gel electrophoresis of IL22RA2 homologous 
regions carrying LTR, MSTB2, from seven primates amplified by PCR. L, ladder; H, 
human; C, chimpanzee; B, bonobo; G, gorilla; O, orangutan; M, crab eating macaque; R, 
rhesus monkey; N, nontemplate control. 
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Figure 2.3: Multiple sequence alignment of PCR products. The PCR products are 
aligned and compared to the consensus sequence of MSTB2. The light blue letters 
indicate the start and end of LTR boundaries. The target exons and sequences in place of 
splice sites are shown in red and green color, respectively. 
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Figure 2.4: Evolutionary history of IL22RA2 gene. A phylogenetic diagram of seven 
primates selected in this study. The numbers next to branches on the tree show the 
approximated divergence time from the last common ancestor in million-year time units 
(MYA). The arrow indicates the estimated point of emergence of the target exon caused 




To date, very little is known about the role and the origin of this additional exon 
(exon 3/4) in transcript variant 1. Being the only CRF2 protein with 32 amino acids 
inserted adjacent to the region important for ligand recognition, this isoform may bind to 
structurally different ligands than other isoforms (GRUENBERG et al. 2001). This 
possibility is supported by the experimental data which show that this variant fails to 
block IL22 activity (DUMOUTIER et al. 2001). The longer MaLR-related isoform may also 
modulate tissue-specific expression. The available data show that the IL22RA2 isoform 1 
is expressed only in placenta while isoform 2 is highly expressed in placenta and 
mammary gland and at a lower level in spleen, skin, thymus and stomach (GRUENBERG et 
al. 2001). However, nothing is known about the factors that control the expression of this 
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longest IL22RA2 variant. Additional experiments should be performed to determine its 
function as well as to identify the possible change in ligand specificity due to the LTR-
derived protein modification. 
CONCLUSIONS 
The distribution of LTR elements that became parts of human protein-coding 
genes shows the distinct preference of LRTS fixation in 5’ and 3’untranslated regions. 
These observations confirm existing concept of LRTS role as a contributor to gene 
regulation evolution. On the other hand, the recruitment of LRTS to encode a part of a 
protein domain leading the exaptation to evolution of the host gene is a less frequent 
event. As shown in the part of this paper related to evolution of IL22RA2 gene, several 
coincidences are necessary to allow the LRTS exonization event. The evolutionary 
analysis elucidates the action of the mechanism of incorporation of LRTS into a novel 
alternatively spliced exon. 
METHODS 
Bioinformatic analysis 
The refGene file (hg17, May2004) with data on 18,241 RefSeq human genes 
(genes on chr_random excluded) including alternatively spliced variants (23,821 
transcripts in total) was retrieved from the UCSC genome browser (KAROLCHIK et al. 
2003). The annotations of 254,542 exons were compared with the transposable elements 
annotations available in the same database to determine the frequency of the LTR 
elements in the exon regions. The descriptions of the LTR elements were provided in the 
Repbase update (Repbase release 8.12) (JURKA 2000). We detected exon overlaps with 
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the LTR flanking regions and/or the internal sequences of LTR elements. The overlaps 
with exons were labeled as complete (LRTS covers the whole exon), partial (LRTS 
partially overlap with exon), or inside overlap (LRTS completely inside the exon). The 
type of exons associated with LRTS were then classified as the first CDS exon (first exon 
containing coding sequence), the last CDS exon (last exon containing coding sequence), 
single protein coding exon (exon containing the whole CDS of a gene), 5’ UTR exon 
(exon located upstream to the first CDS exon/single protein coding exon) and 3’ UTR 
exon (exon located downstream from the last CDS exon/single protein coding exon), and 
internal protein coding exon (all other CDS exons). In cases of the first and last CDS 
exons as well as single protein coding exons, LRTSs could be inserted in either the UTR 
and/or the CDS region. Finally, all the initial results were further processed. Exons 
identical in different transcripts were clustered to remove the redundancy. The LRTS 
fragments were reconstructed manually based on the initial data (e.g. LRTS family, 
human genome coordinates) and the LRTS information available in Repbase (JURKA 
2000).  
For all genes containing LRTS-derived exons, we used data of the Entrez gene 
and UCSC genome browser to infer information on alternative transcripts containing 
LRTS derived exons. Additionally, we checked the consistency of the reading frames in 
the exon overlaps with internal sequences of LRTS. The internal sequences of the LTR 
elements overlapping with CDS regions were translated in six reading frames and 
searched by BLAST and Pfam for the presence of domains of common viral proteins 
(gag, pro, RT, RNaseH, IN and env). The cases when detected viral protein domains 
became parts of human proteins were registered.  
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Given that the first and last CDS exons are commonly less reliably identified than 
the internal coding exons, we have considered further only 41 internal coding exons 
completely covered with LRTS. We have chosen exon 3/4 of the IL22RA2 gene (splice 
variant 1) for in depth study using PCR-sequencing of homologous regions of several 
primate genomes and comparative analysis of the sequence data.  
The primers flanking the target LTR-derived sequence were designed to be 
specific to the conserved human-chimpanzee-rhesus monkey region (data from the UCSC 
genome browser) using the PRIMER3 program (ROZEN and SKALETSKY 2000). 
Sequences of PCR fragments were aligned by the ClustalW program with default 
parameters (THOMPSON et al. 1994) and then were manually adjusted. For human, 
chimpanzee, and rhesus monkey, the annotated sequences of regions in question were 
previously available. In these three cases the known annotated sequences were used in the 
alignment while the PCR data were utilized as a complementary information. The donor-
acceptor sites of the target exon were marked for all sequences based on the 
corresponding positions in the human IL22RA2. The timing of the exonization event was 
estimated via the phylogenetic analysis.  
PCR amplification of the IL22RA2 target exon 
The PCR amplifications of genomic DNA of seven primate species (Homo 
sapiens, Pan troglodytes, Pan paniscus, Gorilla gorilla, Pongo pygmaeus, Macaca 
fascicularis, Macaca mulatta) were carried out by using the following primers, a forward 
primer 5’-ACCGCTACGACTTCTCTCTAC-3’ and a reverse primer 3’-
TCAGGTATTCTGGGGTCTG-5’, which yield a 792 bp amplicon covering the region of 
the LTR in human. The PCR cycle conditions were as follows: initial 4 min and 30 sec 
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pre-denaturation at 94°C, 30 cycles of 30 sec denaturation at 94°C, 30 sec annealing at 
50°C, 1 min elongation at 72°C, and a final 1-cycle extension of 7 min at 72°C. The PCR 
products were then purified on 1% (w/v) agarose gel, Gibco BRL Ultra-Pure, visualized 
by ethidium bromide staining and extracted by using the gel extraction kit (QIAGEN).  
Direct sequencing of the PCR products was performed by the DNA Sequencing Services, 
of the Genomics Core Facility at the Georgia Institute of Technology.   
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CHAPTER 3 
EVALUATING THE PROTEIN CODING POTENTIAL OF 




Transposable element (TE) sequences, once thought to be merely selfish or 
parasitic members of the genomic community, have been shown to contribute a wide 
variety of functional sequences to their host genomes. Analysis of complete genome 
sequences have turned up numerous cases where TE sequences have been incorporated as 
exons into mRNAs, and it is widely assumed that such ‘exonized’ TEs encode protein 
sequences. However, the extent to which TE-derived sequences actually encode proteins 
is unknown and a matter of some controversy. We have tried to address this outstanding 
issue from two perspectives: i-by evaluating ascertainment biases related to the search 
methods used to uncover TE-derived protein coding sequences (CDS) and ii-through a 
probabilistic codon-frequency based analysis of the protein coding potential of TE-
derived exons.   
Results  
  We compared the ability of three classes of sequence similarity search methods to 
detect TE-derived sequences among data sets of experimentally characterized proteins: 1-
a profile-based hidden Markov model (HMM) approach, 2-BLAST methods and 3-
RepeatMasker. Profile based methods are more sensitive and more selective than the 
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other methods evaluated. However, the application of profile based search methods to the 
detection of TE-derived sequences among well-curated experimentally characterized 
protein data sets did not turn up many more cases than had been previously detected and 
nowhere near as many cases as recent genome-wide searches have. We observed that the 
different search methods used were complementary in the sense that they yielded largely 
non-overlapping sets of hits and differed in their ability to recover known cases of TE-
derived CDS. The probabilistic analysis of TE-derived exon sequences indicates that 
these sequences have low protein coding potential on average. In particular, non-
autonomous TEs that do not encode protein sequences, such as Alu elements, are 
frequently exonized but unlikely to encode protein sequences.    
Conclusions  
The exaptation of the numerous TE sequences found in exons as bona fide protein 
coding sequences may prove to be far less common than has been suggested by the 
analysis of complete genomes. We hypothesize that many exonized TE sequences 
actually function as post-transcriptional regulators of gene expression, rather than coding 
sequences, which may act through a variety of double stranded RNA related regulatory 
pathways. Indeed, their relatively high copy numbers and similarity to sequences 
dispersed throughout the genome suggests that exonized TE sequences could serve as 
master regulators with a wide scope of regulatory influence.  
BACKGROUND 
Transposable elements (TEs) are DNA sequences capable of moving 
(transposing) among locations in the genomes of their host organisms. When TEs 
transpose they often replicate themselves and they can accumulate to very high copy 
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numbers. For instance, at least 47% of the human genome is made up of TE-derived 
sequences (LANDER et al. 2001). For many years, TEs were thought to be genomic 
parasites that did not contribute functionally relevant sequences to the genomes in which 
they reside (DOOLITTLE and SAPIENZA 1980; ORGEL and CRICK 1980). However, as of 
late it has become increasingly apparent that TEs can have profound effects on the 
structure, function and evolution of their host genomes (BIEMONT and VIEIRA 2006; 
JURKA et al. 2007; KAZAZIAN 2004; KIDWELL and LISCH 2001).  
One way that TEs have contributed to the function and evolution of their host 
genomes is through the donation of regulatory sequences that control the expression of 
nearby genes. This phenomenon was originally noticed through the elucidation of 
individual cases where host genes were found to be regulated by TE-derived sequences 
(BRITTEN 1996; BRITTEN 1997). Later, genome-scale analyses confirmed that TE-derived 
sequences have contributed diverse and abundant regulatory sequences to host genomes 
(JORDAN et al. 2003; VAN DE LAGEMAAT et al. 2003).  
TEs can also contribute to host genomes by providing protein coding sequences.  
This process is initiated when a new or existing TE sequence becomes captured as an 
exon (exonized) in a host gene mRNA sequence. The exonization of TE sequences 
appears to be quite common in eukaryotic genomes. An early highthroughput analysis of 
the human transcriptome by Nekrutenko and Li revealed that 4% of human protein 
coding regions contained TE sequences (NEKRUTENKO and LI 2001). However, the extent 
to which exonized TE sequences actually contribute bona fide protein coding sequences 
has been called into question. It is simply not clear whether the presence of a TE 
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sequence in a spliced exon, i.e. as part of an mRNA, indicates that it will ultimately be 
translated into a functioning protein.  
Two reports in particular have challenged the figure of 4% of human proteins 
with TE-derived coding sequences. In both of these studies, more conservative 
approaches to the identification of TE-derived protein coding sequences were taken.   
Specifically, these studies employed the analysis of coding sequences taken exclusively 
from proteins that had been experimentally characterized, either through elucidation of 
their 3D structures or via direct peptide sequencing methods. Thus, only the best 
characterized protein coding sequences were studied and gene predictions, or models, 
based on the mapping of expressed sequences to genomes were not considered. This 
approach was first taken by Pavlicek et al. who surveyed a dataset of 781 non-redundant 
human proteins with 3D structures for the presence of TE-derived coding sequences 
(PAVLICEK et al. 2002). They were not able to find a single reliable case of a TE-derived 
protein coding sequence in these data. Considering these results together with the 
previous work of Nekrutenko and Li (NEKRUTENKO and LI 2001), the authors concluded 
that while many alternative transcripts may include TE sequences, these are rarely if ever 
incorporated into the mRNA sequences that are destined to be translated into proteins. 
Pavlicek et al. found it particularly unlikely that non-coding TEs, such as Alu elements, 
could evolve to encode proteins after being incorporated into host mRNAs.  
Gotea and Makalowski conducted a similar, if further reaching, study by looking 
for TE-derived sequences in the coding regions of human proteins taken from the Protein 
Data Bank (BERMAN et al. 2000) (3,764) and from the Swiss-Prot (BOECKMANN et al. 
2003) collection of directly sequenced human peptides (1,765) (GOTEA and 
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MAKALOWSKI 2006). Evaluation of these sequences with the RepeatMasker program 
(SMIT et al. 1996-2004) uncovered 24 cases of TE-derived protein coding sequences. 
However, many of these had relatively low sequence similarity scores that were close the 
RepeatMasker threshold for false-positives. After further evaluation of these cases using 
a variety of comparative sequence analysis techniques, the authors settled on a figure of 
0.1% for the percentage of actual protein coding sequences with TE-derived exons. 
Incidentally, this figure is in line with the initial analysis of the human genome sequence, 
which found 47 cases of human protein coding regions with TE-derived sequences, 
corresponding to ~0.16% of all human genes given the total human gene number count of 
~30,000 used at that time (LANDER et al. 2001).  
While there can be little doubt that these two aforementioned studies used  
appropriately conservative datasets to search for TE-derived protein coding sequences, it 
may also be the case that the primary detection methods they employed are insufficiently 
sensitive since they rely on DNA-DNA sequence comparisons. For instance, 
RepeatMasker, which is the most widely used program for the detection of TE sequences, 
uses pairwise comparisons of genomic DNA sequences with DNA consensus sequences 
that represent TE families. Protein sequence based similarity searches are more sensitive 
than DNA based searches, and profile searches that take advantage of information on 
site-specific variation along protein domains are proven to be the most sensitive approach 
for detecting sequence homology (EDDY 1996; EDDY 1998; SONNHAMMER et al. 1997).  
The increased sensitivity of protein and profile based searches is underscored  
by two recent studies that uncovered many more putative cases of TE-derived protein  
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coding sequences. Roy Britten compared human protein coding sequences to the Repbase 
library of consensus TE sequences (JURKA 2000; JURKA et al. 2005) using both 
RepeatMasker and a protein sequence based approach that used six-frame translations of 
Repbase sequences. Use of the protein (translated) sequence search method resulted in a 
more than two-fold increase, from 814 to 1,950, in the number of genes found to have 
TE-derived protein coding sequences (BRITTEN 2006). An even more sensitive profile 
based search method was used by Zdobnov et al. to search for TE-derived protein coding 
sequences in four vertebrate genomes (ZDOBNOV et al. 2005). These authors compiled a 
set of known protein domains that are characteristic of TEs, and profiles of these domains 
were then used in hidden Markov model (HMM) searches of the protein sequences. This 
analysis resulted in the discovery of 1,000 vertebrate genes containing protein coding 
sequences that are related to TEs. However, neither the Britten nor the Zdobnov et al. 
studies confined their searches to experimentally characterized protein coding sequences 
as did the studies of Pavlicek et al. and Gotea and Makalowski, both of which resulted in 
far smaller estimates for the fraction of genes with TE-derived protein coding sequences.  
Clearly, the extent to which TEs contribute protein coding sequences to vertebrate 
genomes is not a settled matter. Relatively insensitive searches of conservative data sets 
lead to low estimates for the fraction of TE-derived protein coding sequences, while more 
sensitive searches of less conservative data sets yield higher fractions. The aims of this 
study are i-to evaluate the ascertainment biases related to different sequence similarity 
search methods and ii-to try and better understand the potential of TEs to contribute 
protein coding sequences to vertebrate genomes. To these ends, we searched 
conservative, experimentally characterized, protein coding sequence data sets for TE-
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derived sequences using sensitive profile based search methods. We also compared the 
results of profile based search methods with more traditional pairwise DNA and protein 
based search methods. Known cases of experimentally characterized proteins with TE-
related sequences were used as positive controls to assess the sensitivity of the different 
sequence similarity search techniques. Finally, we used probabilistic gene prediction 
methods as well as an analysis of relative nucleotide (GC) frequencies across codon 
positions to evaluate the protein coding probability of TE-derived exon sequences.  
RESULTS AND DISCUSSION 
Searching for TE-associated proteins  
We used a number of approaches to detect molecular domestication events,  
specifically exaptation of host (cellular) CDS from TE sequences, by searching for the  
presence of TE-related sequences in functionally well characterized host protein 
sequences and CDS. A total of 41,492 PDB entries and 21,050 Swiss-Prot directly  
sequenced proteins were taken to represent functionally well characterized proteins  
(genes) since they have been experimentally determined. Viral proteins were excluded 
from these data sets in order to avoid the overlap among protein domains shared between 
viral and retrotransposon-encoded proteins resulting in final data sets of 39,252 PDB and 
20,732 Swiss-Prot entries. Using the combined automatic and manual search procedure 
described in the Methods section, we identified 124 TE related Pfam protein domains 
(See Table B.1). We then searched for the presence of these TE-related domains among 
the experimentally characterized PDB and Swiss-Prot data sets using profile-based 
similarity search methods (HMM profiles) as described in the Methods section. The 
numbers (percentages) of protein sequences found to possess TE-related domains, based 
          
                                                                                                                                                                        
 48
on a series of increasingly stringent HMM search cutoff criteria, are shown in Table 3.1 
and Table 3.2 for the PDB and Swiss-Prot data sets respectively.  
 
Table 3.1: Detection of TE-encoded sequences in PDB proteins 
The number of PDB entries found with TE protein fragments (from autonomous TEs) by 
different search programs is shown. The percentage of total PDB entries is shown in the 
parenthesis. The square bracket indicates the number and the percentage of protein 
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N/A N/A N/A N/A N/A N/A 
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Table 3.2: Detection of TE-encoded sequences in Swiss-Prot directly sequenced 
proteins 
The number of Swiss-Prot directly sequenced proteins found with TE protein fragments 
(from autonomous TEs) by different search programs is shown. The percentage of total 
Swiss-Prot entries is shown in the parenthesis. The square bracket indicates the number 
and the percentage of protein entries associated with sequences derived from TEs 










































































































































14 (0.07%) N/A N/A N/A N/A N/A N/A 
default 
value 







To compare the sensitivity of the HMM profile-based search method with more 
standard sequence-against-sequence similarity search methods, we used the BLAST and 
RepeatMasker programs to search for TE-derived sequences among host proteins and 
their corresponding CDS. To this end, we built CDS databases corresponding to the PDB 
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and Swiss-Prot protein data sets, which contain 34,795 and 38,754 CDS sequences, 
respectively. These CDS data sets correspond to 30,486 PDB and 12,860 Swiss-Prot 
proteins. The difference in the number of proteins versus CDS can be attributed to the 
fact that a number of protein sequences lack the matching CDS because they are 
synthetic, mutated, or chimeric proteins. In addition, some protein entries may be related 
to more than one CDS sequence, while some CDS may match with several PDB entries 
due to the redundancy of protein chains. For use as query sequences in BLAST searches, 
we created three TE sequence libraries from data provided in Repbase: 5,611 TE 
sequences (for all TEs in all taxa), 1,423 TE encoded proteins and 1,349 TE CDS 
sequences. The specific combinations of BLAST program, query set and data base set 
used in each search is shown in Table 3.3. The numbers (percentages) of sequences found 
with TE-related domains, based on a series of increasingly stringent E-value cutoffs, are 
shown in Table 3.1 and Table 3.2 for the PDB and Swiss-Prot data sets respectively.  
Finally, the RepeatMasker program was used to search for TE-related sequences among 
the PDB and Swiss-Prot CDS data sets (see numbers and percentages of hits in Table 3.1 
and Table 3.2).  
Considering the results of the three different classes of search strategies –
HMMER, BLAST and RepeatMasker – together yields some unexpected results. Not  
surprisingly, however, RepeatMasker proved to be the least sensitive strategy to search 
for TE-related host protein coding sequences. Using the fairly liberal default cutoff value, 
which returns a number of hits with marginal reliability, RepeatMasker yields a lower 
number of hits than all but the most conservative searches with the other methods (Table 
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3.1 and Table 3.2). This is consistent with the fact that RepeatMasker relies on DNA-
DNA sequence comparison.    
 
 
Table 3.3: Sequence similarity program-query-database combinations used to 
search for TE-related host sequences  
 
Tool Query Database 
HMMER PDB/Swiss-Prot protein HMM profiles of TE-related 
Pfam domains 
BLASTN TE CDS & all TE sequences PDB/Swiss-Prot CDS 
BLASTP TE protein PDB/Swiss-Prot protein 
BLASTX TE CDS & all TE sequence PDB/Swiss-Prot protein 
TBLASTN TE protein PDB/Swiss-Prot CDS 
TBLASTX TE CDS & all TE sequence PDB/Swiss-Prot CDS 




To compare the results of the HMMER versus BLAST search strategies, we 
plotted the percentage of hits against the E-value threshold used (Figure 3.1A and 3.1B).   
Together with Tables 3.1 and 3.2, these plots show the relative numbers (percentages) of 
hits retrieved using each method. TBLASTX searches, where CDS are translated in all 
six reading frames and are searched against nucleotide databases that are translated in six 
frames, gave the highest number of hits across all but the most liberal E-value cutoffs.  
This is consistent with previous results, showing that translated BLAST searches yield far 
more TE-host protein similarity than BLASTN or RepeatMasker searches (BRITTEN 
2006). The profile-based HMMER searches, which are expected to be the most sensitive, 
did return the highest number of hits at liberal E-values, but after two rounds of 
decreasing E-values, HMMER dropped off to yield the fewest number of hits across all 
the methods (Table 3.1, Table 3.2 and Figure 3.1). Thus, HMMER appears to be 
particularly sensitive to increasingly stringent E-value cutoffs.  
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Figure 3.1: Sensitivity and selectivity comparison for different sequence similarity 
search methods. The percentage of hits returned by different sequence similarity search 
methods are shown across increasingly stringent E-value cutoffs for the PDB (A) and 
Swiss-Prot (B) data sets. The selectivity and sensitivity ranks are compared for different 




To evaluate the selectivity of the search methods we employed, we measured the 
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decreasing E-value thresholds, which allowed us to measure the effect of increasing 
stringency on the number of hits retrieved across methods. This was done by fitting  
exponential trend lines to the data shown in Figure 3.1A and Figure 3.1B and then 
ranking the searches with respect to the exponent of the trend line; the most selective 
methods are ranked the highest (i.e. have the lowest rank number). In this way, HMMER 
was shown to be the most selective method and TBLASTX the least selective. As could 
be expected, selectivity is inversely correlated with sensitivity, and exactly so for the 
Swiss-Prot search, as can be seen when the ranks of method sensitivity (number of hits) 
are compared to the selectivity ranks (Figure 3.1C and Figure 3.1D). Again, this overall 
trend defied the expectations of increased sensitivity of profile methods that we had at the 
outset of the study.  
We also considered the relationships among the different search methods in terms 
of the fraction of hits that they had in common. For each pair of search methods, the 
fraction of shared hits was calculated (see Methods), and the resulting pairwise similarity 
matrix was used to cluster the methods (Figure 3.2). For both the PDB and Swiss-Prot 
searches, the translated BLAST methods group together as do the protein searches 
BLASTP and BLASTX. BLASTN was more similar to the translated methods in the 
PDB search, while it had lower overlap with the other BLAST methods in the Swiss-Prot 
search. HMMER consistently showed the lowest overlap with other methods. Perhaps 
more importantly, the extent of overlap between the different methods was surprisingly 
low. For instance, at the lowest E-value cutoff only 2 out of a total of 4,241 hits for PDB 
and 2 out of 1,724 for Swiss-Prot were identified by all six search methods. This 
underscores the fact that the different search methods are very much complementary and 
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indicates that an exhaustive search for potential TE-CDS exaptation events will require 
the use of a variety of search techniques.  
 
 
Figure 3.2: Relationships among sequence similarity search methods. Colors 
represent the fraction hits shared between methods, from 0 (white) to 1 (purple).  The 
matrices are symmetrical with self-similarity shown along the diagonal. The search 
methods are ordered along both axes of the plots with respect to similarity, and 
dendograms showing the relationships among methods are shown for the PDB  
(A) and Swiss-Prot (B) data sets. 
 
Comparative analysis of cases of TE-CDS exaptation  
HMMER was also run using the most conservative gathering (GA) and trusted  
cutoff (TC) thresholds described in the Methods section. Searches using GA and TC  
yield the fewest number of hits for both the PDB and Swiss-Prot searches. Thus, we  
took these results to be the most reliable (conservative) set of TE-related host proteins  
and further evaluated these results to look for bona fide cases of TE-CDS exaptation.    
By manually evaluating these results, we were able to classify the hits into five  
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distinct categories (see Methods), only one of which represents the kinds of TE-CDS  
exaptation events that we are most interested in (Table 3.4). For instance, the vast 
majority of apparent TE-related proteins in the PDB data set corresponded to either 
synthetic constructs (i.e. artificial sequences) or non-specific, and often ubiquitous, TE-
related protein domains such as RNase H. For this latter category, the non-specific TE-
related domains, it is a formal possibility that they represent ancient TE-CDS exaptation 
events but it is difficult, if not impossible, to unambiguously support that assertion. Other 
proteins detected in the PDB set correspond to TE-encoded proteins and viral proteins.  
Only 11 out of 140 cases (or 7.9%) correspond to likely TE-CDS exaptation events. With 
the GA and TC thresholds, the Swiss-Prot dataset yielded far fewer total hits than did 
PDB and only 3 of these correspond to likely TE-CDS exaptation events (Table 3.4).  
 
 
Table 3.4: Classification of proteins containing TE-associated Pfam domains 
detected by the GA and TC cutoffs of HMMER 
The categories of hits are described in the text and the number (percentage) for each 
category is shown for searches against the PDB and Swiss-Prot data sets. 
 
Category PDB Swiss-Prot 
Potential TE-related proteins 11 (7.86%) 3 (21.43%) 
Viral proteins 14 (10.00%) 0 (0%) 
TE-encoded proteins 18 (12.86%) 7 (50.00%) 
Synthetic construct 47 (33.57%) 0 (0%) 




A set of 12 likely TE-CDS exaptation events, representing the non-redundant 
union of the most reliable cases from the PDB and Swiss-Prot sets in Table 3.4, were  
further analyzed in order to assess the ability of BLAST and RepeatMasker to detect 
these cases. Only one of the 12 proteins was detected using all methods, and again, 
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RepeatMasker was shown to be the least sensitive method (Table 3.5). Indeed, as 
expected, DNA-DNA search methods in general were found to be insensitive; there are 4 
cases where BLASTN and RepeatMasker are the only programs unable to detect the TE-
CDS similarity. There were four individual cases, corresponding to two different Pfam 
domains, where only HMMER was able to detect the TE-protein sequence similarity.  
These results stand in contrast to the results of the previous section, which indicate that 
HMMER is the least sensitive search method overall. There are two possible explanations 
for this dissonance. First of all, HMMER may suffer from a lack of coverage due to its 
reliance on the collection of Pfam domain family definitions. Secondly, and perhaps more 
plausible, the different search methods may in fact be complementary in terms of 
detecting different sets of exaptation events. This may be particularly relevant for DNA 
based, and/or translated, search methods that are able to compare non-coding TE-derived 
sequences to host protein and CDS sequences. 
          
                                                                                                                                                                           
 
Table 3.5: Analysis of the qualified set of TE-associated domain containing proteins 
Twelve PDB/Swiss-Prot proteins with TE-associated Pfam domains detected by HMMER (GA and TC cutoffs) are shown. The results 
from BLAST and RepeatMasker analysis are compared (√ = found, X = not found TE-related sequence). The cutoff E-value of 0.01 
was used as the detection criteria. 
 










E. coli Phage_integrase X X X X X X 
1bw6, 1hlv Centromere protein 
B 
H. sapiens CENP-B_N √ √ √ √ √ X 
1uhu retroviral Gag MA-
like domain of 
RIKEN cDNA 
3110009E22 
M. musculus Gag_MA N/A √ N/A √ N/A N/A 
1y4m Syncytin-2 H. sapiens TLV_coat √ √ √ √ √ √ 
2a3v Site-specific 
recombinase IntI4 
V.cholerae Phage_integrase X X X X X X 
2cqf Lin-28 homolog A 
(Zinc finger CCHC 
domain-containing 
protein 1) 
H. sapiens zf-CCHC X √ √ √ √ X 
2ct5 Zinc finger BED 
domain-containing 
protein 1 
H. sapiens zf-BED X √ √ √ √ X 
2d8r THAP domain-
containing protein 2 
H. sapiens THAP X √ √ √ √ X 
2djr Zinc finger BED 
domain-containing 
protein 2 
H. sapiens zf-BED X √ √ √ √ X 
CBH1_SCHPO CENP-B homolog 
protein 1 
S. pombe  DDE X √ √ √ √ X 
XERC_ECOLI Tyrosine 
recombinase xerC 
E. coli  Phage_integrase X X X X X X 
57 
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Case studies of known TE-derived genes  
There are a number of well verified cases of host proteins (genes) that are known 
to have been derived from TE sequences. These are proteins that have been shown to be 
functionally analogous and evolutionarily derived from their TE-encoded counterparts.  
For instance, the enzyme Telomerase evolved from TE-encoded reverse transcriptase 
enzymes (BLACKBURN 1991; EICKBUSH 1997) and the RAG1 recombinase is related to 
the transposase enzymes (AGRAWAL et al. 1998; KAPITONOV and JURKA 2005). The 
centromere protein CENP-B (KIPLING and WARBURTON 1997) and SETMAR (CORDAUX 
et al. 2006) are other well documented cases of the evolution of host CDS from TEs. We 
have used these cases as positive controls in order to further evaluate the ability of the 
different classes of search methods to detect cases of TE-CDS exaptation. We assessed 
the ability of each program to detect human proteins or CDS for all four of these cases 
(Table 3.6). Translated BLAST searches BLASTX and TBLASTN were the most 
sensitive search methods finding all of the cases in this data set, and HMMER was shown 
to be fairly sensitive in detecting three out of four of the known cases of TE-exaptation.  
RepeatMasker was the least sensitive detecting only the SETMAR case. SETMAR 
represents an evolutionarily recent TE-CDS exaptation event that occurred during the 
primate radiation some 40-58 million years ago (CORDAUX et al. 2006). Thus, the 
SETMAR CDS retains DNA sequence similarity to the Hsmar1-type TE transposase 
gene from which it is derived. In any case, all the search methods were able to detect 
SETMAR, so RepeatMasker would not be necessary to elucidate this case. In general, for 
the BLAST searches, translated and protein based searches are the most sensitive 
followed by DNA-based BLASTN.     
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Table 3.6: Detection of previously identified TE-associated proteins 
The ability of the different sequence similarity search methods to detect well known 
cases of TE-derived CDS is indicated with √ and failure to detect is indicated with X. 
 
















X √ √ √ X X 










√ √ √ √ √ √ 
 
 
Evolutionary relationship between TE and cellular proteins  
In the formal sense, establishing a solid, statistically significant, sequence 
similarity relationship between TE-encoded and cellular proteins is necessary but not  
sufficient to make the claim of a TE-CDS exaptation event. This is exemplified by the 
numerous cases of ubiquitous, non-specific TE-related protein domains uncovered when 
searching the PDB and Swiss-Prot experimentally characterized data sets (Table 3.4). 
These abundant protein domains, such as RNase H, can be functional analogs that have 
evolved convergently in host and TE genomes or they may have their evolutionary 
origins in host (cellular) genomes and been subsequently captured by TEs. Thus, it is 
necessary to document the evolutionary relationships between TE encoded and related 
host-encoded protein domains as accurately as possible in order to evaluate the evidence 
for TE-CDS exaptation. Phylogenetic analysis is best suited to this task. Indeed, 
phylogenetic analysis is needed to unequivocally demonstrate a TE-origin, i.e. the 
direction of the TE-to-host sequence transfer, for protein domains with similarity between 
TEs and host genomes as was shown for the case of Telomerase (EICKBUSH 1997).  
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To illustrate this analytical process, we have chosen the THAP protein domain.  
Sequence similarity between the THAP domain and TEs has been noted previously but 
the evolutionary origins of the domain, and in particular the specific direction of the TE-
host transfer, remains uncertain. The Caenorhabditis elegans C terminal binding protein 
(CtBP) [PDB: 2jm3] contains the THAP domain, a ~90 residue domain, which is 
restricted to animals and shared between the THAP family of cellular DNA-binding 
proteins and transposases encoded by DNA-type TEs. This domain was previously found 
to be homologous to the site-specific DNA-binding domain (DBD) of Drosophila P-
element transposase (ROUSSIGNE et al. 2003). An evolutionary analysis of the domain 
architectures and sequence similarities among THAP domain containing proteins was 
taken to suggest the possibility that cellular proteins have recruited this domain on more 
than one occasion (QUESNEVILLE et al. 2005). In order to characterize all sequence 
relationships between TE and host encoded THAP domains, we used HMMER with the 
Pfam THAP domain HMM profile to search among the Repbase library of TE-encoded 
proteins. The use of HMMER was necessitated by the fact that, consistent with results 
reported in previous sections, BLAST and RepeatMasker can not detect any TE-related 
sequence in C. elegans CtBP. Using HMMER, we found that PROTOP is the identity of 
the autonomous Drosophila melanogaster P element that contains the THAP domain, in 
positions 12 to 94 of its consensus protein sequence. We also identified six additional TE 
families containing THAP domain (KBOC_DB, P1_AG, P3_AG, P4_AG, Kolobok-
1_XT, Kolobok-2_BF). In addition, CtBP was used as a BLASTP search query to 
identify host (cellular) genome encoded THAP domains. All TE and host encoded THAP 
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domains were aligned, globally and locally, and phylogenetically analyzed as described 
in the Methods section. 
 
    
Figure 3.3: Phylogenetic relationship of TE and cellular THAP domains. Neighbor-
joining trees of seven THAP homologous TE sequences and seventeen cellular THAP 
sequences from various species are shown. The trees were created based on (A) the 
multiple sequence alignment of all THAP sequences and (B) the pairwise gamma 
distance matrix calculated from BLAST all-against-all pairwise alignments. TE-THAP 
sequences are indicated by red triangle marks. Bootstrap values (A) represent the fraction 
of times that internal branches, supporting clades, were recovered among trees built from 
1,000 re-sampled alignments. 
 
 
The global and local alignment based phylogenetic analyses consistently identify 
one clade of host encoded THAP domains and a second clade of THAP domains encoded 
by both TEs and cellular genomes (Figure 3.3). Interestingly, the TE and host encoded 
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domains are distributed throughout this clade suggesting the possibility of multiple 
transfers of THAP domain CDS between TE and host genomes. In addition, TE encoded 
THAP domains appear to have greater sequence diversity, reflected by the branch 
lengths, than host encoded THAP domains, consistent with a TE origin of the domain.  
Thus, it appears that THAP indeed evolved among TE sequences and was subsequently 
transferred on more than one occasion to host (cellular) genomes. 
Protein coding potential of TE-derived exons  
By now, it is well known that TE-derived sequences are frequently incorporated 
into the exons of host mRNAs (NEKRUTENKO and LI 2001). What is less clear is the 
extent to which TE-derived exons of host genes are destined to become protein coding 
sequences. Previously, we addressed this issue by searching functionally well 
characterized protein coding sequences for the presence of TE-related domains. Here, we 
take a DNA sequence codon based approach to this question. Our approach is based on 
the fact that protein coding sequences show a specific and marked periodicity of 
nucleotide frequencies across the first, second and third codon positions. This periodicity 
serves as a robust signal for a number of gene prediction algorithms, one of the earliest 
and most prominent example of which is GeneMark (BORODOVSKY and MCININCH 
1993). GeneMark can accurately identify protein coding nucleotide sequences based 
solely on the distribution of observed nucleotide frequencies across codon positions. We 
used the eukaryotic version of GeneMark (BORODOVSKY and MCININCH 1993), to 
evaluate the coding capacity of TE-derived exon sequences in the human genome. First, 
we compared the locations of 14,802 consensus CDS (CCDS) genes mapped to the hg17 
build, from the UCSC Genome Browser (KAROLCHIK et al. 2003), of the human genome 
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to the locations of annotated TEs (see Methods). 761 of the human CCDS genes have TE-
derived exon sequences; there are a total of 817 TE-derived exons. The 761 human genes 
with TE-derived exons include 160 TE-derived fragments with the minimum length of 
100 nt required for GeneMark analysis. Using GeneMark probabilistic models (see 
Methods), we analyzed the TE-derived exon sequences as well as 500 randomly chosen 
representative non TE-derived exons by calculating their probability to be protein coding 
regions. The distributions of protein coding potentials (probabilities) for TE versus non 
TE sequences are shown in Figure 3.4. Visually the distributions are quite distinct, with 
TE-derived exons having far lower coding potential, and accordingly there is a highly 
significant difference between the two coding probability distributions, D=0.67 P=0 
Kolmogorov-Smirnov test (Figure 3.4A). The average coding potential of TE-derived 
exons was 0.26 compared to 0.70 for non TE-derived coding sequences. Using a more 
sensitive custom-trained GeneMark model gave consistent results, 0.35 average TE 
coding probability versus 0.73 for non TE sequences with significantly different 
distributions D=0.59 P=0 Kolmogorov-Smirnov test (Figure 3.4B). Clearly, TE-derived 
exons have much lower coding probability than non TE-derived sequences suggesting 
that many of these exons do not actually encode proteins. Since the TE-derived exons 
evaluated using GeneMark as described above are taken from the RepeatMasker 
annotations on the human genome sequence, they do not include more ancient well 
established cases of TE-derived CDS such as the first three cases shown in Table 3.6.  
One would expect that these TE-derived CDS have higher protein coding potentials than 
the more recently exonized TE sequences revealed by RepeatMasker. In fact, when 
analyzed using GeneMark in the same way as described for the entire set of TE-derived 
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exons, all of their protein coding probabilities are significantly greater (z-test: 
15.5<z<16.9) than the average protein coding probability (0.35) of the aforementioned set 
of TE-derived exons: Telomerase=0.81, RAG1=0.77, CENP-B=0.89. Interestingly, the 
protein coding probability of the relatively recent case of TE-CDS exaptation, SETMAR 
(0.67), is also significantly greater (z=11.8) than the average coding potential for the set 
of RepeatMasker identified TE-derived exons. This is consistent with the fact that, while 
SETMAR does represent a recent case of TE-CDS exaptation, the particular TE-sequence 
that was exonized was already a protein-coding domain prior to becoming a host gene 
(CORDAUX et al. 2006).     
Taken together, these protein coding probability data are consistent with previous 
studies that have suggested caution is warranted when extrapolating genome sequence 
analyses to infer TE-CDS exaptation events (GOTEA and MAKALOWSKI 2006; KRIEGS et 
al. 2005; PAVLICEK et al. 2002; WILSON et al. 2006). In particular, the notion that non-
autonomous TEs that do not encode any protein, including SINEs such as the Alu family 
of elements, can emerge as protein coding sequences after being incorporated into exons 
has been directly challenged (PAVLICEK et al. 2002). On the other hand, Alus are 
frequently incorporated into mRNAs as exons (DAGAN et al. 2004; MAKALOWSKI et al. 
1994; SOREK et al. 2002; YULUG et al. 1995), and there are a number of specific cases of 
Alu-derived CDS that have been proposed to provide novel CDS to primate genes 
(KRULL et al. 2005; SINGER et al. 2004). In light of this controversy, we have specifically 
evaluated the potential coding capacity of Alu-derived exons using GeneMark.  
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Figure 3.4: Coding probability of human CCDS genes. The coding probability of TE-
derived coding sequences (pink) and non TE-derived coding sequences (blue) are shown, 
with results from the original GeneMark model (A) and our custom trained GeneMark 
model (B). TEs are separated in Alu (red) and non-Alu (green) for the original (C) and 




Alu-derived exons were considered separately from all other TE-derived exons 
and their coding probability distributions were plotted along with the distribution for non 
TE-derived exons (Figure 3.4C and Figure 3.4D). Alu-derived exons have coding 
probability distributions that are shifted to the left, i.e. towards lower probability, than all 
other TE-derived exons. Indeed, the average coding probabilities for Alu-derived exons 
are significantly lower than the averages for all other TE-derived exons (Table 3.7). This 
result holds under a number of different analytical conditions (see Methods), including 
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the two different GeneMark models and the consideration of Alu-derived exons as only 
containing Alu sequences or containing Alu plus other TE sequences (composite TE-
exons in Table 3.7).  
 
 
Table 3.7: Comparison of protein coding potential for Alu-derived exons versus 
other TE-derived exons 
Average protein coding potentials are compared between the specific pairs of groups 
indicated using the Student’s t-test. Comparisons were done using two GeneMark 






mean df t P 
Alu-exons vs. other 
TE-exons 
0.0069 vs. 0.3229 158 9.8 5.2e-18 Pre-trained 
Alu-containing 
composite TE-exons 
vs. other TE-exons  
0.0135 vs. 0.3417 158 9.6 1.3e-17 
Alu-exons vs. other 
TE-exons 
0.2034 vs. 0.3802 158 2.9 4.3e-3 Custom-trained 
Alu-containing 
composite TE-exons 
vs. other TE-exons  





In addition to the global analysis of Alu-derived exon protein coding potential, we 
also evaluated several documented cases of Alu exonization events that are assumed to 
represent TE-CDS exaptations (KRULL et al. 2005; SINGER et al. 2004). For these cases, 
the specific evolutionary scenarios giving rise to the Alu-derived exons are quite well 
documented, but the protein coding potential of the Alu-exons appears to be assumed.  
Here, the GeneMark web server (http://exon.gatech.edu/GeneMark/), which runs 
both GeneMark and GeneMark.hmm (LUKASHIN and BORODOVSKY 1998) programs, was 
used to plot protein coding probabilities along the length of the CDS using a sliding 
window (Figure 3.5). This allowed the protein coding potential of the Alu-derived exons 
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to be directly compared to that of the non TE-derived exons in the same genes. Consistent 
with their status as protein coding genes, the coding sequences analyzed tend to show 
uniformly high protein coding probabilities. However, the Alu-derived exons show far 
lower protein coding potential than the rest of the gene sequences. The apparent low 
coding potential of Alu-derived exons may also reflect the fact that these sequences have 
a relatively recent evolutionary origin as exons and thus have not had enough time to 
accumulate the kinds of changes that would yield periodicities that more closely resemble 
other coding sequences. 
 
              
Figure 3.5: Coding probability of genes with Alu-derived exons. GeneMark protein 
coding probability analyses are shown for three genes with well characterized Alu-
derived exons: C-rel-2 [CCDS: CCDS1864.1] (A) MTO1-3 [CCDS: CCDS4979.1] (B) 
and PKP2b-4 [CCDS: CCDS8731.1] (C) (KRULL et al. 2005). Coding probabilities were 
calculated within windows sliding along the length of the genes. The locations of the 
Alu-derived exons are shown in red.  
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GC codon distribution for TE-derived exons  
The distribution of GC content across codon positions can also be used to 
evaluate the protein coding potential of genomic sequences. This kind of analysis is based 
on the fact that the GC level (%G+C) is distinctly lower in the second (GC2) than in the 
third (GC3) codon positions for protein coding sequences in species ranging from human 
to Escherichia coli (CRUVEILLER et al. 2007; JABBARI et al. 2004). Thus, for protein 
coding sequences, regression analysis of %GC2 x %GC3 should yield a trend line with a 
slope y<<1. Here, we used GC2/GC3 regression analysis to compare the protein coding 
potential of TE-derived versus non TE-derived exons.      
For the first analysis, GC2/GC3 trends were computed for entire genes that 
contain one or more TE-derived exons versus entire genes with no TE-derived exons  
(Figure 3.6A). In this case, the GC2/GC3 distributions are indistinguishable and do not 
have significantly different slopes (t=0.36, df=14,798, P=0.71). However, 27.93% of  
TE associated genes were located outside the 95% confidence band of non TE-associated 
gene set. On the other hand, when TE-derived exons are considered alone (Figure 3.6B), 
the slopes of the TE-derived versus non TE-derived sets are significantly different 
(t=2.84, df=14,384, P=4.6e-3), and 31.70% of TE-derived exons are found outside the 
95% confidence interval for the non TE-derived set. Thus, while the GC2/GC3 analysis 
appears to suffer from a lack of resolution compared to the GeneMark coding potential 
analysis, it too points to a relatively low coding probability for TE-derived exons.  
We also analyzed Alu-derived exons separately using GC2/GC3 codon analysis as 
was done with GeneMark. Visual inspection of the location of Alu-derived exons on the 
GC2/GC3 plot shows that they have relatively higher GC2, typical of non-coding 
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sequence, and 41.79% fall outside the 95% confidence interval, all of which fall above 
the upper confidence interval boundary (See Figure B.1). In addition, Alu-derived exons 
have average GC2/GC3 ratios that are significantly higher than the GC2/GC3 ratios for 
all other TE-derived exons and for the non TE-derived gene set (Table 3.8).  In other 
words, the GC2/GC3 analysis also suggests that Alu-derived exons are less likely to 
encode protein sequences than other TE-derived exons. 
 
 
Figure 3.6: The GC composition of human CCDS genes. The scatter plots of %G+C of 
second (GC2) versus third (GC3) codon positions for TE-associated genes (red) and non 
TE-associated genes (green) are shown. The light blue line represents the linear 
regression line of non TE-associated genes while the blue lines show the 95% confidence 
interval. For the TE-associated group, the GC content for the whole sequence of TE-
associated genes (A) and for TE-derived gene fragments only (B) are shown. The yellow 
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Table 3.8: Comparison of GC2/GC3 ratios for different classes of TE-derived and 
non TE genes (exons) 
Average GC2/GC3 ratios are compared for pairs of groups indicated using the Student’s 
t-test. 
 
Comparison groups averages df t P 
TE-genes vs. non TE-genes 0.82 vs. 0.76 14800 7.4 1.2e-13 
TE-exons vs. non TE-genes 0.96 vs. 0.76 14386 9.4 6.8e-21 
Alu-exons vs. other TE-exons 1.01 vs. 0.95 345 1.9 6.2e-2 
Alu-exons vs. non TE-genes 1.01 vs. 0.76 14106 8.2 3.9e-16 
 
 
CONCLUSIONS     
The potential for TE sequences to become exapted as host protein coding 
sequences through the process of exonization has received a great deal of attention as  
of late (BOWEN and JORDAN 2007; MAKALOWSKI and TODA 2007; PIRIYAPONGSA et al. 
2007b; VOLFF 2006; VOLFF and BROSIUS 2007). Implicit in much of this literature is the 
assumption that exonized TE nucleotide sequences, i.e. TE sequences that are spliced into 
mRNAs, actually encode protein sequences. However, this assumption has been 
challenged on several different fronts (GOTEA and MAKALOWSKI 2006; KRIEGS et al. 
2005; PAVLICEK et al. 2002; WILSON et al. 2006). In particular, it is unclear whether non-
autonomous TEs that do not encode any protein, such as Alu elements, actually provide 
protein coding sequences after becoming exonized (PAVLICEK et al. 2002). Nevertheless, 
recent studies continue to turn up numerous apparent cases of TE-CDS exaptation 
(BRITTEN 2006; ZDOBNOV et al. 2005). So the matter of TE-CDS exaptation remains 
unsettled, and in this report we have tried to address the issue from two perspectives: i-
with respect to the ascertainment biases that arise from the use of different sequence 
similarity search methods and ii-in terms of the protein coding potential revealed by the 
probabilistic analysis of exonized TE nucleotide sequences.    
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Our use of profile-based (HMM) sequence similarity searches did allow for 
greater sensitivity than the more widely used DNA-DNA (e.g. RepeatMasker) search  
methods when employed on a test set of well-characterized exapted TE-CDS (Table 3.5  
and Table 3.6). Thus, ascertainment biases could explain the paucity of reliable examples 
of TE-derived protein coding sequences uncovered via the analysis of experimentally 
characterized protein sequence data sets (GOTEA and MAKALOWSKI 2006; PAVLICEK et 
al. 2002). However, when profile-based search methods are similarly applied to large-
scale datasets of experimentally characterized proteins, they did not turn up many more 
cases than previously found (Tables 3.1, Table 3.2 and Table 3.4). In fact, the profile-
based search method appeared to be less sensitive than all BLAST-based search methods 
– nucleotide, protein or translated (Table 3.1 and Table 3.2). This apparent lack of power 
can actually be attributed to the superior selectivity of the profile-based methods (Figure 
3.1) and suggests that many of the putative TE-CDS exaptation events turned up in 
BLAST searches may be spurious. In other words, profile-based search methods possess 
a valuable combination of sensitivity, measured by their ability to recover positive 
control test cases, and selectivity than any of the other search methods used. 
Nevertheless, the different search methods are complementary to the extent that 
combined search approaches are needed to thoroughly check any data set for all potential 
TE-CDS associations. Different search methods will also be more or less appropriate 
depending on the kind of exonization event that is being analyzed; for instance, it will not 
be possible to search for the contribution of non-coding TEs to exapted protein domains 
using profile methods based on protein sequence alignments. 
The codon based analysis of exonized TE sequences suggests that many, if not  
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most, of these sequences do not actually encode any protein. Non-coding TEs that are  
exonized, such as Alu, have particularly low protein coding probabilities. The lack of  
protein coding potential does not mean that exonized TE sequences are necessarily non-
functional. They may in fact play a role in post-transcriptional gene regulation. We 
hypothesize that many exonized TE sequences serve as natural anti-sense transcripts, 
which can function as double stranded RNA regulators of gene (protein) expression. The 
repetitive dispersed nature of exonized TE sequences may provide a mechanism by which 
they can serve as master regulators with influence over the expression of numerous genes 
throughout the genome. 
METHODS 
Detection of TE-encoded protein fragments  
Sequence data sets  
The set of functionally well characterized proteins was taken from two databases: 
Protein Data Bank (PDB) (BERMAN et al. 2000) (downloaded on 03/02/07) and Swiss-
Prot Protein Database (BOECKMANN et al. 2003) (version 52.0). For the Swiss-Prot 
entries, only directly sequenced proteins were included in the data set. These directly 
sequenced proteins are the proteins whose amino acid sequence has been partially or 
completely determined experimentally by Edman degradation or by mass spectrometry 
and can be found by searching the Swiss-Prot database with the keyword ‘Direct Protein 
Sequencing’. The data set of experimentally characterized protein sequences from PDB 
and Swiss-Prot was then filtered to remove the sequences from viruses. The nucleotide 
coding sequences (CDS) corresponding to the final set of protein sequences was obtained 
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from EMBL CDS database (http://www.ebi.ac.uk/embl/cds/). It should be noted that PDB 
entries can contain more than one distinct protein sequence (chain) and the same protein 
sequence (chain) may be found in more than one PDB entry. A data set of protein 
sequences encoded by TEs and their corresponding CDS sequences were extracted from 
Repbase (JURKA 2000) version 12.02. The data set of all TE nucleotide sequences 
(including non-autonomous TEs) was retrieved from Repbase website 
(http://www.girinst.org/repbase/).  
Identification of TE-related protein domains  
Protein domains that are associated with TEs were identified in version 21.0 of 
the Pfam database (SONNHAMMER et al. 1997) and the associated InterPro annotation 
(APWEILER et al. 2001). Pfam entries, both keywords and domain descriptions, were 
automatically searched using a set of related terms (e.g. transposon, retrotransposon, 
retroviral/ retrovirus, transposase, reverse transcriptase, etc.) as in (ZDOBNOV et al. 2005). 
The resulting putative TE-related Pfam entries were then manually inspected to remove 
spurious hits corresponding to protein families that are not encoded by any TEs. Manual 
inspection was done using the Pfam domain descriptions and literature references. HMM 
profiles, representing the site-specific sequence variation, of the TE-related Pfam 
domains were used in searches with the HMMER program as described below.      
Sequence similarity searches  
The experimentally characterized PDB/Swiss-Prot protein sequence data sets  
described above were searched for the presence of the TE-related protein domains  
using version 2.3.2 of the HMMER program (http://hmmer.janelia.org/). HMMER 
searches were run using a series of increasingly stringent threshold E-values, from E-
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value≤1 to E-value≤0.00001, in addition to the gathering threshold (GA) and trusted 
cutoff (TC) threshold values (Table 3.1 and Table 3.2). The GA and TC threshold cutoffs 
are values that have been bench-marked by the developers of HMMER to ensure that a 
minimum number of false-positive hits are detected. The GA thresholds are empirically 
set for each Pfam model and correspond to the score used to collect all of the sequences 
included in the Pfam full alignment. In other words, the GA threshold corresponds to the 
complete absence of false-positives. The TC threshold is similar to GA in the sense that it 
corresponds to the lowest scoring hit to any sequence included as a true member of a 
particular Pfam domain. TE-associated PDB/ Swiss-Prot proteins detected by HMMER 
were classified into five categories: i-potential TE-related proteins (the host proteins 
containing TE-associated protein domains), ii-viral proteins (genuine viral proteins 
though the PDB source organism is not listed as a virus), iii-TE-encoded proteins found 
in TEs as opposed to cellular host proteins, iv-synthetic construct (synthesized protein 
sequences), and v-ubiquitous non-specific TE-related protein domains (i.e. host protein 
containing Pfam domains which are not specific to TE protein sequences but can be 
found in TEs as well).    
Various BLAST programs (ALTSCHUL et al. 1990) and the program 
RepeatMasker (SMIT et al. 1996-2004) were used to search the protein sequence and CDS 
data sets described above for TE-related protein sequences and/or TE-related CDS. The 
specific program-query-database combinations used for each search are shown in Table 
3.3. BLAST programs were run using a series of E-value thresholds, from E-value≤1 to 
E-value≤0.00001, with default parameters and without low-complexity filtering.  
The fraction (f) hits shared between any two methods was taken as the ratio of  
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the number of hits retrieved in both searches to the total number of hits in both searches.  







All pairwise similarity values were calculated in this way, and the resulting matrix was 
clustered using hierarchical clustering. Matrix clustering and visualization were done 
using the programs Genesis (STURN et al. 2002) and Matrix2png 
(http://bioinformatics.ubc.ca/matrix2png/) respectively.  
Analysis of known cases of TE-derived proteins (genes)  
Several well known cases of proteins (genes) derived from TEs were evaluated by 
the HMMER, BLAST and RepeatMasker programs to determine the efficiency of 
different search methods in detecting TE-CDS exaptation events. The TE sequence data 
set sources as described in the previous section were used for these searches. The 
Genbank sequence accessions for the known cases are Telomerase Reverse Transcriptase 
[RefSeq: NM_198253, NM_198255, NP_937983, NP_937986], Recombination 
Activating Gene 1 (RAG1) [RefSeq: NM_000448, NP_000439], Centromere protein B 
(CENPB) [RefSeq: NM_001810, NP_001801], SET domain and Mariner transposase 
fusion gene (SETMAR) [RefSeq: NM_006515, NP_006506].  
Evolutionary analysis of TE-associated protein domain  
We used the THAP domain-containing protein, C. elegans C-terminal binding  
protein (CtBP) [PDB: 2jm3], for a phylogenetic analysis of THAP domain shared 
between TE and cellular proteins. The position of the THAP domain in C. elegans CtBP 
[RefSeq: NP_508983] was identified using HMMER program. The BLASTP program 
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was used to search for the homologous sequences of CtBP THAP in other species, using 
the Genbank non-redundant database, and the sequence fragments corresponding to the 
THAP domain were extracted as “cellular THAP”. The library of TE proteins sequences 
(described in the sub-section Detection of TE-encoded protein fragments: Sequence data 
sets) was searched for the THAP-containing entries by using HMMER program with 
gathering (GA) threshold cutoff. The sequence fragments corresponding to the THAP 
domain in TE proteins were extracted as “TE-THAP” sequences.  
Phylogenetic analysis of THAP sequences was done using the neighbor joining 
algorithm (SAITOU and NEI 1987) implemented in the MEGA program (KUMAR et al. 
2004). Two sources of pairwise distances were used based on i-global sequence 
alignment of THAP domains with CLUSTALW (THOMPSON et al. 1994) and ii-local 
alignment of THAP domains using all-against-all pairwise BLASTP. For the global 
THAP domain sequence alignments, Poisson distances were used, and for the local 
THAP domain comparisons, p-values (proportion of differences) taken from the BLAST 
output were transformed into gamma distances using α=2.25 (NEI and KUMAR 2000).  
Bootstrap analysis, based on 1,000 replicates, was performed on the global THAP 
sequence alignment.   
Codon based analysis of TE-derived exons  
The UCSC Genome Brower (KAROLCHIK et al. 2003) and Table Browser tools 
(KAROLCHIK et al. 2004) were used to search for human protein coding sequences co-
located with TEs. Genomic locations  of the CCDS genes mapped to the hg17 (NCBI 
Build 35) version of the human genome sequence were compared to the locations of TEs 
annotated with the RepeatMasker program (SMIT et al. 1996-2004). The CCDS gene data 
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set (http://www.ncbi.nlm.nih.gov/CCDS/) was chosen because it represents a highly 
reliable set of gene models that are built from multiple lines of evidence and undergo 
quality analysis across several genomic centers before being released. Two data sets were 
created in this way: i-genes containing TE-derived exon sequences and ii-genes without 
TE-derived exons.   
Version 2.5f of the GeneMark program (BORODOVSKY and MCININCH 1993) was 
used to compare the protein coding probabilities of TE-derived and non TE-derived 
human exons. GeneMark uses three-periodic inhomogeneous Markov models to analyze 
protein coding sequences and we used two models in our analysis. The first model is the 
GeneMark model pre-trained on validated coding and non-coding sequences of the 
human genome. This model is made available with the program. We also trained a 
customized GeneMark model using protein coding exon sequences from the non TE- 
derived gene set for the coding training set and intron sequences from the same genes as 
the non-coding training set. Each training set was classified into five groups based on 
%GC content (<41, 41-47, 47-53, 53-59, >=59) for separate training of the fifth order 
Markov chain models. Note that 100 non TE-derived genes of each GC level were 
randomly selected as a set of non TE test sequences and removed from the training set 
before model training. The GeneMark program was run on the set of genes with TE-
derived exons using the custom made model parameters corresponding to the GC content 
of each gene. The sliding window size was chosen to be 96 nt long and the step size to be 
3 nt. The average posterior probability, which characterizes the probability that the 
sequence encodes a protein, was calculated for each TE-derived exon sequence fragments 
(>100 nt) using the following formula:  
          
                                                                                                                                                                        
 78
x..y 1
1P(cod ) =  P(cod |F)
in
∑     
where x+W/2<=i<=y-W/2, x=start position of TE fragment, y=end position of TE 
fragment, n=# of sliding windows for which the midpoint lies within the range of  x+W/2  
to y-W/2, i=the midpoint of each sliding window, P(cod1|F)=posterior probability of the 
event that given the fragment F, it carries genetic code in frame 1 (starting from the very 
first nucleotide), W=the width of sliding window. The coding probability was calculated 
in the same way for the non TE test sequences. The analysis was repeated for the same 
test set using the pre-trained GeneMark models for human genome.  
For the GC2/GC3 analysis, the GC level (%G+C) of second (GC2) and third  
(GC3) codon positions were calculated for each coding sequence of both the TE-derived 
 and non TE-derived gene data sets. In addition, %GC2 and %GC3 were calculated for 
TE-derived fragments that are at least 60nt long.    
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CHAPTER 4 
ORIGIN AND EVOLUTION OF HUMAN MICRORNAS  
FROM TRANSPOSABLE ELEMENTS 
 
ABSTRACT 
We sought to evaluate the extent of the contribution of transposable elements 
(TEs) to human microRNA (miRNA) genes along with the evolutionary dynamics of TE-
derived human miRNAs. We found 55 experimentally characterized human miRNA 
genes that are derived from TEs, and these TE-derived miRNAs have the potential to 
regulate thousands of human genes. Sequence comparisons revealed that TE-derived 
human miRNAs are less conserved, on average, than non TE-derived miRNAs. However, 
there are 18 TE-derived miRNAs that are relatively conserved, and 14 of these are related 
to the ancient L2 and MIR families. Comparison of miRNA vs. mRNA expression 
patterns for TE-derived miRNAs and their putative target genes showed numerous cases 
of anti-correlated expression that are consistent with regulation via mRNA degradation. 
In addition to the known human miRNAs that we show to be derived from TE sequences, 
we predict an additional 85 novel TE-derived miRNA genes. TE sequences are typically 
disregarded in genomic surveys for miRNA genes and target sites; this is a mistake. Our 
results indicate that TEs provide a natural mechanism for the origination of miRNAs that 
can contribute to regulatory divergence between species as well as a rich source for the 
discovery of as yet unknown miRNA genes. 
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INTRODUCTION 
MicroRNAs (miRNAs) are small, ~22 nt long, noncoding RNAs that regulate 
gene expression (AMBROS 2004). In animals, miRNA genes are transcribed into primary 
miRNAs (pri-miRNAs) and processed by Drosha to yield ~70-90 nt pre-miRNA 
transcripts that form hairpin structures. Mature miRNAs are liberated from these longer 
hairpin structures by the RNaseIII enzyme Dicer (BARTEL 2004). Drosha acts in the 
nucleus, cleaving the pri-miRNA near the base of the hairpin stem to yield the pre-
miRNA sequence. The pre-miRNA is then exported to the cytoplasm where the stem is 
cleaved by Dicer to produce a miRNA duplex. One strand of this duplex is rapidly 
degraded and only the mature ~22 nt miRNA sequence remains. The mature miRNA 
associates with the RNA-induced silencing complex (RISC), and together the miRNA-
RISC targets mRNAs for regulation. miRNA target specificity is determined by partial 
complementarity with the 3’ untranslated region (UTR) sequence of the mRNA, and 
regulation is achieved by translational repression and/or mRNA degradation. miRNAs 
have been implicated in a variety of functions, including developmental timing (LEE et al. 
1993; REINHART et al. 2000), apoptosis (BRENNECKE et al. 2003), and hematopoetic 
differentiation (CHEN et al. 2004). 
miRNAs were first discovered in Caenorhabditis elegans through genetic analysis 
of developmental mutants (LEE et al. 1993). The small RNA product of the lin-4 gene 
was found to negatively regulate lin-14 expression via interaction with a complementary 
region in the lin-14 3’-UTR. This system appeared to be unique until a second example of 
a similar small regulatory RNA in C. elegans, let-7, was discovered 7 years later 
(REINHART et al. 2000). Shortly thereafter, let-7 homologs and transcripts were detected 
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among a phylogenetically diverse set of animals (PASQUINELLI et al. 2000). The 
realization that miRNAs represent a distinct, coherent, and abundant class of regulatory 
genes was finally crystallized in 2001 with the publication of three back-to-back articles 
in Science, reporting the discovery of numerous novel miRNA genes (LAGOS-QUINTANA 
et al. 2001; LAU et al. 2001; LEE and AMBROS 2001). These articles introduced the term 
miRNA to refer to all small RNAs with similar genomic features but unknown functions, 
and miRNAs have now been found in all metazoans surveyed for their presence (BARTEL 
2004). 
Given their relatively recent discovery and characterization, a number of open 
questions concerning the function and evolution of miRNAs remain. In particular, the 
evolutionary origins of miRNAs are not well appreciated. For instance, many miRNA 
genes were found to be evolutionarily conserved and this was thought to be a general 
characteristic of miRNAs. However, a number of non-conserved miRNAs have been 
recently discovered (BENTWICH et al. 2005). The extent to which miRNA genes evolve as 
paralogous gene families is also unknown. Even the upper bound on the number of 
miRNA genes encoded by any given genome is not known (BEREZIKOV et al. 2006), and 
the number of new entries in the miRBase registry of miRNA genes continues to grow 
steadily (GRIFFITHS-JONES et al. 2006).  
We sought to evaluate the contribution of transposable elements (TEs) to the 
origin and evolution of human miRNA genes. Another class of regulatory RNAs, small 
Interfering RNAs (siRNAs), are known to be related to TEs. Interestingly, this has been 
pointed out as a distinction between miRNAs and siRNAs, which are closely related in 
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terms of structure, function, and biogenesis. As opposed to siRNAs, miRNAs were 
thought to derive from loci distinct from other genes or TEs (BARTEL 2004). However, 
several examples of miRNA genes that are derived from TEs have been recently 
identified (BORCHERT et al. 2006; PIRIYAPONGSA and JORDAN 2007; SMALHEISER and 
TORVIK 2005). We wanted to look at this phenomenon more closely to identify the full 
extent of human miRNA genes that are related to TEs and to characterize how these 
genes evolve as well as their regulatory and functional potential.  
TEs have several characteristics that make them interesting candidates for 
donating miRNA sequences. First of all, TEs are ubiquitous and abundant genomic 
sequences. Thus, they could provide for the emergence of paralogous miRNA gene 
families as well as multiple target sites dispersed throughout the genome. Since TEs tend 
to be among the most rapidly evolving of all genomic sequences, they may also provide a 
mechanism for the emergence of lineage-specific miRNA genes that could exert 
diversifying regulatory effects. Finally, the full contribution of TEs to miRNA sequences 
is likely to be underestimated due to ascertainment biases. This is because computational 
methods aimed at the detection of novel miRNAs tend to purposefully exclude TE 
sequences (BENTWICH et al. 2005; LI et al. 2006; LINDOW and KROGH 2005; NAM et al. 
2005). This is often done for reasons of tractability, but also reflects the widely held 
notion that TEs are genomic parasites that do not play any functional role for their host 
species (DOOLITTLE and SAPIENZA 1980; ORGEL and CRICK 1980). However, many 
studies have identified a variety ways in which TEs have been domesticated (MILLER et 
al. 1992) to provide functions to their hosts (KIDWELL and LISCH 2001). These cases 
include the donation of coding sequences (VOLFF 2006) as well as numerous instances of 
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TE-derived regulatory sequences (BRITTEN 1996; JORDAN et al. 2003; VAN DE 
LAGEMAAT et al. 2003). 
To evaluate the contribution of TEs to human miRNAs, we compared the 
genomic locations of TEs to the locations of experimentally validated human miRNA 
sequences reported in the miRBase database (GRIFFITHS-JONES et al. 2006). The 
evolutionary dynamics of TE-related miRNAs were evaluated by within- and between-
genome sequence comparisons. The potential regulatory and functional significance of 
TE-derived miRNAs was explored by combining information on miRNA target site 
prediction, expression data for miRNA-mRNApairs, and gene functional annotations. We 
also sought to discover putative cases of novel TE-derived miRNA genes in the human 
genome through ab initio prediction. 
MATERIALS AND METHODS 
Detection 
Human miRNA sequences and predicted target sites were taken from version 8.2 
of the miRBase database (GRIFFITHS-JONES et al. 2006). These data do not include ab 
initio miRNA gene predictions. The UCSC Genome Browser (KENT et al. 2002) and 
Table Browser (KAROLCHIK et al. 2004) tools were used to search for miRNA genes co-
located with TEs and to compare the evolutionary rates of miRNA genes. Human miRNA 
sequences were mapped to the hg18 (NCBI build 36.1) version of the human genome 
sequence and a generic feature format ‘‘custom track’’ was created (available upon 
request). Genomic locations of the miRNAs were compared to the locations of TEs 
annotated with the RepeatMasker program (SMIT et al. 1996-2004). For this purpose, pre-
computed RepeatMasker annotations of hg18 were combined with RepeatMasker 
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determined genomic locations of a set of  96 ‘‘conserved’’ TE families recently added to 
Repbase (JURKA et al. 2005). These conserved consensus sequences correspond to low 
copy number TEs that show anomalously low levels of between genome orthologous 
sequence divergence and can be found by searching Repbase (http://www.girinst.org/) 
with the keyword ‘‘conserved’’. Sequences of TE-derived miRNAs were compared to the 
human genome sequence using BLAT (KENT 2002) criteria used for genome sequence 
hits were (1) ≥80% sequence identity with the query miRNA sequence and (2) the 
genomic hit region must be ≥80% and ≤120% of the length of the miRNA query 
sequence. The latter requirement was used to ensure that long genomic insertions were 
not identified as putative paralogous miRNAs. 
Evolution 
Comparative genomic sequence data from the UCSC Genome Browser were used 
to analyze the relative evolutionary rates of human miRNAs. Evolutionary rates were 
derived from multiple whole genome sequence alignments between the human and 16 
other vertebrate genomes (BLANCHETTE et al. 2004; KENT et al. 2003). Human miRNA 
evolutionary rates were calculated in two ways: (1) by evaluating the number of 
conserved sites per miRNA and (2) by evaluating the per-site conservation scores of 
miRNA sequences. Conserved human genome sites were predicted by the phastCons 
program, which uses a phylogenetic hidden Markov model to calculate the probabilities 
of sites being either conserved or non-conserved (SIEPEL et al. 2005). Conservation 
scores for human genome sites were also taken from the phastCons analysis of the 
vertebrate multiple genome sequence alignment, and these scores correspond to the 
posterior probability that a site is conserved or non-conserved. 
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Regulation and function  
Human miRNA target site predictions were taken from miRBase, which uses a 
modified protocol based on the miRanda algorithm (ENRIGHT et al. 2003). The locations 
of target site sequences in the human genome were compared to the RepeatMasker-based 
TE annotations. Expression levels for human miRNAs across five tissues (thymus, brain, 
liver, placenta, and testis) were taken from an oligonucleotide-based microarray study 
(BARAD et al. 2004). Human mRNA expression levels from corresponding mRNA targets 
were taken from the Novartis Symatlas data set (SU et al. 2004). Corresponding miRNA 
and mRNA expression profiles were normalized using standard z-score transformation 
with the program Spotfire (http://www.spotfire.com) and compared using the Pearson 
correlation coefficient. Gene expression data were visualized using the Genesis program 
(STURN et al. 2002). Gene ontology (GO) analysis (ASHBURNER et al. 2000) was done 
using the GOTree Machine program (ZHANG et al. 2004). GOTree Machine was used to 
identify significantly over-represented biological process GO terms from a set of genes 
predicted to be regulated by a particular miRNA and to plot the location of these GO 
terms along the GO directed acyclic graph. 
TE-miRNA prediction 
TE locations in the human genome were considered together with the output of 
the program EvoFold, which combines RNA secondary structure prediction with the 
evaluation of multiple sequence alignments to identify conserved secondary structures 
(PEDERSEN et al. 2006). TE sequences that encode conserved hairpin structures with 
length ≥55 bp, a single terminal loop ≤20 bp, and at least six paired bases in the stem 
region (BENTWICH et al. 2005) were chosen for further analysis. For conserved TE-
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encoded hairpins of <55 bp that met all other criteria, the predicted secondary structure 
sequences were extended manually and rechecked for the ability to form hairpin 
structures using the program RNAfold from the Vienna RNA package (HOFACKER et al. 
1994). Sequences that were able to encode hairpins ≥55 bp after manual extension were 
chosen for further analysis. The potential for putative TE-derived miRNAs identified in 
this way to be expressed was evaluated using EST and mRNA data. Our TE-miRNA 
prediction protocol is represented in Figure C.1. 
RESULTS 
Transposable element-derived miRNAs 
miRBase is an online database of miRNA gene sequences and predicted target 
sites (GRIFFITHS-JONES et al. 2006); version 8.2 of miRBase contained 462 human 
miRNA gene sequences. Of these human miRNA genes, 379 are defined on the basis of 
experimental information, cloning of mature miRNA sequences for the most part, while 
83 are predictions on the basis of sequence similarity with miRNAs that have been 
experimentally characterized in related species. We mapped these human miRNA genes 
to the complete genome sequence and compared their locations to the locations of 
annotated TEs. A total of 68 human miRNA genes share sequences with TEs, and all but 
7 of these correspond to miRNAs experimentally characterized from human samples. The 
absence of ab initio miRNA gene predictions in the miRBase data set ensures that we are 
uncovering bona fide TE-miRNA relationships. Of these TE-related miRNAs, 49 are 
found in intron sequences while 19 are intergenic.  
TE-related miRNAs differ in terms of the extent of overlap with TE sequences 
and the number of distinct TE sequences from which they are derived. For each 
          
                                                                                                                                                                        
 87
individual TE-related human miRNA, a schematic in Figure C.2 illustrates the identity of 
all co-located TE sequences along with the extent and position of the TE-miRNA overlap 
and the relationship between the strand-specific orientation of the TE and the miRNA. 
The majority (50 of 68) of TE-related miRNAs consist of >50% TE-derived positions 
(Figure 4.1A), and this figure is likely to be an underestimate since many TE sequences 
are known to have diverged beyond the ability to be recognized by the RepeatMasker 
annotation software. The TE-miRNA overlap distribution for the region of the miRNA 
gene that corresponds to the processed (mature) regulatory sequence is even more 
bimodal (Figure 4.1B); 47 sequences have >95% of mature miRNA positions covered by 
TE sequence. Nevertheless, there are a handful (7 of 68) of TE-related miRNA genes that 
have <20% of their sequences co-located with TE sequence. These may represent 
spurious cases of TE-miRNA overlap. Visual inspection of the TE-miRNA alignments 
(Figure C.2) was used to eliminate these unreliable cases. Only the 55 cases with at least 
50% TE coverage of the pre-miRNA sequence and/or 100% TE coverage of the mature 
miRNA sequence were considered as actual TE-derived miRNAs and used for further 
analysis (Table 4.1). These 55 TE-derived miRNAs represent ~12% (55/462) of all 
human miRNAs reported in miRBase version 8.2. 
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Figure 4.1: Percentage of TE-derived residues in miRNA genes. Frequency 
distributions are shown for the percentages of TE-derived residues relative to miRNA 




Table 4.1: TE-derived human miRNAs 
Table 4.1 continued      
Namea Accnb Coordsc TEd Overlape Consf Targetsg 
hsa-mir-130b MI0000748 chr22:20337593-20337674(+) MIRm 65.85 0.8492 865 (10.75%) 
hsa-mir-151 MI0000809 chr8:141811845-141811934(-) L2 100.00 0.9317 863 (12.28%) 
hsa-mir-28 MI0000086 chr3:189889263-189889348(+) L2 93.02 0.9979 1136 (10.21%) 
hsa-mir-325 MI0000824 chrX:76142220-76142317(-) L2 89.80 0.9905 751 (13.32%) 
hsa-mir-330 MI0000803 chr19:50834092-50834185(-) MIRm 53.19 0.9867 927 (5.18%) 
hsa-mir-345 MI0000825 chr14:99843949-99844046(+) MIR 39.80 0.8265 895 (7.82%) 
hsa-mir-361 MI0000760 chrX:85045297-85045368(-) MER5A 81.94 0.9998 882 (14.51%) 
hsa-mir-370 MI0000778 chr14:100447229-100447303(+) MIRm 100.00 0.9893 1006 (4.77%) 
hsa-mir-374 MI0000782 chrX:73423846-73423917(-) L2 54.17 0.9970 773 (7.50%) 
hsa-mir-378 MI0000786 chr5:149092581-149092646(+) MIRb 90.91 1.0000 0 (0%)  
hsa-mir-421 MI0003685 chrX:73354937-73355021(-) L2 89.41 0.9999 1023 (14.47%) 
hsa-mir-422a MI0001444 chr15:61950182-61950271(-) MIR3 100.00 0.0018 940 (7.34%) 
hsa-mir-493 MI0003132 chr14:100405150-100405238(+) L2 66.29 0.9990 0 (0%) 
hsa-mir-513-1 MI0003191 chrX:146102673-146102801(-) MER91C 100.00 0.0543 1065 (7.14%) 
hsa-mir-513-2 MI0003192 chrX:146115036-146115162(-) MER91C 100.00 0.0003 1065 (7.14%) 
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Table 4.1 continued      
Namea Accnb Coordsc TEd Overlape Consf Targetsg 
hsa-mir-544 MI0003515 chr14:100584748-100584838(+) MER5A1 100.00 0.9337 1056 (10.42%) 
hsa-mir-545 MI0003516 chrX:73423664-73423769(-) L2 82.08 0.9958 1065 (16.35%) 
hsa-mir-548a-1 MI0003593 chr6:18679994-18680090(+) MADE1 78.35 0.0391 1255 (7.09%) 
hsa-mir-548a-2 MI0003598 chr6:135601991-135602087(+) LTR16A1, 
MADE1 
100.00 0.0047 1255 (7.09%) 
hsa-mir-548a-3 MI0003612 chr8:105565773-105565869(-) MLT1G1, 
MADE1 
100.00 0.0044 1255 (7.09%) 
hsa-mir-548b MI0003596 chr6:119431911-119432007(-) MADE1 83.51 0.0175 1197 (5.93%) 
hsa-mir-548c MI0003630 chr12:63302556-63302652(+) MADE1 83.51 0.0092 1302 (6.76%) 
hsa-mir-548d-1 MI0003668 chr8:124429455-124429551(-) MADE1 83.51 0.0076 1055 (10.24%) 
hsa-mir-548d-2 MI0003671 chr17:62898067-62898163(-) MADE1 83.51 0.0000 1055 (10.24%) 
hsa-mir-552 MI0003557 chr1:34907787-34907882(-) L1MD2 100.00 0.0000 1067 (11.62%) 
hsa-mir-558 MI0003564 chr2:32610724-32610817(+) MLT1C 45.74 0.0112 778 (7.58%) 
hsa-mir-562 MI0003568 chr2:232745607-232745701(+) L1MB7 100.00 0.0019 954 (11.64%) 
hsa-mir-566 MI0003572 chr3:50185763-50185856(+) AluSg 100.00 0.0000 1184 (80.07%) 
hsa-mir-570 MI0003577 chr3:196911452-196911548(+) MADE1 82.47 0.0000 1115 (4.22%) 
hsa-mir-571 MI0003578 chr4:333946-334041(+) L1MA9 96.88 0.0000 948 (8.33%) 
hsa-mir-575 MI0003582 chr4:83893514-83893607(-) MIR 61.70 0.0001 1048 (7.35%) 
hsa-mir-576 MI0003583 chr4:110629303-110629400(+) L1MB7 100.00 0.0121 921 (10.53%) 
hsa-mir-578 MI0003585 chr4:166526844-166526939(+) L2 44.79 0.0064 1012 (7.61%) 
hsa-mir-579 MI0003586 chr5:32430241-32430338(-) MADE1, 
L1MB8 
100.00 0.3543 1202 (6.32%) 
hsa-mir-582 MI0003589 chr5:59035189-59035286(-) L3, L3 85.71 0.9954 1017 (8.06%) 
hsa-mir-584 MI0003591 chr5:148422069-148422165(-) MER81 92.78 0.0008 794 (10.96%) 
hsa-mir-587 MI0003595 chr6:107338693-107338788(+) MER115 100.00 0.0053 970 (6.39%) 
hsa-mir-588 MI0003597 chr6:126847470-126847552(+) L1MA3 100.00 0.0000 873 (10.77%) 
hsa-mir-603 MI0003616 chr10:24604620-24604716(+) MADE1 84.54 0.0102 1008 (7.44%) 
hsa-mir-606 MI0003619 chr10:76982222-76982317(+) L1MCc 100.00 0.0014 776 (8.38%) 
hsa-mir-607 MI0003620 chr10:98578416-98578511(-) MIR 100.00 0.9990 985 (8.83%) 
hsa-mir-616 MI0003629 chr12:56199213-56199309(-) L2 100.00 0.0004 922 (10.30%) 
hsa-mir-619 MI0003633 chr12:107754813-107754911(-) L1MC4, 
AluSx 
100.00 0.0008 765 (8.89%) 
hsa-mir-625 MI0003639 chr14:65007573-65007657(+) L1MCa 100.00 0.0018 1065 (4.41%) 
hsa-mir-626 MI0003640 chr15:39771075-39771168(+) L1MB8, 
L1MCa 
56.38 0.0086 1022 (6.65%) 
hsa-mir-633 MI0003648 chr17:58375308-58375405(+) MIRb 100.00 0.0136 843 (7.12%) 
hsa-mir-634 MI0003649 chr17:62213652-62213748(+) L1ME3A 48.45 0.0019 886 (5.08%) 
hsa-mir-640 MI0003655 chr19:19406872-19406967(+) MIRb 100.00 0.0074 853 (28.49%) 
hsa-mir-644 MI0003659 chr20:32517791-32517884(+) L1MB3 61.70 0.1035 970 (4.95%) 
hsa-mir-645 MI0003660 chr20:48635730-48635823(+) MER1B 62.77 0.0002 682 (13.49%) 
hsa-mir-648 MI0003663 chr22:16843634-16843727(-) L2 98.94 0.0008 943 (6.15%) 
hsa-mir-649 MI0003664 chr22:19718465-19718561(-) L1M4, 
MER8, 
AluSx 
100.00 0.0005 1033 (10.65%) 
hsa-mir-652 MI0003667 chrX:109185213-109185310(+) MER91C 100.00 0.9883 803 (39.36%) 
hsa-mir-659 MI0003683 chr22:36573631-36573727(-) Arthur1 46.39 0.0027 890 (8.20%) 
hsa-mir-95 MI0000097 chr4:8057928-8058008(-) L2 95.06 0.9862 847 (16.06%) 
 
amiRNA name (from miRBase) 
bmiRBase accession number 
cHuman genome (hg18) coordinates of the miRNA 
dName of co-located TE 
ePercent of miRNA overlapping with TE sequence 
fAverage conservation score 
gTotal number of targets with percent derived from TEs shown in parentheses 
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The TE-related miRNAs that we identified are derived from all four major classes 
of human TEs: long- and short- interspersed nuclear elements (LINE and SINE), 
long terminal repeat containing elements (LTR) and DNA-type transposons (Table 4.1). 
Specific classes and families of TEs show marked over- or under-representation among 
human miRNAs (Figure 4.2). The related L2 (LINE) and MIR (SINE) families, as well as 
DNA elements, show far more overlap with miRNA genes than is expected on the basis 
of their relative frequency in the genome (37 observed versus 11 expected; χ2=30.74 
P=3.0e-8). Most of the DNA-type elements that contribute to miRNA genes are short 
non-autonomous derivatives of full-length transposons known as miniature inverted-
repeat transposable elements (MITEs). This includes a group of seven closely related 
miRNA genes (hsa-mir-548), which are all derived from the Made1 family of MITEs 
(PIRIYAPONGSA and JORDAN 2007). Alu (SINE) elements and LTR type TEs are 
generally under-represented among TE-derived miRNA genes. Most TE-related miRNA 
genes are derived from a single TE insertion, but there are several examples where nested 
insertion events have led to the origin of a single miRNA gene from two or even three 
TEs (Figure C.2). For instance, there are two cases where a Made1 element inserted into 
an LTR element yielded a miRNA gene (examples 24 and 27 in Figure C.2), and an 
insertion of an Alu into a L1 (LINE) sequence also gave rise to a miRNA gene (example 
46 in Figure C.2). 
TE-derived human miRNA genes were used as queries in BLAT searches against 
the human genome sequence to search for putative paralogs. There are 19 cases of TE-
derived miRNA genes with closely related paralogs in the human genome (Table 4.2). 
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The number of paralogs per miRNA ranges from 1, for the L1-derived hsa-mir-552, to 
145, for the Made1-derived hsa-mir-548d-2. 
 
 
                           
 
Figure 4.2: Percentage of TE sequences among different classes and families for the 
human genome (shading) and for TE-derived miRNA genes (solid). Relative 





Table 4.2: Putative TE-derived miRNA paralogs 
Table 4.2 continued   
Namea Accnb TEc Paralogsd 
 hsa-mir-513-1 MI0003191 MER91C 3 
 hsa-mir-513-2 MI0003192 MER91C 3 
 hsa-mir-548a-1 MI0003593 MADE1 24 
 hsa-mir-548a-2 MI0003598 LTR16A1, MADE1 81 
 hsa-mir-548a-3 MI0003612 MLT1G1, MADE1 82 
 hsa-mir-548b MI0003596 MADE1 23 
 hsa-mir-548c MI0003630 MADE1 124 
 hsa-mir-548d-1 MI0003668 MADE1 71 
 hsa-mir-548d-2 MI0003671 MADE1 145 
 hsa-mir-552 MI0003557 L1MD2 1 
 hsa-mir-562 MI0003568 L1MB7 2 
 hsa-mir-566 MI0003572 AluSg 87 
 hsa-mir-570 MI0003577 MADE1 48 
 hsa-mir-571 MI0003578 L1MA9 4 
 hsa-mir-579 MI0003586 MADE1, L1MB8 3 
 hsa-mir-603 MI0003616 MADE1 30 
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Table 4.2 continued   
Namea Accnb TEc Paralogsd 
 hsa-mir-607 MI0003620 MIR 1 
 hsa-mir-649 MI0003664 L1M4, MER8, AluSx 4 
 hsa-mir-652 MI0003667 MER91C 4 
 
amiRNA name (from miRBase) 
bmiRBase accession number 
cName of co-located TE 
dNumber of paralogous sequences in the human genome 
 
Evolution of TE-derived miRNAs 
Comparative genomic sequence data were used to assess the relative evolutionary 
rates of TE-derived miRNAs. This analysis was based on whole genome sequence 
alignments between humans and 16 other vertebrate species. Two related approaches 
were used to evaluate the conservation of individual miRNA sequence sites across 
vertebrate genomes; the first approach results in a binary characterization of either 
conserved or non-conserved for each site, while the second rests on a more continuous 
score that relates the probability of a site being conserved. All genome sites for human 
miRNAs were considered using these two metrics, and the relative conservation levels 
for TE-derived vs. non TE-derived miRNA genes were compared. A total of 32.1% of 
sites in TE-derived miRNAs map to the most conserved elements in the human genome. 
This is far greater than the ~5% of conserved sites seen for the entire human genome but 
significantly less than seen for non TE-derived miRNAs, which have 63.2% conserved 
sites (t=4.39 P=1.4e-5 Student’s t-test) (Figure 4.3A). When the per-site conservation 
probabilities of human miRNAs were measured, a similar pattern was observed. The 
average conservation score of TE-derived miRNAs was 0.33 compared to 0.63 for non 
TE-derived miRNAs (t=4.37 P=1.5e-5 Student’s t-test) (Figure 4.3B). In addition, the 
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frequency distribution of the average conservation scores for all human miRNA genes 
reveals that, compared to non TE-derived miRNAs, there are far more TE-derived 
miRNAs that show little or no conservation and fewer that are highly conserved (Figure 
4.3C). Thus, on the whole, TE-derived miRNAs are significantly less conserved than 
non TE-derived miRNAs.  
 
 
       
 
Figure 4.3: Evolutionary conservation of human miRNA genes. (A) The percentage 
of conserved residues for non TE-derived miRNAs (shading) versus TE-derived miRNAs 
(solid) with 95% confidence intervals shown. (B) The average per-site conservation score 
for non TE-derived miRNAs (shading) versus TE-derived miRNAs (solid) with 95% 
confidence intervals shown. (C) Frequency distribution of the average per-site 
conservation scores for non TE-derived miRNAs (shading) versus TE-derived miRNAs 
(solid).  
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We used the frequency distribution of average conservation scores to divide TE-
derived miRNAs into conserved (≥0.8 average conservation probability) and non-
conserved (<0.8 average conservation probability) groups. Using this criteria, there are 37 
non-conserved and 18 conserved TE-derived miRNAs (Table 4.1). The least conserved 
TE-derived miRNAs are primate specific, having orthologous sequences in the 
chimpanzee only or both the chimpanzee and rhesus genomes. Of 18 conserved miRNAs, 
14 are derived from the L2 and MIR families; this is far more than would be expected on 
the basis of the overall frequency of L2 and MIR sequences among TE-derived miRNAs 
(χ2=17.8 P=3.6e-5). The conservation of L2 and MIR TE-derived miRNAs is consistent 
with a previous study that found many anomalously conserved L2 and MIR sequences 
(SILVA et al. 2003). Indeed, L2 and MIR are relatively ancient TE families with many 
sequences that inserted prior to the divergence of the human and mouse evolutionary 
lineages. We observed 10 of the conserved L2- and MIR-derived miRNA sequences to 
have orthologous sequences in the mouse genome, and there are 9 orthologous mouse 
miRNAs in these regions that are annotated in miRBase (Table 4.3). All of the 8 
conserved L2 miRNAs are derived from the same region near the 3’end of the L2 
consensus sequence (approximately positions 3200–3400), while the 6 MIR-derived 
miRNAs are found in dispersed locations on the MIR consensus sequence. 
A frequency distribution of conserved vs. non-conserved TE-derived miRNA 
genes, compared to genome wide relative TE frequencies, reveals distinct conservation 
levels for miRNAs derived from particular TE classes/families (Figure 4.4). For instance, 
L2 and MIRs contribute far more conserved than non-conserved miRNAs, and the 
fraction of conserved L2 and MIR elements in miRNAs is much higher than seen for 
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these same elements in the genome as a whole. DNA-type elements show the opposite 
pattern. There is a higher fraction of non-conserved DNA-type elements among miRNAs 
than is seen for the whole genome. All of the miRNAs derived from Alu and L1 elements 
are non-conserved. 
 
Table 4.3: Human-mouse orthologous miRNAs derived from L2 and MIR TEs 
Human miRNAa Human coordsb TEc Mouse miRNAa Mouse coordsb 
hsa-mir-345: MI0000825 chr14:99843949-
99844046(+) 








L2 mmu-mir-151: MI0000173 gap 
hsa-mir-95: MI0000097 chr4:8057928-
8058008(-) 
L2 - gap 
hsa-mir-330: MI0000803 chr19:50834092-
50834185(-) 



































MIRb mmu-mir-378: MI0000795 gap 
 
amiRBase names and accessions for human and mouse orthologous miRNAs 
bGenome coordinates for human and mouse orthologous regions; ‘gap’ means no 
orthologous region. 
cName of the related TE sequence 
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Figure 4.4: Percentage of TE sequences among different classes and families for the 
human genome (shading), for conserved TE-derived miRNAs (solid) and for non-
conserved TE-derived miRNAs (open). Relative percentages are shown such that the 
total will sum to 100% for the genome and for each group of miRNAs. 
   
 
Regulation and function 
Given their high copy numbers, there is a potential for TE-derived miRNAs to 
regulate multiple genes via homologous target sites dispersed throughout genome. Using 
the miRBase target predictions, TE-derived miRNAs were found to have hundreds of 
putative target sites (Table 4.1; Figure 4.5A). However, while many of these target sites 
are also derived from TEs, in most cases the proportion of TE-derived target sites is 
~10% (Table 4.1; Figure 4.5B). Thus, TE-derived miRNAs also have the potential to 
regulate host genes with non TE-derived targets. The relative paucity of TE-derived 
target sites can be attributed, in part, to the fact that target site prediction methods employ 
conservation of 3’ UTR sequences as one criteria and TEs tend to be lineage specific and 
non-conserved. 
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Figure 4.5: Target site frequencies for TE-derived miRNAs. (A) Frequency 
distribution showing the number of target sites per TE-derived miRNA. (B) Frequency 




There are several outliers that have a substantially higher fraction of TE-derived 
target sites. For instance, hsa-mir-566 is derived from Alu and it has 1,184 predicted 
targets with 948 (80%) derived from TEs. Most of these TE-derived hsa-mir-566 target 
sites are related to Alu insertions and this is consistent with previous studies that have 
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found numerous putative Alu-related miRNA target sites in the human genome 
(DASKALOVA et al. 2006; SMALHEISER and TORVIK 2006).  
The predicted target sites analyzed here are all putative sites and it is difficult to 
know with certainty whether they are actually involved in miRNA-mediated gene 
regulation. Another way to evaluate the regulatory potential of miRNAs is to compare the 
expression patterns of miRNAs to the expression patterns of the genes they are thought to 
regulate (FARH et al. 2005; HUANG et al. 2006; SOOD et al. 2006; STARK et al. 2005). The 
rationale behind the miRNA-mRNA expression pattern comparison is based on the 
mRNA degradation model of miRNA action. According to this model, miRNA binding to 
mRNA target sites causes the mRNA transcripts to be degraded. This model predicts anti-
correlations between expression levels of miRNAs and the mRNAs of their target genes; 
i.e., high levels of miRNA would lead to decreased levels of targeted mRNA. 
We sought to compare miRNA expression levels for TE-derived miRNA genes to 
mRNA expression levels of their target genes to look for anti-correlations that are 
consistent with regulation via mRNA degradation. miRNA expression data were taken 
from a microarray study of 150 human miRNAs across five tissue samples (BARAD et al. 
2004), and mRNA expression data were taken from the Novartis SymAtlas (SU et al. 
2004). Pairs of miRNA-mRNA gene expression profile vectors were compared using the 
Pearson correlation coefficient (r). There were only three TE-derived miRNA genes with 
expression data available. Despite this small sample size and the fairly low resolution 
afforded by the comparison of only five tissues, we found numerous cases of strongly 
anti-correlated miRNA-mRNA pairs (Figure 4.6). Since this anti-correlation is consistent 
with the mRNA degradation model of miRNA gene regulation, it provides an additional 
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source of support for putative miRNA target sites and the regulatory action of TE-derived 
miRNAs. 
We also evaluated the GO biological process annotations of the anti-correlated 
gene sets to look for over-represented functional categories that may indicate specific 
functional roles for TE-derived miRNAs. The top 10% of anti-correlated mRNAs (i.e., 
those with the lowest r-values) for each of the three TE-derived miRNAs with expression 
data were evaluated for over-represented GO terms. The miRNA hsa-mir-130b gave the 
strongest signal of GO term over-representation; 39 of 80 genes were found to 
correspond to significantly over-represented GO terms (Table C.1). Many of these genes 
correspond to metabolism and transcriptional regulation in general as well as to several 
negative regulators of DNA metabolism (Figure C.3). This negative regulation is 
achieved in part by chromatin remodeling, silencing, and heterochromatin formation. 
Thus, hsa-mir-130b may act to indirectly up-regulate DNA metabolism by down-
regulating chromatin-based repressors. 
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Figure 4.6: Anti-correlated expression patterns for TE-derived miRNAs and their 
targeted mRNAs. Results for three TE-derived miRNAs with expression data are shown: 
hsa-mir-130b (A), hsa-mir-28 (B) and hsa-mir-95 (C). The top row shows the relative 
miRNA expression across five human tissues, and the subsequent rows show relative 
expression levels for targeted mRNAs. The 50 most negative Pearson correlation 
coefficients (range r=-0.99 to -0.51; P=1.2e-10 to 1.3e-1) are shown for each plot.  
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Prediction of novel TE-derived miRNAs  
The function of miRNAs, and of noncoding RNAs in general, is related to their 
secondary structure (MATTICK and MAKUNIN 2006). Selective constraint on such 
sequences often leads to compensatory mutations that maintain the base-pair interactions 
in the double-stranded regions of the structures, such as miRNA stem regions. Sequence 
alignments can be evaluated for the signal of conserved base-pair interactions as well as 
compensatory mutations to identify conserved, and thus presumably functionally 
relevant, secondary structural elements. Recent application of such techniques has led to 
the discovery of many novel putative regulatory RNA sequences (PEDERSEN et al. 2006; 
WASHIETL et al. 2005b). It has even been shown that orthologous regions that are not 
constrained at the level of primary sequence may nevertheless encode conserved 
secondary structural elements (TORARINSSON et al. 2006). Given the contribution of TEs 
to experimentally characterized miRNAs shown here and elsewhere (BORCHERT et al. 
2006; PIRIYAPONGSA and JORDAN 2007; SMALHEISER and TORVIK 2005), we sought to 
evaluate human TE sequences for the ability to form hairpin structures along with the 
signals of conserved base pairs and compensatory mutations that indicate putatively 
functional secondary structures. This approach provides a way to predict further 
contributions of TEs to miRNAs. 
Human genome TE sequences were evaluated for the potential to encode 
conserved secondary structures (PEDERSEN et al. 2006) that meet the criteria of miRNA 
genes (BENTWICH et al. 2005). This approach is conservative in the sense that it relies on 
sequence conservation and most of the experimentally characterized TE-derived miRNAs 
that we observe (37 of 55) are not evolutionarily conserved. Using this conservative 
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approach, we found 587 human TEs with the potential to encode conserved secondary 
structures (Table C.2); 4 of these sequences corresponded to previously known human 
miRNAs annotated in miRBase. Evaluation of these conserved secondary structures was 
used to identify 85 TE-derived sequences that meet the structural criteria of putative 
miRNA genes, and 70 of these sequences also show evidence of being expressed (Table 
4.4). These 70 putative TE-derived miRNA sequences meet the previously defined 
biogenesis, conservation, and, at least in principle, expression criteria used for the 
identification of miRNA genes (AMBROS et al. 2003). 
An example of a predicted TE-derived miRNA gene is shown in Figure 4.7. The 
MER135 sequence shown is a member of a family of recently characterized non-
autonomous DNA-type elements, i.e., MITEs, with ~500 copies in the human genome 
(JURKA 2006). Since MITEs have palindromic structures with terminal inverted repeats 
that flank short internal regions, their expression as RNA results in the formation of the 
kinds of hairpins seen for pre-miRNAs. Indeed, MITEs have previously been shown to 
contribute miRNA genes in the Arabidopsis and human genomes (METTE et al. 2002; 
PIRIYAPONGSA and JORDAN 2007). 
 
Table 4.4: Predicted TE-derived miRNA genes 
Table 4.4 continued   
Namea Coordsb TEc Expression datad 
3715_0_+_61 chr1:3131597-3131629(+) MER121 EST/mRNA/KG/RS 
15086_0_-_78 chr1:15041842-15041859(-) HAL1 EST/mRNA/KG/RS 
25288_0_-_83 chr1:23621848-23621877(-) MIRb EST/mRNA/KG/RS 
30647_0_+_38 chr1:27752374-27752433(+) MIRb EST/mRNA/KG/RS 
52664_0_-_50 chr1:44571346-44571464(-) Eulor9A EST/mRNA/KG/RS 
67626_0_-_76 chr1:57127400-57127465(-) Eulor1 EST/mRNA/KG/RS 
85615_0_+_83 chr1:76474930-76474947(+) MIRb EST/mRNA/KG/RS 
120809_0_+_79 chr1:111021701-111021719(+) MIR EST/mRNA 
122080_0_-_62 chr1:112177611-112177631(-) MIR EST/mRNA/KG/RS 
124780_0_-_66 chr1:114214379-114214407(-) MIRb EST/mRNA/KG/RS 
154818_0_-_64 chr1:162825371-162825437(-) MER135 EST/mRNA/KG/RS 
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Table 4.4 continued   
Namea Coordsb TEc Expression datad 
188052_1_-_92 chr1:198460508-198460590(-) Eulor3 - 
204532_0_-_104 chr1:211522027-211522054(-) UCON31 EST 
230542_0_-_67 chr1:244286075-244286098(-) L1MB3 EST/mRNA/KG/RS 
1231553_0_+_75 chr2:67238894-67239028(+) Eulor4 EST/mRNA 
1258257_0_+_85 chr2:104314401-104314489(+) MER134 - 
1361323_0_+_57 chr2:213067475-213067509(+) Eulor5A EST/mRNA/KG/RS 
1573547_0_+_44 chr3:61643441-61643518(+) MER126 EST/mRNA/KG/RS 
1573643_0_+_95 chr3:61718341-61718381(+) MER134 EST/mRNA/KG/RS 
1620066_0_-_64 chr3:116298434-116298458(-) Eulor1 EST/mRNA/KG/RS 
1651767_0_+_52 chr3:146074810-146074873(+) Eulor3 - 
1668216_0_-_58 chr3:168436231-168436447(-) MER126 - 
1730972_0_-_56 chr4:46681709-46681733(-) L1ME3B EST/mRNA/KG/RS 
1747758_0_-_63 chr4:74275595-74275629(-) L1M5 EST/mRNA/KG/RS 
1757379_0_+_70 chr4:85466757-85466855(+) MER134 - 
1827751_0_+_75 chr4:181988895-181988914(+) MIRb EST 
1830405_0_+_49 chr4:183690755-183690850(+) MER135 EST/mRNA/RS 
1873731_0_+_53 chr5:58495675-58495729(+) UCON9 EST/mRNA/KG/RS 
1902777_0_+_53 chr5:90643387-90643420(+) AmnSINE1_GG EST/mRNA 
1920501_0_+_72 chr5:113735156-113735173(+) L2 EST/mRNA/KG/RS 
1966281_0_+_83 chr5:156681824-156681841(+) MIR3 EST/mRNA/KG/RS 
1975838_0_-_80 chr5:165688874-165688944(-) Eulor5A - 
1979031_0_+_61 chr5:167506770-167506888(+) Eulor9A EST/mRNA/RS 
1987527_0_+_59 chr5:175727565-175727628(+) L2 EST/mRNA/KG/RS 
2000476_0_-_85 chr6:8499794-8499914(-) Eulor6C EST/mRNA 
2031067_0_+_44 chr6:39048083-39048162(+) Eulor5A EST/mRNA/KG/RS 
2075048_0_-_91 chr6:94484941-94484963(-) ERVL-E EST/mRNA 
2115069.5_0_+_82 chr6:141179709-141179763(+) Eulor5B - 
2165103_0_+_104 chr7:28447122-28447144(+) MER121 EST/mRNA/KG/RS 
2195049_0_+_117 chr7:73161289-73161306(+) MIR3 EST/mRNA/KG/RS 
2232211_0_+_45 chr7:113190696-113190791(+) Eulor6B - 
2247695_1_+_65 chr7:129521966-129521985(+) L1ME4a EST/mRNA/KG/RS 
2265159_0_+_85 chr7:146833245-146833271(+) UCON4 EST/mRNA/KG/RS 
2330918_0_-_108 chr8:79081399-79081462(-) Eulor3 - 
2344217_0_+_65 chr8:97188471-97188580(+) MER135 EST 
2348773_0_+_51 chr8:102229956-102230022(+) Charlie9 - 
2401146_0_-_96 chr9:16787222-16787246(-) MIR EST/mRNA/KG/RS 
2421368_0_-_79 chr9:37811135-37811158(-) L1MC4a EST/mRNA/KG/RS 
2426661_0_+_64 chr9:70297285-70297306(+) MER91A EST/KG/RS 
2455634_0_-_64 chr9:105918396-105918420(-) MER5A EST/mRNA/KG/RS 
2469999_0_+_79 chr9:118715772 -118715795(+) UCON11 EST/mRNA/KG/RS 
2500550_0_-_83 chrX:10899595-10899617(-) L4 EST/mRNA/KG/RS 
2519737_0_+_67 chrX:24557155-24557175(+) L1ME4a EST/mRNA/KG/RS 
2598753_0_+_171 chrX:123865376-123865447(+) Eulor11 EST/mRNA/KG/RS 
2607024_0_-_68 chrX:131689852-131689873(-) L1MB5 EST/mRNA/KG/RS 
2625375_0_+_86 chrX:152562536-152562556(+) L2 EST/mRNA/KG/RS 
276291_0_+_66 chr10:62836157-62836220(+) L1M5 - 
285555_0_+_63 chr10:72980870-72980944(+) MER125 EST/mRNA/KG/RS 
334961_0_+_78 chr10:117579937-117579954(+) L2 EST/mRNA/KG/RS 
335779_0_+_54 chr10:118027456-118027512(+) Eulor6D EST 
377681_0_+_96 chr11:19331037-19331062(+) L3 mRNA/KG 
425555_0_+_71 chr11:71985685-71985701(+) MIR EST/mRNA/KG/RS 
438439_0_+_83 chr11:83316376-83316398(+) L2 EST/mRNA/KG/RS 
486187_0_+_68 chr11:130861130-130861151(+) MIRb EST/mRNA/KG/RS 
487071_2_+_103 chr11:131453921-131453949(+) MER122 EST/mRNA/KG/RS 
492576_0_-_95 chr12:2125422-2125443(-) MIRb mRNA/KG/RS 
533638.0_0_-_122 chr12:50492331-50492353(-) MIRb mRNA/KG 
542148_0_-_83 chr12:55246557-55246574(-) LTR37B EST/mRNA/KG/RS 
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Table 4.4 continued   
Namea Coordsb TEc Expression datad 
551096_0_-_85 chr12:64538090-64538148(-) Eulor5A EST/mRNA/KG/RS 
596947_0_+_93 chr12:115505370-115505426(+) MER123 EST/mRNA 
697653_0_+_69 chr14:33093444-33093479(+) UCON11 EST/mRNA/KG/RS 
700890_0_-_65 chr14:35855217-35855366(-) Eulor6A EST/mRNA/KG/RS 
775713_0_+_77 chr15:25703141-25703162(+) L1MCc EST/mRNA/KG/RS 
787092_0_-_65 chr15:35993736-35993832(-) Eulor5A - 
896537_0_+_81 chr16:30749660-30749680(+) MIR EST 
928869_0_+_74 chr16:70304015-70304037(+) MIR3 EST/mRNA/KG/RS 
976169_0_+_86 chr17:24040248-24040268(+) L1ME4a EST/mRNA/KG/RS 
989909_0_+_100 chr17:34009010-34009024(+) MIR3 EST/mRNA/KG/RS 
1000039.8_0_+_109 chr17: 39468501-39468532(+)  L1MC4 EST/mRNA/KG/RS 
1077028_0_-_58 chr18:33875730-33875789(-) MIRb - 
1105916_0_-_78 chr18:71369451-71369514(-) UCON11 - 
1435354_0_-_79 chr20:44235903-44235921(-) MIR EST/mRNA/KG/RS 
1443968_0_-_61 chr20:53838763-53838824(-) UCON29 - 
1466070_0_-_70 chr21:33853177-33853203(-) L2 EST/mRNA 
1496941_0_+_79 chr22: 35289947-35289989(+) L1MC4 EST 
 
aName of the EvoFold locus from the hg18 UCSC Genome Browser annotation. The last 
field in the name corresponds to the EvoFold score. 
bGenome coordinates and strand of the EvoFold locus 
cName of the co-located TE 
dSource of the expression data for the locus: KG=UCSC Genome Browser Known gene 








          




Figure 4.7: Ab initio prediction of a human TE-derived miRNA genes. (A) Multiple 
sequence alignment of the MER135 consensus sequence with the human genome 
sequence and orthologous genomic regions from 11 other vertebrate genomes. The 
predicted secondary structure is shown below the alignment with paired and unpaired 
positions indicated by ‘( )’ and ‘.’ characters respectively. Residues are colored according 
to the annotated secondary structure base pairs and their substitutions: gray=unpaired & 
no substitution, purple=unpaired & substitution, black=paired & no substitution, 
blue=paired & single substitution, green=paired & double substitution, red=not 
compatible with annotated pair. (B) Phylogenetic tree of the aligned species showing the 
double substitutions that maintain the secondary structure. Paired double substitutions are 
indicated with brackets and their positions in the alignment are shown. (C) Secondary 
structure of the predicted miRNA gene. Positions of the double substitutions are indicated 
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DISCUSSION 
Abundance of TE-derived miRNAs  
Noncoding regulatory RNAs, such as miRNAs, are a recently discovered class of 
genes, and the number of miRNA genes that exist among eukaryotic genomes is very 
much an open question (BEREZIKOV et al. 2006). Sustained efforts at high throughput 
characterization of miRNA genes, based on both experimental and computational 
approaches, continue to result in the discovery of many novel miRNAs (BENTWICH et al. 
2005; CUMMINS et al. 2006). This can be appreciated by examining the release statistics 
of miRBase (ftp://ftp.sanger.ac.uk/pub/mirbase/sequences/CURRENT/README). 
Plotting the number of miRNA gene entries against the miRBase release dates suggests 
that the number of known miRNA genes has experienced two distinct phases of linear 
increase, before and after the June 2005 release, and the current rate of increase in known 
miRNA genes is even greater than for the initial phase (Figure C.4). 
For the most part, the miRBase data do not include substantial numbers of 
computationally predicted miRNA genes. The only computational predictions 
represented in miRBase are highly conserved sequences that are orthologous to 
experimentally characterized miRNAgenes in other species. Consideration of 
computationally identified miRNAs would suggest that miRNA gene numbers are 
substantially higher than currently appreciated. However, a number of computational 
methods for miRNA prediction do not consider TE-derived miRNAs (BENTWICH et al. 
2005; LI et al. 2006; LINDOW and KROGH 2005; NAM et al. 2005). This is because, 
mainly for reasons of tractability, one of the first steps in computational analysis of 
eukaryotic genome sequences is the exclusion of repetitive DNA by RepeatMasking. TEs 
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will also tend to be excluded from predictions based solely on conservation between 
species because they are rapidly evolving and lineage-specific genomic elements. This is 
underscored by the fact that the set of TE-derived human miRNAs that we identify here 
is enriched for genes experimentally characterized in humans (93% for TE-derived vs. 
81% for non TE-derived miRNAs; χ2=4.76 P=0.03).  
The factors described above that suggest the exclusion of TE-derived miRNAs led 
us to speculate as to how many more miRNA genes would be discovered if TE sequences 
were not eliminated from consideration a priori. To investigate this, we employed our 
own ab initio computational approach to try and predict TE-derived miRNA sequences. 
Application of this method to the human genome revealed 587 cases of human TE 
sequences that encode conserved RNA secondary structures, 85 of which are most likely 
to represent bona fide miRNA genes. Fifteen of the TE-derived miRNA genes that we 
predicted using this approach overlap with previous miRNA computational predictions 
(BEREZIKOV et al. 2005; PEDERSEN et al. 2006) as well as experimentally characterized 
miRNAs from miRBase.  
Conservation of TE-derived miRNAs 
Many miRNA genes are evolutionarily conserved and may have functional 
orthologs in multiple species. Indeed, sequence conservation is one of the criteria used to 
aid the computational discovery of miRNAs. While the TE-derived miRNA genes 
analyzed here are less conserved, on average, than non TE-derived miRNAs, there are a 
number of well-conserved miRNAs that evolved from TE sequences (Table 4.1). The 
majority of these conserved miRNAs are related to the ancient L2 and MIR TE families, 
and some of these sequences have been previously identified (SMALHEISER and TORVIK 
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2005). This is particularly interesting because numerous L2 and MIR sequences have 
been shown to be anomalously conserved between the human and mouse genomes 
(SILVA et al. 2003). Specifically, Silva et al. (2003) demonstrated that many L2 and MIR 
sequences found in orthologous human-mouse intergenic regions were present in the 
common ancestor of the two species and, following their divergence, evolved under 
strong selective constraint. From this, they reasoned that these selectively constrained 
sequences probably play some role related to gene regulation, although no specific 
functional role was ascribed to them. Here, we show that at least some of these conserved 
L2 and MIR fragments provide miRNA sequences with the potential to regulate 
numerous human genes. 
As in the case of L2 and MIR (SILVA et al. 2003), comparative genomic 
approaches are used to infer functionally important genomic regions, particularly 
noncoding regions, by virtue of their high sequence conservation (ZHANG and GERSTEIN 
2003). It is becoming increasingly apparent that a number of such highly conserved 
genomic sequences correspond to TEs (BEJERANO et al. 2006; KAMAL et al. 2006; 
NISHIHARA et al. 2006; XIE et al. 2006). While enhancer activity has been demonstrated 
for one of these conserved TEs (BEJERANO et al. 2006), for the most part, the specific 
function encoded by conserved TE sequences remains unknown. The collection of 
conserved TE sequences recently assembled by Repbase corresponds to <1% of all 
human genome TEs, but these sequences contribute >50% of all TE-encoded conserved 
secondary structures that we detected (Figure 4.2). Thus, our results suggest that many 
conserved TE sequences may encode miRNAs or perhaps other noncoding regulatory or 
structural RNAs. 
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Lineage-specific effects of TE-derived miRNAs 
Most of the TE-derived miRNAs analyzed here are not evolutionarily conserved 
(Table 4.1). This is not surprising when you consider that TEs are the most lineage-
specific and non-conserved elements found in eukaryotic genomes (LANDER et al. 2001). 
The over-representation of non-conserved sequences among TE-derived miRNAs is also 
consistent with previous work that has shown TE-derived cis-regulatory binding sites to 
be more divergent than non TE-derived cis sites (MARINO-RAMIREZ et al. 2005). From a 
practical perspective, this means that computational discovery methods that employ 
conservation as a criterion will necessarily overlook many TE-derived regulatory 
sequences. In terms of evolution, this means that the greatest differences between 
eukaryotic genomes will correspond to TE sequences. In this sense, TEs can be 
considered as drivers of genome diversification. This may be uninteresting if TEs serve 
only to replicate themselves and do not play any role for their host genomes as 
the selfish DNA theory of TEs holds (DOOLITTLE and SAPIENZA 1980; ORGEL and CRICK 
1980). However, if some TEs are in fact functionally relevant to their hosts, as we have 
shown here for the case of TE-derived miRNAs, then their divergence may have 
important evolutionary implications. Indeed, TE-derived regulatory sequences may be 
particularly prone to contribute to regulatory differences among species that lead to 
lineage-specific phenotypes. This has been shown for the case of TE-derived regulatory 
sequences that are associated with high levels of expression divergence between humans 
and mice (MARINO-RAMIREZ and JORDAN 2006). 
While most computational efforts to discover noncoding regulatory sequences 
have focused on conserved genomic elements, recent studies have begun to emphasize 
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rapidly evolving regions as well (POLLARD et al. 2006a; POLLARD et al. 2006b; 
PRABHAKAR et al. 2006). The rationale behind this is the notion that rapidly evolving 
regulatory regions may yield species-specific differences. An emphasis on the discovery 
of TE-derived regulatory sequences would complement current approaches to the 
discovery of rapidly evolving regulatory regions that are likely to contribute to the 
phenotypic divergence among species. 
Genome defense and global gene regulatory mechanisms 
Finally, we speculate that our results point to a connection between genome 
defense mechanisms necessitated by TEs and the emergence of global gene regulatory 
systems that may have allowed for the complex regulatory phenotypes characteristic of 
multicellular eukaryotes. TE insertions are highly deleterious and, as a consequence, a 
number of global gene silencing mechanisms, including methylation (YODER et al. 1997), 
imprinting (MCDONALD et al. 2005), and heterochromatin (LIPPMAN et al. 2004), may 
have evolved originally as TE defense mechanisms. siRNAs are also thought to have 
evolved as a defense mechanism against TEs (MATZKE et al. 2000; SLOTKIN et al. 2005; 
VASTENHOUW and PLASTERK 2004), and the results reported here and elsewhere 
(BORCHERT et al. 2006; PIRIYAPONGSA and JORDAN 2007; SMALHEISER and TORVIK 
2005) indicate that miRNAs can emerge from TEs as well. More recently, an analogous 
TE defense mechanism based on small RNAs complementary to TEs in Drosophila has 
been reported (BRENNECKE et al. 2007). Apparently, different RNA interference systems 
may have evolved convergently on multiple occasions to help silence TEs. Later, these 
regulatory mechanisms could have been co-opted to exert controlling effects over 
thousands of host genes as is the case for miRNAs. The evolution of such complex gene 
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regulatory systems can be considered nonadaptive (LYNCH 2007) in the sense that they 
did not evolve by virtue of selection for the role that they play now. However, neither did 
these global regulatory mechanisms evolve passively since they were swept to fixation by 
selective pressure to defend against TEs. Therefore, the emergence of TE-related global 
regulatory systems, exemplified by RNA interference, can be considered to be 
exaptations (GOULD and VRBA 1982) driven by the internal mutational dynamics 
(STOLTZFUS 2006) of the genome. 
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CHAPTER 5 
A FAMILY OF HUMAN MICRORNA GENES FROM MINIATURE 
INVERTED-REPEAT TRANSPOSABLE ELEMENTS 
  
ABSTRACT 
While hundreds of novel microRNA (miRNA) genes have been discovered in the 
last few years alone, the origin and evolution of these non-coding regulatory sequences 
remain largely obscure. In this report, we demonstrate that members of a recently 
discovered family of human miRNA genes, hsa-mir-548, are derived from Made1 
transposable elements. Made1 elements are short miniature inverted-repeat transposable 
elements (MITEs), which consist of two 37 base pair (bp) terminal inverted repeats that 
flank 6 bp of internal sequence. Thus, Made1 elements are nearly perfect palindromes, 
and when expressed as RNA they form highly stable hairpin loops. Apparently, these 
Made1-related structures are recognized by the RNA interference enzymatic machinery 
and processed to form 22 bp mature miRNA sequences. Consistent with their origin from 
MITEs, hsa-mir-548 genes are primate-specific and have many potential paralogs in the 
human genome. There are more than 3,500 putative hsa-mir-548 target genes; analysis of 
their expression profiles and functional affinities suggests cancer-related regulatory roles 
for hsa-mir-548. Taken together, the characteristics of Made1 elements, and MITEs in 
general, point to a specific mechanism for the generation of numerous small regulatory 
RNAs and target sites throughout the genome. The evolutionary lineage-specific nature 
of MITEs could also provide for the generation of novel regulatory phenotypes related to 
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species diversification. Finally, we propose that MITEs may represent an evolutionary 
link between siRNAs and miRNAs. 
INTRODUCTION 
Numerous human genome transcripts lack protein coding capacity, and these non-
coding RNA (ncRNAs) perform a variety of structural, enzymatic and regulatory 
functions (MATTICK and MAKUNIN 2006). MicroRNAs (miRNAs) are a class of short, 
~22 nt ncRNA that function as post-transcriptional regulators of gene expression 
(AMBROS 2004). Mature miRNAs are processed from longer RNA sequences that form 
local stem-loop (hairpin) structures (BARTEL 2004). The first step of the miRNA 
biogenesis pathway occurs in the nucleus where the RNase III enzyme Drosha cleaves 
both strands of the so-called pri-miRNA at the base of the stem. This yields a ~70–90 bp 
pre-miRNA hairpin that is exported to the cytoplasm where it is further processed by 
Dicer, another RNase III endonuclease. Dicer recognizes the double stranded portion of 
the RNA close the base of the pre-miRNA stem and cleaves both strands of the duplex in 
two places. This reaction cuts off the loop portion of the molecule as well as the terminal 
part of the stem leaving a short duplex that consists of the mature miRNA and a 
complementary miRNA* sequence that is rapidly degraded. Once liberated in this way, 
the mature miRNA sequence binds to partially complementary target sites in the 3’ 
untranslated regions (UTRs) of messenger RNAs (mRNAs) and regulates expression 
through a process of mRNA degradation and/or translational repression (BARTEL 2004).  
miRNAs were only recently discovered (LEE et al. 1993), and details regarding 
their origin and evolution have yet to be fully worked out. Since their original discovery, 
miRNAs have been detected in all metazoa surveyed for their presence (BARTEL 2004). 
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However, the full extent of miRNA genes in any particular genome is unknown, and a 
number of studies aimed at the detection of novel miRNA genes have been conducted to 
address this issue. Bioinformatic miRNA discovery relies primarily on the sequence 
conservation of miRNA genes and secondary structure of the pre-miRNAs (BENTWICH et 
al. 2005), while experimental efforts consist of forward (LEE et al. 1993) and reverse 
(CHEN et al. 2004) genetic studies as well as efforts to clone short mature miRNA 
sequences (LAGOS-QUINTANA et al. 2001; LAU et al. 2001; LEE and AMBROS 2001). 
Cloning mature miRNA sequences is technically challenging given their small size and 
associated instability. Thus, direct miRNA cloning is not well suited to large scale 
discovery efforts and may have already reached the point of diminishing returns (LAGOS-
QUINTANA et al. 2001). A recently published report described a novel high-throughput 
miRNA cloning technique aimed at increasing the efficiency of miRNA discovery 
(CUMMINS et al. 2006). This technique is based on the serial analysis of gene expression 
(SAGE) and takes advantage of well established protocols tailored to small RNA 
sequences. Application of this SAGE-based approach to human transcripts confirmed the 
presence of numerous miRNA genes that had been detected previously through 
computational and/or experimental surveys and also yielded more than 100 novel miRNA 
sequences (CUMMINS et al. 2006). Including these new data, version 8.2 of miRBase, the 
online microRNA database (GRIFFITHS-JONES et al. 2006), reports 462 human miRNA 
genes. The importance of miRNAs for human gene regulation is underscored by target 
site predictions (ENRIGHT et al. 2003), which reveal that these human miRNAs have the 
potential to regulate thousands of human genes. 
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miRNAs are closely related to another class of ncRNA, known as small 
interfering RNAs (siRNA), in terms of both biogenesis and regulatory function (AMBROS 
et al. 2003; BARTEL 2004). The mature biologically active forms of siRNA and miRNA 
are both processed from double stranded RNA (dsRNA) by Dicer. However, siRNAs are 
generated from long dsRNA precursors, which can be either endogenous or exogenous 
transcripts, whereas mature miRNAs are processed from shorter endogenous transcripts 
that form local hairpin structures. Numerous siRNA molecules are processed from both 
strands of the long dsRNA precursor, whereas a single mature miRNA sequence is 
generated from only one strand of the pre-miRNA hairpin. While miRNAs can act 
through translational repression of their targets, they may also cause mRNA degradation 
of their target genes in the same way that siRNAs do (HUTVAGNER and ZAMORE 2002a; 
LLAVE et al. 2002; YEKTA et al. 2004; ZENG et al. 2003). 
One previously recognized distinction between these two classes of regulatory 
RNA is the fact that miRNAs are generally found in unique genomic loci, such as 
intergenic regions (BARTEL 2004), while siRNAs originate from within already 
characterized sequences such as genes and transposable elements (TEs) (MATZKE et al. 
2000; SLOTKIN et al. 2005; VASTENHOUW and PLASTERK 2004). However, a recent report 
indicated that a number of mammalian miRNAs, including six human miRNAs, are in 
fact derived from TEs (SMALHEISER and TORVIK 2005). The abundance and repetitive 
nature of TE sequences could provide a natural mechanism for the generation of multiple 
miRNA genes, along with homologous target sites, dispersed throughout the human 
genome. TEs may also provide an evolutionary connection between siRNAs and 
miRNAs. In light of these possibilities, we sought to investigate the relationship between 
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human miRNAs and TEs by evaluating whether there exist families of related 
(paralogous) miRNA genes that are derived from TE sequences. We compared the 
genomic locations of experimentally characterized human miRNA genes to the annotated 
human TE sequences and discovered a set of closely related miRNA genes derived from 
a family of miniature inverted repeat transposable elements (MITEs). The palindromic 
sequence structure of MITEs, considered together with their insertion into 
transcriptionally active regions of the human genome, suggests a specific mechanism by 
which these kinds of elements could give rise to emergent mature miRNAs. 
METHODS 
TE-miRNA sequence analysis 
The UCSC Genome and Table Browsers (KAROLCHIK et al. 2003; KAROLCHIK et 
al. 2004) were used to analyze the March 2006 human genome reference sequence 
(http://www.genome.ucsc.edu/cgi-bin/hgGateway?org = Human&db = hg18). This 
sequence is referred to as the hg18 assembly on the UCSC Genome Bioinformatics 
website and corresponds to the human genome build 36.1 assembled by the National 
Center for Biotechnology Information (NCBI). The Table Browser was used to search 
genome-wide for co-located TE and miRNA gene sequences, and the Genome Browser 
was used to visualize the results on a case-by-case basis. The genome locations and 
identities of human TE sequences were taken from annotation generated by the 
RepeatMasker program (http://www.repeatmasker.org) (SMIT et al. 1996-2004). The 
genome locations and identities of experimentally characterized human miRNA gene 
sequences were taken from release 8.2 of the miRBase sequence database 
(http://microrna.sanger.ac.uk/sequences/) (GRIFFITHS-JONES et al. 2006). Evolutionary 
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conservation between human Made1-derived miRNA gene sequences and six mammalian 
genomes – chimp, rhesus, mouse, rat, dog and cow – was assessed based on the 
Alignment Net track of the UCSC Genome browser, which shows the best pairwise 
between-genome alignments corresponding to orthologous regions (KENT et al. 2003). 
The sequences of Made1-derived miRNAs were compared to the human genome 
sequence using the BLAT program (KENT 2002). Homologous genomic sequences were 
counted as statistically significant hits that matched ≥80% of the length of the query 
miRNA sequence and were confined to a local genomic region no longer than 120% of 
the query length (i.e. long genomic insertions were not counted). Made1 and hsa-mir-548 
sequences were aligned to each other using the program ClustalW (THOMPSON et al. 
1994). NCBI’s BLASTN program (http://www.ncbi.nlm.nih.gov/BLAST/) (ALTSCHUL et 
al. 1997) was used to search the Expressed Sequence Tags Database (dbEST) (BOGUSKI 
et al. 1993) for expressed human MITE sequences. Human genomic expression data from 
Affymetrix tiling GeneChips (CHENG et al. 2005), represented in the UCSC Genome 
Browser, were evaluated in order to identify transcriptionally active regions of the human 
genome. RNA sequences were folded using the Mfold (ZUKER 2003) web server 
(http://www.bioinfo.rpi.edu/applications/mfold/rna/form1.cgi). 
Regulatory analysis 
Putative miRNA target sites were taken from the miRBase Targets website 
(http://microrna.sanger.ac.uk/targets/v3/), which uses a modified implementation of the 
miRanda algorithm (ENRIGHT et al. 2003). 3’ UTRs of Ensembl genes were also searched 
for Made1-derived target sites. In this case, the same approach used by the current 
miRBase implementation of miRanda for annotating 3’ UTRs was employed. 
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Specifically, if there is no hexamer of ‘A’ residues in the last 30 bp of the 3’ UTR, the 
sequence is extended 2,000 bp. The random expectation for the number of target genes 
identified by both methods was calculated by taking their joint probability multiplied by 
the total number of human genes (n = 23,269 from Ensembl version 41). The joint 
probability was calculated by multiplying the relative human genome frequencies of each 
target set. The difference between the expected and observed number of target genes 
identified using both methods was calculated using the binomial distribution. 
Comparative genomic sequence data from the UCSC genome browser were used 
to analyze the relative evolutionary conservation levels for predicted hsa-mir-548 target 
sites. Position-specific conservation scores were derived from multiple whole genome 
sequence alignments between the human and 16 other vertebrate genomes (KENT et al. 
2003; ZUKER 2003). The scores correspond to the posterior probability that a human 
genome site is conserved as determined by the phastCons program (SIEPEL et al. 2005), 
and position-specific scores were averaged across target sites. 
Human gene expression patterns across 79 tissues were taken from the Novartis 
Research Foundation’s Symatlas (SU et al. 2004). Relative expression profiles for genes 
with hsa-mir-548 target sites were computed for each gene by dividing the gene’s tissue-
specific expression (signal intensity) values by the gene’s median expression value over 
all 79 tissues and then log2 normalizing the resulting ratios. The program Genesis (STURN 
et al. 2002) was used to visualize the relative expression profiles, to group related 
expression profiles with k-means clustering and to group tissues with hierarchical 
clustering. 
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Clusters of coexpressed genes were analyzed with the program GOTree Machine 
(GOTM) (ZHANG et al. 2004) to look for over-represented Gene Ontology (ASHBURNER 
et al. 2000) functional annotations. To do this, genes in each cluster were annotated with 
their biological process GO terms. The frequencies of these terms were then compared to 
their expected frequencies based on their occurrences in the human genome, and 
statistically over-represented terms were identified using the hypergeometric test. 
Statistically over-represented terms were then mapped to the GO directed acyclic graph. 
RESULTS AND DISCUSSION 
A TE-derived miRNA gene family 
When we compared the genomic locations of experimentally characterized human 
miRNA sequences stored in miRBase (GRIFFITHS-JONES et al. 2006) to the locations of 
human TEs characterized by the program RepeatMasker (SMIT et al. 1996-2004), we 
found that seven closely related miRNA genes (hsa-mir-548) were co-located with 
dispersed members of a single family of TEs known as Made1 (Table 5.1). These hsa-
mir-548 miRNA genes were recently characterized by mapping mature cloned miRNA 
sequences to the human genome sequence (CUMMINS et al. 2006). The hsa-mir-548 
mature miRNAs meet both the expression and biogenesis criteria that were articulated to 
ensure the accurate identification of miRNAs and the distinction between miRNAs and 
siRNAs (AMBROS et al. 2003). In particular, the mature hsa-mir-548 miRNAs are all 22 
nt in length, they were identified from a cDNA library made of size fractionated RNA 
and they map precisely to genomic regions that are predicted to form local hairpin 
structures. 
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Inspection of the multiple sequence alignment of a full length Made1 sequence 
with all seven hsa-mir-548 miRNAs provides clear evidence that the miRNAs are in fact 
derived from the Made1 elements (Figure 5.1). Individual hsa-mir-548 sequences were 
queried against the human genome sequence to search for duplicates. Each hsa-mir-548 
gene showed significant similarity to numerous genomic regions (Table 5.1), suggesting 




Table 5.1:  Made1-derived miRNA genes in the human genome 
 
Namea Accnb Chrc Startc Stopc Strc Duplicatesd 
hsa-mir-548a-1 MI0003593 6 18679994 18680090 + 24 
hsa-mir-548a-2 MI0003598 6 135601991 135602087 + 81 
hsa-mir-548a-3 MI0003612 8 105565773 105565869 - 82 
hsa-mir-548b MI0003596 6 119431911 119432007 - 23 
hsa-mir-548c MI0003630 12 63302556 63302652 + 124 
hsa-mir-548d-1 MI0003668 8 124429455 124429551 - 71 
hsa-mir-548d-2 MI0003671 17 62898067 62898163 - 145 
 
amiRNA gene name 
bmiRBase accession number 
cHuman genome chromosome coordinates and strand information 
dDuplicate sequences taken as the number of statistically significant human genome 




   
Figure 5.1: Multiple sequence alignment of Made1 and hsa-mir-548 genes. The 
location of the mature miRNA sequence is indicated by the bar over the alignment. The 
strand of the Made1 element (+/-) from which the miRNA genes are derived is shown to 
the right of the alignment. 
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Made1 elements were independently characterized by several groups as non-
autonomous derivatives of the human mariner-like transposable element (TE) Hsmar1 
(MORGAN 1995; OOSUMI et al. 1995; SMIT and RIGGS 1996). Hsmar1 elements are DNA-
type TEs, approximately 1,300 bp in length, which possess a transposase-encoding open 
reading frame flanked by terminal inverted repeat (TIR) sequences (Figure 5.2A) 
(ROBERTSON and ZUMPANO 1997). Related Made1 elements are only 80 bp long with two 
37 bp TIRs and a 6 bp intervening region (Figure 5.2B). In this sense, Made1 sequences 
are palindromes, and if they were to be transcribed, they would form highly stable hairpin 
loops reminiscent of the pre-miRNA structures that are processed to form mature 




           
 
Figure 5.2: Schematic illustrating the relationship between Hsmar DNA-type TEs 
(A), Made1 MITEs (B) and hairpins (C) of the kind recognized by the miRNA 
enzymatic processing machinery. (A) A full length DNA-type element with terminal 
inverted repeats (TIRs) flanking an open reading frame (ORF) is shown. (B) Non-
autonomous MITE derivative of a full length DNA-type element, containing TIRs but no 
internal ORF. (C) Predicted hairpin structure that would be formed by base-pair 
interactions of the MITE TIRs. 
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The formation of TIR-based dsRNA hairpins from Made1 would require the 
generation of full-length (or nearly so) element transcripts. The human expressed 
sequence tag (EST) database was searched using BLASTN (ALTSCHUL et al. 1997), with 
a full-length Made1 query sequence, to test for this. We found 141 human ESTs that 
showed >80% sequence similarity to the Made1 query sequence over >80% of the length 
of the element (Table D.1). Furthermore, the EST analysis indicates that Made1 
sequences are widely expressed in a variety of tissue-types, providing ample opportunity 
for the formation of mature miRNAs. 
Interestingly, Made1 transcripts destined to become hsa-mir-548 miRNAs are 
generated from both strands of the element (Figure 5.1). Because the element sequences 
are palindromes, transcripts produced in either orientation (+/-) would yield local hairpin 
structures. Indeed, the only difference between strand-specific transcripts is seen for the 
intervening 6 bp sequence that forms the loop in the structure (positions 51–56 in Figure 
5.1). This suggests that Made1 expression may result from read-through transcripts 
promoted from adjacent genomic positions, as opposed to a strand specific promoter 
encoded by the element itself. Consistent with this notion, we found that a number of 
Made1 homologous ESTs include substantial upstream and downstream sequences 
(Table D.1). 
Therefore, we propose a model whereby Made1 insertions into transcriptionally 
active genomic regions would yield viable pri-miRNA structures that would be processed 
into mature miRNA sequences by the RNA interference enzymatic machinery. An 
example of such a scenario can be seen for the human EST corresponding to the Genbank 
accession BU608159. This 754 base pair (bp) EST maps to chromosome 13 at positions 
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24,718,360–24,719,104; it includes a nearly full length Made1 element as well as 325 bp 
of 5’ flanking DNA and 353 bp of sequence 3’ to the element. Visualization of genomic 
expression data, generated with human genome tilling arrays (CHENG et al. 2005), shows 
that this particular Made1 is inserted into an intergenic region of the genome that is 
transcriptionally active (Figure 5.3). In this case, the entire Made1 element is transcribed 
as a read-through initiated from an adjacent genomic position. When the RNA structure 
of the EST, which includes the Made1 element along with expressed genomic flanking 
regions, is evaluated using the program Mfold, the Made1 region can be seen to form the 
most stable stem-loop structural element in the RNA (Figure 5.4A). The tight hairpin 
formed by the element is similar to the structures processed by Drosha and Dicer, and the 
location of the mature miRNA sequence, in the stem close to the 3’ end of the structure, 




   
 
Figure 5.3: Made1 insertion in a transcriptionally active region of the human 
genome. The Made1 element shown is expressed by read-through from an adjacent 
promoter position in the genome. The EST BU608159 consists of the Made1 element 
along with 678 bp of flanking DNA. 
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Figure 5.4: RNA secondary structures of the entire BU608159 EST (A) and the 
Made1 element contained within this transcript (B). The Made1 hairpin region of the 
BU608159 structure is indicated with a blue bar (A), and the location of the mature 
miRNA sequence is shown with the red bar (B). 
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Regulatory effects of hsa-mir-548 
Mature miRNA sequences associate with the RNA-induced silencing complex 
(RISC), which facilitates their regulatory interactions with target mRNAs (BARTEL 
2004). miRNAs wield specific regulatory effects on gene expression through physical 
interactions with partially complementary sequences in the 3’ untranslated regions 
(UTRs) of their target genes’ transcripts. We sought to characterize the potential 
regulatory and functional effects of hsa-mir-548 miRNAs by analyzing the genes that 
they are predicted to target. 
Putative hsa-mir-548 target sites were identified using two methods: i-by the 
modified miRanda algorithm implemented in miRBase and ii-by searching 3’ UTRs for 
Made1 sequences that are complementary to the mature hsa-mir-548 miRNAs. According 
to the miRBase predictions, the seven hsa-mir-548 genes have 3,527 potential target 
genes. Made1 related targets, on the other hand, are found in only 179 genes. This was 
slightly surprising given that there are 7,850 annotated Made1 sequences in the human 
genome. When the search for Made1-derived target sites was extended to entire 
transcripts, only one additional target was found in a 5’ UTR. Apparently, Made1 
sequences avoid protein coding gene exon regions and thus are poorly represented among 
potential hsa-mir-548 target sites. Furthermore, the intersection of  the target gene sets 
derived from the miRBase versus Made1 consists of a mere 29 genes, and this figure is 
only slightly higher than the random expectation of 27 shared targets (P=0.07 binomial 
distribution). That both target prediction methods detect such a small number of the same 
targets can be attributed to the fact that Made1 targets are likely to be avoided by the 
miRanda based approach due to its criterion of sequence conservation and the fact that 
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Made1 is an evolutionarily young TE family. Indeed, when the sequence conservation 
levels of target sites identified by the two methods were compared, Made1 related targets 
were found to be significantly less conserved, on average, than miRanda predicted targets 
(conservation scores: Made1 targets=0.0826±0.017 miRanda targets=0.3196±0.007; 
t=11.27 P=5.7e-29 Student’s t-test). 
The potential functional relevance of genes with Made1-derived target sites was 
evaluated by considering their Gene Ontology (GO) biological process annotations and 
looking for over-represented functional categories. This procedure identified seven 
over-represented GO biological process categories that include a total of 11 genes (Table 
D.2). The relationships among the over-represented GO functional categories in the 
Made1 target gene set can be visualized on the GO directed acyclic graph (Figure 5.5). 
This set includes genes with functional roles in cell proliferation, mitosis and apoptosis, 
all categories that are related to cancer. The hsa-mir-548 genes were characterized by 
virtue of their expression in colorectal cancer cell lines and tissue samples (CUMMINS et 
al. 2006). If hsa-mir-548 expression is up-regulated in colorectal cancer tissue, it may 
lead to the repression of genes that normally control cellular proliferation. Consistent 
with this scenario, several of the genes that correspond to over-represented functional 
categories were found to be down regulated in colorectal cancer tissue (Table D.2). These 
include genes encoding a cell division cycle protein (ENSG00000004897), a C epsilon 
type protein kinase (ENSG00000171132) and a centromere/kinetochore protein 
(ENSG00000086827). 
As mentioned previously, the paucity of Made1 related target sites was somewhat 
unexpected. Nevertheless, the identification of numerous non-Made1 related target sites 
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is interesting in the sense that it suggests that TE-derived miRNAs may be able to 
regulate host genes that do not have any related TE sequences. There are two models to 
explain the repressive effects that miRNAs exert on target gene expression: i-translational 
repression and ii-mRNA degradation (BABAK et al. 2004; YEKTA et al. 2004; ZENG et al. 
2003). Recently, anti-correlated expression patterns between miRNA sequences and their 
target mRNAs have provided evidence in favor of the mRNA degradation model (HUANG 
et al. 2006). We sought to further evaluate the potential mRNA degradation-based 
regulatory effects of the hsa-mir-548 miRNAs by searching for down regulation of 
putative target genes in tissue samples similar to the colorectal samples from which they 
were cloned (CUMMINS et al. 2006). Consideration of target gene relative expression 
levels can also be used to help validate target site predictions, which are prone to false 
positives. 
Gene expression profiles for potential hsa-mir-548 targets were taken from the 
Novartis Research Foundation’s Symatlas (SU et al. 2004). For the miRBase set, a total 
of 2,045 target genes were found with corresponding Symatlas expression data across 79 
human tissues. The expression data were median and log normalized to yield relative 
tissue-specific gene expression profiles, and these profiles were separated into 20 co-
expressed groups of genes using k-means clustering. Three of these clusters – 12, 15 and 
20 –showed marked down-regulation of the colorectal adenocarcinoma sample (Figure 
5.6). Interestingly, the genes found in these same clusters tended to be down-regulated in 
all five of the other cancer-related samples in the data set (Figure 5.7). This suggests the 
possibility that hsa-mir-548 miRNA genes may play some global role related to the 
regulation of gene expression in cancer. Indeed, hierarchical clustering of the tissue-
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samples based on the gene expression data unites all of the cancer samples into a single 
group to the exclusion of all normal tissues (Figure D.1); however, the colorectal 
adenocarcinoma sample is the outlier of this group (Figure 5.8). When the log2 median 
expression ratios were averaged for all genes with putative hsa-mir-548 target sites, the 
colorectal sample had the lowest relative expression level (q=9.72, v=12738, k=6, 
P<0.001 Tukey test; Figure 5.8). This finding is consistent with the fact that the hsa-mir-
548 genes were isolated from colorectal cancer samples, and points to an additional more 
specific role for these genes in colorectal cancer related gene regulation. The functional 
affinities of the genes in the three down regulated clusters were assessed using the same 
GO-based approach as for the set of genes with Made1 target sites. There are 29 GO 
biological process categories, encompassing 104 genes, which contain an over-
representation of genes from these clusters (Table D.3). These include genes involved in 
cell adhesion, cell signalling and signal transduction. The positions of these categories on 
the GO biological process DAG can be seen in Figure D.2. 
We also compared putative hsa-mir-548 target genes to a recently published 
collection of genes that were indicated as being involved in colorectal cancer by 
microarray expression profiling (SHIH et al. 2005). We found 22 examples of putative 
hsa-mir-548 target genes that were previously found to be related to colorectal cancer 
based on down-regulation in six separate microarray studies (Table D.4). These include a 
number of genes encoding various immune cell receptors as well as transcription factors 
and tumor necrosis factors. The apparent connection between cancer and the immune 
system in our dataset is supported by the similar down-regulated expression patterns seen 
for hsa-mir-548 target genes among the cancer and immune tissue samples (Figure 5.7). 
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However, a number of genes previously implicated in colorectal cancer etiology by virtue 
of up-regulation in previous studies were also found to have predicted hsa-mir-548 target 
sites. These cases may represent false positive target site predictions or could point to 
instances where hsa-mir-548 miRNAs act through translational repression and thus do 




          




Figure 5.5: GO biological process terms over-represented among the set of genes 
with Made1-derived hsa-mir-548 target sites. The portion of the directed acyclic graph  
(DAG) containing all paths from the root biological process term to the over-represented 
functional category terms is shown. Over-represented functional categories are indicated 
in red. 
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Figure 5.6: Coexpressed clusters of putative hsa-mir-548 target genes. Centroid 
views with average tissue-specific expression values are shown for all 20 clusters. 
Clusters containing genes down-regulated in the colorectal adenocarcinoma sample are 
shown in red and arrows indicate the colorectal sample. 
 
          




Figure 5.7: Representative gene expression profiles for putative hsa-mir-548 target 
genes from three coexpressed clusters (12, 15 and 20 in Figure 5.6). Expression 
profiles are median centered and log2 normalized, and the log2 ratio color scale is shown 
above the plot. Overexpressed genes are shown in red and underexpressed genes are 
shown in green. 
          




Figure 5.8: Relationships and average relative expression levels among the cancer 
tissues samples from the Novartis Symatlas microarray dataset. A dendogram 
relating the cancer samples based on similarities (differences) among relative expression 
levels is shown along with the average relative expression levels for all genes with hsa-




We report here a human miRNA gene family derived from TEs. The palindromic 
structure of the Made1 elements from which the hsa-mir-548 miRNA genes originated, 
together with their insertion into transcriptionally active genomic regions, points to a 
specific mechanism by which these sequences can be recognized and processed by the 
enzymatic machinery that yields mature miRNA sequences. In addition, the dispersed 
repetitive nature of TE sequences provides for the emergence of multiple novel miRNA 
genes as well as numerous homologous target sites throughout the genome. 
TEs also tend to be among the most lineage-specific, i.e. recently evolved, 
sequences in the human genome (LANDER et al. 2001). Made1 elements emerged along 
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the primate evolutionary lineage, and orthologous hsa-mir-548 sequences are confined to 
the human, chimpanzee and rhesus macaque genome sequences (Figure D.3). While 
many miRNA genes are conserved across more distantly related species, a recent analysis 
of the human genome detected numerous putative miRNAs that are not evolutionarily 
conserved (BENTWICH et al. 2005). TEs, such as Madel, represent a natural source of 
such lineage-specific miRNAs, which could in turn be responsible for regulatory 
phenotypes that contribute to evolutionary diversification between species. The relatively 
low conservation of Made1-derived target sites is also consistent with this lineage-
specific mode of evolution. 
MITEs are widely distributed among eukaryotes (FESCHOTTE et al. 2002a) and 
could provide for the emergence of regulatory RNAs, such as miRNAs, siRNAs or other 
small non-coding RNAs, in many different genomic contexts. For instance, MITEs are 
particularly prevalent in plants where they were first discovered (BUREAU and WESSLER 
1992); the rice genome alone contains ~90,000 MITEs (JIANG et al. 2004). A striking 
feature of plant MITEs is their apparent preference for insertion in gene regions (MAO et 
al. 2000; ZHANG et al. 2000). Accordingly, many thousands of plant MITEs must be 
expressed along with the gene sequences in which they are inserted. This would provide 
ample opportunities for the processing of MITE hairpins by RNA interference enzymatic 
machinery, which is known to play a particularly important role in plant gene regulation 
(MATZKE and MATZKE 2004). 
Finally, we would like to propose that MITEs, such as Made1, may represent an 
evolutionary intermediate between siRNAs and miRNAs. A number of epigenetic gene 
silencing mechanisms, such as cytosine methylation (YODER et al. 1997), genomic 
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imprinting (MCDONALD et al. 2005) and heterochromatin (LIPPMAN et al. 2004) are 
thought to have evolved as defense mechanisms against transposition. Subsequently, 
these TE silencing mechanisms were co-opted as global regulators to control the 
expression patterns of host genes. This may have led to the increase in regulatory and 
phenotypic complexity seen among members of the eukaryotic crown group. In a similar 
way, RNA interference by siRNAs is considered to have evolved to silence TEs 
(MATZKE et al. 2000; VASTENHOUW and PLASTERK 2004). Consistent with this model, 
there are a number of cases of siRNAs that originate from TEs in different species 
(ARAVIN et al. 2003; HAMILTON et al. 2002; LIPPMAN et al. 2003; ZILBERMAN et al. 
2003). Perhaps the best characterized example of this is the Muk TE repressor in maize 
(SLOTKIN et al. 2005). Muk is an effective silencer of the MuDR DNA-type TE, and the 
Muk locus consists of an inverted duplication of a partially deleted MuDR element. 
When Muk is transcribed, it yields a long (>2 kb) dsRNA hairpin structure that is 
processed to yield siRNAs. The connection between TEs and siRNAs has led to the 
proposal that origination from TEs distinguishes siRNAs from miRNAs (BARTEL 2004). 
However, as reported here and elsewhere (SMALHEISER and TORVIK 2005), more and 
more TE-derived miRNAs are being discovered. 
The model of miRNA emergence from MITEs that we propose here (Figure 5.2) 
suggests a way that miRNAs could have evolved from TE encoded siRNAs. One possible 
source of the TE encoded dsRNAs that serve as siRNA precursors is snap back panhandle 
structures between TIRs of autonomous DNA-type elements (VASTENHOUW and 
PLASTERK 2004). Such panhandle structures would include long internal loop regions that 
correspond to the internal open reading frames that are lost when autonomous elements 
          
                                                                                                                                                                        
 136
are converted to non-autonomous MITE derivatives. MITEs retain the TIRs, and those 
same TIRs that were processed from longer RNAs to form siRNA could be similarly 
processed to form miRNAs. The shorter hairpin structures formed by MITE transcripts 
could lead to steric constraints that result in the liberation of only one mature miRNA 
sequence as opposed to the numerous siRNAs that are produced from longer dsRNAs. In 
this way, short hairpin loop derived miRNAs may have evolved from TE encoded 
siRNAs. Many of the extant miRNA genes characterized today may have evolved beyond 
recognition to their progenitor TEs, while others may have originated from other genomic 
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CHAPTER 6 




Short interfering RNA (siRNA) sequences encoded by transposable elements 
(TEs) are used to silence expression of the elements in order to defend against the 
harmful effects of transposition. Recently, our group and others demonstrated that TE 
sequences can also encode miRNAs that are used to regulate cellular (host) genes. We 
proposed a specific model whereby miRNAs encoded from short non-autonomous DNA-
type TEs, known as MITEs, evolved from corresponding ancestral full-length 
(autonomous) elements that originally encoded siRNAs. This model predicts that 
evolutionary intermediates may exist as TEs that encode both siRNAs and miRNAs. We 
analyzed Arabidopsis thaliana and Oryza sativa (rice) genomic sequence and expression 
data to test this prediction. We found that there are in fact a number of examples of 
individual plant TE insertions that encode both siRNAs and miRNAs. We also show 
evidence that these dual coding TEs can be expressed as read-through transcripts from 
the intronic regions of spliced RNA messages. These TE-transcripts can fold to form the 
hairpin (stem-loop) structures characteristic of miRNA genes along with longer double 
stranded RNA regions that are typically processed as siRNAs. Taken together with a 
recent study showing Drosha independent processing of miRNAs from Drosophila 
introns, our results indicate that ancestral miRNAs could have evolved from TEs prior to 
the full elaboration of the miRNA biogenesis pathway. Later, as the specific miRNA 
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biogenesis pathway evolved, and numerous other expressed inverted repeat regions came 
to be recognized by the miRNA processing endonucleases, the host gene related 
regulatory functions of miRNAs emerged. In this way, host genomes were afforded an 
additional level of regulatory complexity as a by-product of TE defense mechanisms.  
The siRNA-to-miRNA evolutionary transition is representative of a number of other 
regulatory mechanisms that evolved to silence TEs and were later co-opted to serve as 
regulators of host gene expression. 
INTRODUCTION 
 The phenomenon of RNA-mediated gene regulation was originally discovered in 
plants (MATZKE and MATZKE 2004). Plant biologists found that posttranscriptional gene 
silencing (PTGS) seemed to involve RNA or DNA sequence interactions between 
transgenes, or transgenes and homologous plant genes, which led to sequence-specific 
RNA degradation (DE CARVALHO et al. 1992; NAPOLI et al. 1990; VAN BLOKLAND et al. 
1994; VAN DER KROL et al. 1990). It soon became apparent that plant RNA viruses could 
also stimulate PTGS. Transgenic tobacco plants that expressed a truncated form of a viral 
coat gene recovered from initial infection with the virus and ultimately became resistant 
(LINDBO et al. 1993). This resistance was found to be conferred through degradation of 
viral RNA. Subsequently, PTGS was shown to serve as a natural mechanism employed 
by plants to defend against viral infection (COVEY et al. 1997; RATCLIFF et al. 1997).  
Ultimately, these findings led to the notion that a number of plant gene silencing 
mechanisms initially evolved as defense mechanisms against invading genetic elements 
(MATZKE et al. 2000). 
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The broader significance of RNA-mediated gene regulation became widely 
apparent only later, when the specific role of double stranded RNA (dsRNA) in RNA 
interference (RNAi) was elucidated for Caenorhabditis elegans (FIRE et al. 1998). RNAi 
in C. elegans was related to genome defense mechanisms by studies showing that RNAi 
deficient mutants lost the ability to silence Tc1 transposable elements (TEs) in the 
germline (KETTING et al. 1999; TABARA et al. 1999). The mechanism behind RNAi-
based silencing of C. elegans TEs was found to be based on the production of dsRNAs 
from the terminal inverted repeat (TIR) sequences found at the ends of Tc1 elements 
(SIJEN and PLASTERK 2003). This work demonstrated that RNAi is initiated by read-
through transcription of full-length Tc1 elements, which then fold into ‘snap-back’ 
structures with the complementary sequences of the TIRs bound as dsRNA (Figure 6.1).  
These dsRNA TIR sequences are processed by the RNAi enzymatic machinery to yield 
short interfering RNAs (siRNAs) that silence expression via mRNA degradation of the 
transposase gene required for Tc1 transposition. The sequence-specificity of the mRNA 
degradation is caused by binding of the TIR-derived single stranded siRNAs to 
complementary sequences of the transposase encoding mRNA. Later, TE-encoded 
siRNAs were shown to silence the highly active MuDR TE family in maize (SLOTKIN et 
al. 2005). In light of the ability to defend against viral infection and TE mobilization, 
RNAi has been considered as an immune system for the genome (PLASTERK 2002).   
As described above, the connection between the siRNA molecules that mediate 
RNA-based gene silencing and TEs, or viruses, has been appreciated since PTGS and 
RNAi were first studied. MicroRNAs (miRNAs) are a related class of short RNA 
molecules with an analogous functional role in RNAi (AMBROS 2004; BARTEL 2004).  
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miRNAs are processed from the dsRNA regions of short, ~70-90bp, stem-loop (hairpin) 
RNA structures by the same endonuclease, Dicer (or Dicer-like in plants), which cleaves 
siRNAs from longer dsRNA sequences. A connection between TEs and miRNAs was 
more recently established when a number of miRNA genes were found to be derived 
from TE sequences (BORCHERT et al. 2006; METTE et al. 2002; PIRIYAPONGSA and 
JORDAN 2007; PIRIYAPONGSA et al. 2007a; SMALHEISER and TORVIK 2005). 
 In the human genome, a group of related miRNA genes was found to be derived 
from the Made1 family of TEs (PIRIYAPONGSA and JORDAN 2007). Made1 elements 
(MORGAN 1995; OOSUMI et al. 1995; SMIT and RIGGS 1996) are members of a specific 
class on DNA-type TEs known as miniature inverted-repeat transposable elements 
(MITEs) (BUREAU and WESSLER 1992; BUREAU and WESSLER 1994). MITEs are short 
non-autonomous derivatives of full-length DNA-type elements (FESCHOTTE and 
MOUCHES 2000; FESCHOTTE et al. 2002b). Full-length DNA-type elements are typically 
several kb in length and contain a single open reading frame, which encodes the 
transposase enzyme that catalyzes transposition, flanked by two TIR sequences on either 
end of the elements (Figure 6.1A). As is the case with the Tc1 elements of C. elegans, 
full-length transcripts of DNA-type elements can fold into ‘snap-back’ structures with the 
two TIRs forming a dsRNA region (Figure 6.1B). This dsRNA region can be processed 
to yield siRNAs that silence expression of the elements. MITEs are shorter sequences of 
~80-500bp, which lack the internal ORF of full-length elements but retain the TIRs 
(Figure 6.1C). So MITEs are closer to being palindromes, and read through transcription 
of MITEs will lead to RNA sequences that can fold into hairpin structures reminiscent of 
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the pre-miRNA the sequences processed by Dicer to yield mature miRNAs (Figure 
6.1D).   
 
              
Figure 6.1: Model for the TE-based siRNA-miRNA evolutionary transition. (A) Full-
length DNA-type element with terminal inverted repeats (TIRs) flanking a long open 
reading frame. (B) Snap-back secondary structure of the full-length element with TIRs 
bound as dsRNA. (C) MITE, a non-autonomous derivative of a full-length DNA-type 
element, containing TIRs and a small internal region. (D) Hairpin (stem-loop) secondary 




The relationship between full-length DNA-type elements and siRNAs on the one 
hand, and MITEs and miRNAs on the other, led us to propose a specific model for how 
miRNAs could have evolved from siRNA encoding TEs in a step-wise manner 
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(PIRIYAPONGSA and JORDAN 2007). As illustrated in Figure 6.1, our model posits that 
siRNAs were first processed from the two TIRs of full-length elements bound as dsRNA.  
Later, as derivative MITEs evolved from full-length elements and proliferated in the 
genome, the same RNA endonucleolytic processing machinery cleaved the dsRNA from 
the hairpin stem regions yielding mature miRNA sequences. A corollary prediction of our 
model holds that evolutionary intermediates may exist as TE sequences that encode both 
siRNAs and miRNAs. We tested the prediction of dual coding siRNA-miRNA TEs using 
a computational analysis of genome sequences, annotation and expression data from the 
plants Arabidopsis thaliana and Oryza sativa (rice).   
RESULTS 
 We searched Arabidopsis and rice genome sequence and expression data (see 
Methods) to determine whether there are individual TE insertions that encode both 
siRNA and miRNA sequences. The Arabidopsis and rice genome sequences, along with 
their functional genomic datasets, afford several specific advantages for this kind of 
search. Both model species have been studied extensively, particularly by biologists 
interested in TEs, and accordingly their TEs are relatively well characterized. In addition, 
RNA expression levels for Arabidopsis and rice genes have been extensively 
characterized using the high-throughput massively parallel signature sequencing (MPSS) 
technique (BRENNER et al. 2000a; BRENNER et al. 2000b). The original MPSS technique 
was later modified to characterize small RNA sequences such as siRNAs and miRNAs 
(LU et al. 2006). MPSS for short RNAs yields many thousands of sequence tags that can 
be unambiguously mapped to the Arabidopsis or rice genomes to determine where mature 
siRNAs and miRNAs are encoded.       
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 The miRBase Sequence Database (GRIFFITHS-JONES et al. 2006) contains genome 
annotations for experimentally characterized miRNA gene sequences from a number of 
species including Arabidopsis and rice. Release 10.0 of miRBase contains 184 
Arabidopsis and 231 rice miRNAs. We compared the genomic locations of these 
miRNAs to the locations of TEs annotated using the RepeatMasker program. 12 
Arabidopsis miRNAs (6.5%) and 83 rice miRNAs (35.9%) were found to be co-located 
with TE sequences (Table E.1). 10 out of 12 TE co-located Arabidopsis miRNA 
sequences and 38 out of 83 TE co-located rice miRNA sequences share 100% of their 
sequences with TEs. The TE sequences were all annotated based on RepeatMasker scores 
well above the threshold for false positives (average SW score=20,357). In other words, 
these data represent unequivocal cases of plant miRNA genes that have been derived 
from TE sequences (Table 6.1). These miRNAs are derived from members of a variety of 
TE sequence families including gypsy- and copia-like LTR retroelements, but the vast 
majority are encoded by the short non-autonomous DNA-type transposable elements 
known as MITEs. MITE-derived miRNAs are particularly enriched in rice consistent 
with the genomic abundance of MITEs in this species (JIANG et al. 2004).   
 
Table 6.1: Plant miRNA genes derived from TEs 
 
Table 6.1 continued    
Namea Accnb Coordsc TEd TE sizee 
ath-MIR855 MI0005411 chr2:4681509-4681780(+) Athila4B_LTR 
(LTR/Gypsy) 
fragment 
ath-MIR416 MI0001427 chr2:7015602-7015681(+) Vandal1 (DNA/MuDR) fragment 
ath-MIR405a MI0001074 chr2:9642037-9642193(-) SIMPLEHAT2 
(DNA/hAT) 
fragment 
ath-MIR405d MI0001077 chr4:2789653-2789738(-) SIMPLEHAT2 
(DNA/hAT) 
fragment 
ath-MIR401  MI0001070 chr4:5020234-5020483(-) Athila4B_LTR 
(LTR/Gypsy) 
fragment 
          
                                                                                                                                                                        
 144
Table 6.1 continued    
Namea Accnb Coordsc TEd TE sizee 
ath-MIR854b  MI0005413 chr5:11341600-11341820(-) Athila6A_I 
(LTR/Gypsy) 
intact 
ath-MIR854d  MI0005415 chr5:11707091-11707311(-) Athila6A_I 
(LTR/Gypsy) 
intact 
ath-MIR854c  MI0005414 chr5:11855326-11855546(+) Athila6A_I 
(LTR/Gypsy) 
intact 
ath-MIR854a  MI0005412 chr5:11864949-11865169(+) Athila6A_I 
(LTR/Gypsy) 
intact 
ath-MIR405b  MI0001075 chr5:20649740-20649863 (+) SIMPLEHAT2 
(DNA/hAT) 
fragment 
osa-MIR439a MI0001691 chr1:20206990-20207082(+) MuDR4_OS 
(DNA/MuDR) 
fragment 
osa-MIR814a MI0005239 chr1:22701877-22701973(+) STOWAWAY47_OS 
(DNA/Stowaway) 
intact 
osa-MIR812a MI0005233 chr1:34273999-34274232(+) STOWAWAY51_OS 
(DNA/Stowaway) 
intact 
osa-MIR819a MI0005252 chr1:41534243-41534367(+) STOWAWAY1_OS 
(DNA/Stowaway) 
intact 
osa-MIR812b MI0005234 chr2:1936324-1936493(-) STOWAWAY51_OS 
(DNA/Stowaway) 
intact 
osa-MIR818b MI0005248 chr2:4007187-4007299(+) STOWAWAY15-2_OS 
(DNA/Stowaway) 
intact 
osa-MIR806b MI0005211 chr2:5044109-5044323(-) TREP215 
(DNA/Stowaway) 
intact 
osa-MIR814c MI0005241 chr2:10889670-10889752(-) STOWAWAY47_OS 
(DNA/Stowaway) 
fragment 
osa-MIR817 MI0005246 chr2:12276361-12276443(-) ENSPM3_OS 
(DNA/En-Spm) 
fragment 
osa-MIR807b MI0005218 chr2:24481931-24482076(-) ECR (DNA/Tourist) intact 
osa-MIR814b MI0005240 chr2:26335342-26335415(+) STOWAWAY47_OS 
(DNA/Stowaway) 
intact 









osa-MIR443 MI0001708 chr3:29972009-29972156(+) STOWAWAY47_OS 
(DNA/Stowaway) 
intact 
osa-MIR420 MI0001440 chr4:6098543-6098697(+) TRUNCATOR2_OS 
(LTR/Gypsy) 
intact 
osa-MIR416 MI0001436 chr4:17268776-17268884(+) CPSC3_LTR 
(LTR/Copia) 
intact 
osa-MIR807c MI0005219 chr4:23886344-23886527(+) ECR (DNA/Tourist) intact 
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Table 6.1 continued    
Namea Accnb Coordsc TEd TE sizee 
osa-MIR819f MI0005257 chr4:35070636-35070779(-) STOWAWAY50_OS 
(DNA/Stowaway) 
intact 
osa-MIR819g MI0005258 chr5:28003948-28004094(+) STOWAWAY1_OS 
(DNA/Stowaway) 
intact 
osa-MIR819h MI0005259 chr6:10052973-10053127(-) STOWAWAY50_OS 




osa-MIR811a MI0005230 chr6:13901553-13901742(+) TAMI2 (DNA) intact 
osa-MIR812c MI0005235 chr6:26259310-26259473(+) STOWAWAY9_OS 
(DNA/Stowaway) 
intact 




osa-MIR812d MI0005236 chr7:22393529-22393681(+) STOWAWAY44_OS 
(DNA/Stowaway) 
intact 
osa-MIR445a MI0001709 chr7:28117531-28117798(+) NDNA2TNA_OS 
(DNA/Tourist) 
intact 
osa-MIR818e MI0005251 chr7:28152738-28152962(-) STOWAWAY21_OS 
(DNA/Stowaway) 
intact 
osa-MIR531 MI0003204 chr8:1214013-1214093(-) SC-1_int-int 
(LTR/Copia) 
fragment 
osa-MIR812e MI0005237 chr8:16268303-16268472(+) STOWAWAY44_OS 
(DNA/Stowaway) 
intact 





osa-MIR811b MI0005231 chr10:2372014-2372203(+) TAMI2 (DNA) intact 
osa-MIR439b MI0001692 chr10:5338996-5339055(+) MuDR4_OS 
(DNA/MuDR) 
fragment 




osa-MIR806g MI0005216 chr10:22588399-22588638(+) TREP215 
(DNA/Stowaway) 
intact 
osa-MIR811c MI0005232 chr11:5200383-5200541(-) TAMI2 (DNA) fragment 
osa-MIR813 MI0005238 chr11:23113437-23113639(+) NDNA1TNA_OS 
(DNA/Tourist) 
fragment 
osa-MIR531 MI0003204 chr11:26423868-26423948(+) SC-1_int-int 
(LTR/Copia) 
intact 




amiRBase database miRNA names 
bmiRBase database miRNA accessions 
cgenomic location coordinates of co-located TE sequences 
dname, class and family of the TE sequences 
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esize of TE sequences which encode miRNA genes: intact (full-length element), almost 
full-length (≥80% of full-length element consensus sequence), fragment (<80% of full-




miRBase was used to count the number of orthologs for each Arabidopsis and rice 
miRNA. TE-derived miRNA genes in Arabidopsis and rice have fewer orthologs on 
average (0.07), i.e. they are less evolutionarily conserved, than non repetitive miRNAs 
(3.0) and the difference is highly significant (Student’s t-test; t=18.8 df=413 P=2e-57).  
This is similar to what is seen for many mammalian TE-derived miRNAs  
(PIRIYAPONGSA et al. 2007a) and is consistent with the fact that TEs represent the most 
lineage-specific and rapidly evolving sequences in eukaryotic genomes (MARINO-
RAMIREZ et al. 2005).  On the one hand, this may suggest that caution is warranted when 
evaluating TE-derived plant miRNAs since they are not conserved (AMBROS et al. 2003). 
However, there are a number of bona fide miRNAs that are not evolutionarily conserved 
(BENTWICH et al. 2005). The low conservation of TE-derived miRNAs can be taken to 
imply that the regulatory effects exerted by TE-derived miRNAs may be relevant for 
species-specific differences in gene expression (PIRIYAPONGSA et al. 2007a). 
In addition to using miRBase to characterize TE-derived miRNAs, we searched 
the literature to confirm TE-derived plant miRNA genes with documented effects on the 
expression of host genes. There are five TE-derived miRNAs uncovered here (ath-
MIR854a-d & ath-MIR855 in Table 6.1), including a repetitive family derived from 
dispersed LTR sequences, with experimentally characterized effects on the regulation of 
Arabidopsis genes (ARTEAGA-VAZQUEZ et al. 2006). First of all, mature ath-MIR854 
sequences were found to be absent in plants with mutant alleles for three genes critical to 
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miRNA biogenesis: Dicer-like1 (dcl1), Hyponastic leaves1 (hyl1) and HUA Enhancer1 
(hen1). However, ath-MIR854 expression was found in mutants of the RNA-dependent 
RNA polymerase2 gene, which is required for siRNA processing. Together, these results 
indicate that ath-MIR854 is processed specifically as an miRNA. The mature sequences 
of ath-MIR854 and ath-MIR855 have multiple binding sites in the 3’ untranslated region 
(UTR) of the Oligouridylate binding protein1b gene (UBP1b), which encodes a 
heterogenous nuclear RNA binding protein. The UBP1b 3’UTR mRNA: miRNA 
interactions resemble those that lead to translational repression and/or mRNA cleavage in 
mammals. The ability of these TE-derived miRNAs to repress expression of UBP1b was 
demonstrated by using the 3’ UTR of the gene in a reporter protein expression assay.  
Mature ath-MIR854 and ath-MIR855 sequences are expressed in rosette leaves and 
flowers but absent in cauline leaves. Accordingly, the 3’ UTR of UBP1b can repress 
protein reporter expression in rosette leaves and flowers not in cauline leaves.  
Furthermore, comparison of mRNA versus protein expression for the reporter indicated 
that the ath-MIR854a-d and ath-MIR855 genes exert their effects at the translational 
level.        
 We used expression data taken from the Arabidopsis MPSS Plus (MEYERS et al. 
2004) and Rice MPSS Plus (NOBUTA et al. 2007) databases to evaluate whether any of 
the TEs that encode miRNA genes are also processed to yield siRNA sequences. The 
siRNA MPSS sequence tags were unambiguously mapped, using 100% tag-TE sequence 
identity, to the TEs that were found to encode miRNAs. 8 of the Arabidopsis TEs that 
encode miRNAs and 13 of the miRNA encoding rice TEs were found to encode siRNA 
sequences as well (Table 6.1). 
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 We also explored the possibility that TE-derived miRNAs and siRNAs are 
passively transcribed as part of longer host gene RNA messages. To do this, genome-
wide EST and mRNA maps for Arabidopsis and rice were examined to look for cases 
where dual coding miRNA-siRNA TE sequences are located within the start and stop 
coordinates of spliced transcripts. We were able to find several examples of such cases, 1 
for Arabidopsis and 2 for rice (Figure 6.2).      
 Finally, all of the miRNA-siRNA dual coding TE sequences were folded to 
predict their secondary structures (Figure E.1). The predicted secondary structures show 
long double stranded regions that correspond to the locations of mapped siRNA sequence 
tags along with stem-loop regions characteristic of known miRNA gene structures. The 
MITE encoded secondary structures are particularly striking in the sense that they form 
long, almost perfect, hairpins possessing extensive double stranded regions (Figure 6.3 
and Figure E.1). These folding patterns are based on the sequence complementarity 
between the terminal inverted repeats (TIRs) encoded by this class of TEs.      
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Figure 6.2: Genomic structure and expression of TE-derived miRNAs. The schematic 
diagrams representing the co-location between miRNA genes, TEs and EST/mRNAs (see 
legend) are shown for (A) osa-MIR439a (B) osa-MIR422 and (C) ath-MIR405b. 
             
 
DISCUSSION 
 Our analysis of Arabidopsis and rice genomic data revealed the existence of TE 
sequences that encode both siRNAs and miRNAs. We believe that the dual coding 
capacity for small regulatory RNAs by plant TEs reflects an evolutionary connection 
between related mechanisms of RNAi. This notion is based on the recent discovery of a 
family of human miRNA genes derived from MITEs, which led us to propose a step-wise 
model for the evolution of miRNAs from TEs that originally encoded siRNAs 
(PIRIYAPONGSA and JORDAN 2007). The expression of siRNAs from autonomous DNA-
type elements is known to be based on read-through transcription of full-length elements 
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(SIJEN and PLASTERK 2003), and our model is based on read-through transcription of 
shorter non-autonomous MITEs (Figure 6.1). MITEs retain the TIR sequences of 
autonomous DNA-type elements but do not encode any open reading frame between the 
TIRs. As such, MITEs are made up mostly of TIR sequences, i.e. they are palindromic, 
and when expressed as read-through transcripts, they will fold to form hairpin structures 
similar to those of miRNA genes (BARTEL 2004). Apparently, these MITE-derived 
hairpins can be processed to yield functionally relevant mature miRNA sequences 
(PIRIYAPONGSA and JORDAN 2007; PIRIYAPONGSA et al. 2007a). Consistent with this 
model, our results demonstrate that several of the siRNA-miRNA encoding TEs found in 
plants are in fact expressed as read-through transcripts by virtue of their presence in the 
introns of spliced RNA messages (mRNAs/ESTs in Figure 6.2). After TE-containing 
introns are spliced from the mRNAs, they can fold to form the kinds of structures 
recognized by the endonucleases involved in RNAi (Figure 6.3 and Figure E.1). 
In addition to their palindromic sequence-structure characteristics, MITEs are also 
distinguished by their preference for insertion into gene rich regions (MAO et al. 2000; 
ZHANG et al. 2000). Taken together with their genomic abundance (JIANG et al. 2004), 
this means that thousands of MITEs will be expressed as read-through transcripts as 
required by our model. The particular enrichment of MITEs in plant gene regions has 
been taken to suggest that they play some functional role for their host genomes. Our 
results, and our model of miRNA evolution via the autonomous TE-to-MITE transition, 
suggest that the host relevant function of MITEs is related, at least in part, to RNA-
mediated gene regulation.    
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Figure 6.3: RNA secondary structure and sequences of an siRNA-miRNA dual 
encoding MITE sequence. Partial predicted secondary structures of a read-through 
transcript of a MITE encoding both siRNA and miRNA sequences are shown for the rice 
miRNA gene osa-MIR821b. (A) A schematic of the miRNA stem-loop region along with 
the miRNA mature sequence. The location of the miRNA mature sequence in the stem-
loop is indicated with blue shading, and the mature miRNA sequence residues are shown 
in blue. (B) A schematic of the double-stranded RNA region that is cleaved to yield 
siRNAs. The locations of the siRNA signatures in the sequence are indicated with red 
shading, and the siRNA signature sequences are shown in red. Note that the entire 
secondary structure for this MITE is shown in Figure E.1R. 
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There is recent evidence from Drosophila in support of the notion that miRNAs 
can be processed from the introns of expressed genes in a manner similar to that which 
we propose for TE-derived miRNA genes (RUBY et al. 2007). Spliced introns that can 
fold into pre-miRNA like structures and be cleaved to yield mature miRNA sequences 
are called ‘mirtrons’. Interestingly, the processing of mirtrons to yield mature miRNAs 
does not rely on the RNA endonuclease Drosha. Drosha, or its plant functional analog 
Dicer-like1, is the enzyme that cleaves the longer pri-miRNA sequence near the base of 
the stem region in the nucleus to yield the pre-miRNA hairpin, which is then cleaved by 
Dicer to liberate the mature miRNA. Similar to the processing of mirtrons, PTGS via 
siRNAs does not require Drosha since dsRNAs are processed by Dicer alone to yield 
siRNAs (BARTEL 2004). Thus, the work of Ruby et al. (2007) indicates that miRNAs can 
arise in any organism that possesses both spliceosomal introns and PTGS via siRNAs; 
this was taken to suggest that miRNAs may have emerged in ancient eukaryotes prior to 
the evolution of the complete miRNA biogenesis pathway. Our model points to MITEs as 
a potential source for the evolution of such ancient miRNAs, processed by Dicer (or 
Dicer-like1) alone, from full-length TEs that previously encoded siRNAs only.  
Consistent with an ancient origin of miRNAs from TEs, full-length DNA-type elements 
and MITEs are widely distributed among eukaryotes (FESCHOTTE et al. 2002b), 
indicating that they were likely to be present in ancestral eukaryotic species. In addition, 
a recent phylogenetic analysis of the miRNA biogenesis enzymes indicates that Dicer is 
the more ancient of the endonucleases involved the processing of mature miRNAs, with 
Drosha having evolved more recently along the animal evolutionary lineage (CERUTTI 
and CASAS-MOLLANO 2006). 
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 dsRNA sequences are processed to yield multiple siRNAs from a given stretch of 
sequence, while pre-miRNA hairpins are cleaved into a single distinct mature miRNA 
sequence (BARTEL 2004). This may be related to the steric hindrance entailed by the 
substantially shorter hairpin structures that are processed to yield miRNAs. Over 
evolutionary time, once the endonucleolytic machinery became tuned to the structural 
characteristics, and limited spacing, of the MITE-encoded hairpins, then it would have 
been able to recognize any number of hairpin structures that are formed when genomic 
sequences with inverted repeats are expressed as read-through transcripts. Indeed, this 
has been shown to be important in Arabidopsis where miRNA genes evolved via local 
inverted duplication events, which generated sequences capable of folding back into 
hairpin structures when expressed (ALLEN et al. 2004). In this way, MITEs could have 
stimulated the RNAi biogenesis enzymes to process non TE-related hairpin structures to 
yield miRNAs with host gene regulatory functions. 
Relatively ancient siRNA sequences originally evolved as defense mechanisms 
against genomic invaders, such as viruses and TEs, and genome defense appears to 
remain the primary function of this class of regulatory sequence. On the other hand, 
miRNAs are evolutionarily emergent regulators, and accordingly they function primarily 
to regulate host genes. The siRNA to miRNA evolutionary transition is one of a growing 
number of examples (LIPPMAN et al. 2004; MATZKE et al. 2000; MCDONALD et al. 2005; 
YODER et al. 1997) of gene silencing mechanisms that were originally employed to 
defend against TE proliferation and were later co-opted to serve the regulatory needs of 
the host organism (PIRIYAPONGSA et al. 2007a). 
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MATERIALS AND METHODS 
 The Arabidopsis thaliana genomic sequence was obtained from the National 
Center for Biotechnology (NCBI) genome assembly/annotation projects ftp site 
(ftp://ftp.ncbi.nih.gov/genomes/Arabidopsis_thaliana). The Oryza sativa (rice) genomic 
sequence was taken from release 4.0 of The Institute for Genomic Research (TIGR) rice 
genome annotation database (OUYANG et al. 2007) 
(ftp://ftp.tigr.org/pub/data/Eukaryotic_Projects/o_sativa/annotation_dbs/pseudomolecules
/). The genome locations of different classes of TEs in Arabidopsis and rice genomes 
were identified by using the RepeatMasker program (SMIT et al. 1996-2004) to compare 
genomic sequences against the species-specific Repbase libraries (JURKA 2000; JURKA et 
al. 2005) of TE consensus sequences. The Smith-Waterman (SW) algorithm (SMITH and 
WATERMAN 1981) was used with RepeatMasker to do local pairwise comparisons of 
genome-against-TE consensus sequences and to score the resulting alignments. The 
genome locations and identities of experimentally characterized Arabidopsis and rice 
miRNA gene sequences were taken from release 10.0 of the miRBase database 
(GRIFFITHS-JONES et al. 2006) (http://microrna.sanger.ac.uk/sequences/).   
Arabidopsis and rice MPSS small RNA signatures were downloaded from the 
Arabidopsis MPSS Plus database (MEYERS et al. 2004) (http://mpss.udel.edu/at/) and the 
Rice MPSS Plus database (NOBUTA et al. 2007) (http://mpss.udel.edu/rice/). The 
signatures matching to tRNAs, rRNAs, snRNAs or snoRNAs were not included in the 
data set we used. Only the small RNA signatures of size 17 to 25 bp were chosen for the 
analysis. For each species, the small RNA signatures were divided into two groups: 
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miRNA signatures and siRNA signatures according the organism-specific MPSS 
database annotations.   
The genome locations of TEs and miRNAs were compared to identify the co-
located TEs and miRNA gene sequences in both species. Post-processing of 
RepeatMasker annotations were done such that the continuous TE sequences of the same 
family, which are oriented in the same direction on the genome, were counted as the 
same TE sequence. TE sequences which encoded entire miRNA gene sequences were 
searched for the presence of small RNA signatures using the vmatch program 
(ABOUELHODA et al. 2004) demanding 100% sequence identity between the TE 
sequences and siRNA tags. The TE sequences that completely covered miRNA gene 
sequences and contained siRNA signatures outside the miRNA gene regions were chosen 
for further analysis. These TE sequences were folded using the program RNAfold from 
the Vienna RNA package (HOFACKER et al. 1994) and their secondary structures were 
visualized by xrna program (http://rna.ucsc.edu/rnacenter/xrna/xrna.html). The potential 
of TE-derived miRNAs and siRNAs to be processed from read-through transcripts was 
assessed via the analysis of EST and mRNA data. EST and mRNA sequences mapped to 
the Arabidopsis genome sequence were obtained from NCBI genome assembly/ 
annotation projects (ftp://ftp.ncbi.nih.gov/genomes/Arabidopsis_thaliana/GNOMON).  
Mapped rice EST, full-length cDNA sequences and transcript assemblies were obtained 
from TIGR rice genome annotation database (OUYANG et al. 2007). 
 
          





In summary, this dissertation is composed of five different studies that provide 
new insights into the same field of biological investigation, namely the contribution of 
TEs to host gene sequences. The first two studies (CHAPTER 2 and CHAPTER 3) 
present new results with respect to the extent, evolution, and coding property of TE-
derived CDS in the human genome as well as the ability of the different search methods 
used to detect such sequences. These results contribute significantly to the understanding 
of molecular domestication events of TEs in the human genome. The detailed analysis of 
the relationship between TEs and a recently discovered class of non-coding regulatory 
gene, miRNA, presented in CHAPTER 4 and CHAPTER 5 provides new evidences 
supporting the hypothesis of TE contributions to regulatory gene evolution. Furthermore, 
the last study (CHAPTER 6) proposes a novel concept for the possible role of one 
particular class of TEs, MITEs, as an evolutionary link between miRNAs and closely 
related siRNAs.  
Dismissed for some time as “junk”, or “selfish” DNA (DOOLITTLE and SAPIENZA 
1980; HICKEY 1982; OHNO 1972; ORGEL and CRICK 1980), TEs are now generally 
considered as significant contributors to gene and genome evolution (BROSIUS 1999; 
BROSIUS and GOULD 1992; KAZAZIAN 2004; KIDWELL and LISCH 2001; MAKALOWSKI 
2003; MCDONALD 1993; MCDONALD 1999). 
In CHAPTER 2, a detailed analysis of exonization events in the human genome 
associated with one specific class of TE, LTR elements, is reported. 5.8% of human 
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genes were found to contain sequences derived from LTR retrotransposons. The 
distribution of these elements in genes shows the preference towards the fixation in gene 
untranslated regions, which supports the existing concept a major role of LTR elements 
as a natural source of regulatory sequences. On the other hand, the recruitment of LTR 
retrotransposon sequence as host CDS is not a frequent event. Several coincidences are 
necessary to allow for an LTR exonization event that yields a CDS. Only 50 protein 
coding exons were completely derived from LTR retrotransposon sequences. Finally, as 
shown in the part of this study, the evolutionary analysis using new experimental 
evidence elucidates the mechanism of incorporation of LTR sequence into an 
alternatively spliced exon of IL22RA2 gene and estimates the emergence time of this 
exon in great ape species. A single mutation in the proto-splice site was hypothesized to 
cause the recruitment of this novel exon prior to the divergence of orangutans and 
humans from a common ancestor. 
Although a number of large-scale analyses have been used to identify the 
instances of TE-derived CDSs in human genome (BRITTEN 2006; GOTEA and 
MAKALOWSKI 2006; LANDER et al. 2001; NEKRUTENKO and LI 2001; PAVLICEK et al. 
2002), the actual proportion of human CDS that have evolved from TEs remains to be 
defined. In particular, it is unclear whether non-autonomous TEs that do not encode any 
protein can indeed provide protein coding sequences after becoming exonized (PAVLICEK 
et al. 2002). The ascertainment biases related to different sequence similarity search 
methods used and the potential of TEs to contribute protein coding sequences are 
evaluated in CHAPTER 3. The profile-based search methods (i.e. HMM) show a 
beneficial combination of sensitivity and selectivity compared to other search methods 
          
                                                                                                                                                                        
 158
used. However, possibly due to the superior selectivity of the profile-based methods, not 
many novel cases were detected when these methods were similarly applied to large-scale 
datasets of experimentally characterized proteins. In general, the different search methods 
are found to be complementary, and combined search approaches are needed to 
systematically check any data set for all potential TE-CDS associations. The codon based 
analysis of exonized TE sequences implies that many of the sequences derived from non-
coding TEs, such as Alu elements, are not likely to actually encode any protein. The 
apparent low coding potential of Alu-derived exons may also reflect the fact that these 
sequences have a relatively recent evolutionary origin as exons and thus have not had 
enough time to establish sequence periodicities that resemble other coding sequences. 
The lack of protein coding capacity does not directly imply the non-functionality of 
exonized TE sequences. Alternatively, they may play a role in post-transcriptional gene 
regulation, e.g. serve as natural anti-sense transcripts as was recently shown (CONLEY et 
al. 2008). The repetitive dispersed nature of exonized TE sequences may provide a 
mechanism by which they can serve as master regulators with influence over the 
expression of numerous genes throughout the genome.    
In addition to the contribution to host gene coding sequences, TEs are well 
recognized for their influences on host gene regulation (BROSIUS 1999; HAMDI et al. 
2000; JORDAN et al. 2003; KIDWELL and LISCH 1997; KIDWELL and LISCH 2001; 
TOMILIN 1999; VAN DE LAGEMAAT et al. 2003). Considerable evidence now indicates that 
small noncoding RNAs can play a major role in regulating eukaryotic gene expression 
(CULLEN 2002; HUTVAGNER and ZAMORE 2002b). Of particular interest are a class of 
~22-nt RNAs: siRNAs and miRNAs (AMBROS et al. 2003). The connection between TEs 
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and siRNAs has led to the proposal that origination from TEs distinguishes siRNAs from 
miRNAs (BARTEL 2004).  
In CHAPTER 4, the evolutionary relationship between miRNAs and TEs is 
revealed. About 12% of experimentally verified human miRNA genes were shown to 
originate from TEs. The dispersed repetitive nature of TE sequences provides for the 
emergence of multiple novel miRNA genes as well as numerous homologous target sites 
throughout the genome. Overall, TE-derived miRNA genes are less conserved than non 
TE-derived miRNAs. This result is generally consistent with the observation that TEs are 
the most lineage-specific, recently evolved sequences in the human genome (LANDER et 
al. 2001). However, there are a number of TE-derived miRNAs that are well-conserved. 
The majority of these conserved miRNAs are related to the ancient L2 and MIR TE 
families, which have been shown to be anomalously conserved between the human and 
mouse genomes although no specific functional role was assigned to them (SILVA et al. 
2003). At least some of these conserved L2 and MIR fragments were shown to provide 
miRNA sequences with the potential to regulate numerous human genes. Along with this 
study, 85 putative miRNA genes were predicted from the set of TE sequences encoding 
conserved RNA secondary structures. The high frequency (>50%) of TE-encoded 
conserved secondary structures which were associated with recently identified conserved 
TE famlies suggest that many conserved TE sequences may encode miRNAs or perhaps 
other noncoding RNAs.  
 Out of 55 TE-derived miRNAs analyzed, a miRNA gene family, hsa-mir-548, 
was found to be derived from Made1 elements, which are non-autonomous DNA-type 
TEs known as MITEs (CHAPTER 5). The palindromic structure of the Made1 elements 
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together with their insertion into transcriptionally active genomic regions, points to a 
specific mechanism by which these sequences can be recognized and processed by the 
miRNA biogenesis pathway. Made1 elements emerged along the primate evolutionary 
lineage, and thus represent a natural source of lineage-specific miRNAs, which could in 
turn be responsible for regulatory phenotypes that contribute to evolutionary 
diversification between species. 
The model of miRNA emergence from MITEs presented here, together with the 
relationship between full-length DNA-type elements and siRNAs (VASTENHOUW and 
PLASTERK 2004), leads to the original idea that MITEs may represent an evolutionary 
link between siRNAs and miRNAs. A step-wise model for the evolution of miRNAs 
from TEs that originally encoded siRNAs is proposed in CHAPTER 6. In this model, 
miRNAs evolved from the autonomous TE-encoded siRNA to MITE-encoded miRNA. 
This model is supported by the presence of evolutionary intermediate TE sequences that 
encode both siRNAs and miRNAs in the Arabidopsis and rice genomes. These results 
demonstrate that several of the siRNA-miRNA encoding TEs found in introns can be 
expressed as read-through transcripts. After TE-containing introns are spliced from the 
mRNAs, they can fold to form structures recognized by the RNAi enzyme machinery. 
Spliced introns that can fold into pre-miRNA like structures and be cleaved to yield 
mature miRNA sequences are called ‘mirtrons’ (RUBY et al. 2007). Because the 
processing of mirtrons to yield mature miRNAs does not depend on the RNA 
endonuclease Drosha, miRNAs can arise in any organism that possesses both 
spliceosomal introns and PTGS via siRNAs. This suggests that miRNAs may have 
emerged in ancient eukaryotes prior to the evolution of the complete miRNA biogenesis 
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pathway. Consistent with an ancient origin of miRNAs from TEs, full-length DNA-type 
elements and MITEs are widely distributed among eukaryotes (FESCHOTTE et al. 2002b), 
indicating that they were likely to be present in ancestral eukaryotic species. In addition, 
a phylogenetic analysis of the miRNA biogenesis enzymes indicates that Dicer is the 
more ancient of the endonucleases involved the processing of mature miRNAs, with 
Drosha having evolved more recently along the animal evolutionary lineage (CERUTTI 
and CASAS-MOLLANO 2006).  
In conclusion, the results from miRNA-TE analysis point to a connection between 
genome defense mechanisms necessitated by TEs and the emergence of global gene 
regulatory systems. A number of epigenetic gene silencing mechanisms, such as cytosine 
methylation (YODER et al. 1997), genomic imprinting (MCDONALD et al. 2005) and 
heterochromatin (LIPPMAN et al. 2004) are thought to have evolved originally as TE 
defense mechanisms. Subsequently, these TE silencing mechanisms were co-opted as 
global regulators to control the phenotypic complexity seen among members of the 
eukaryotes. The evolutionary transition from siRNA to miRNA through MITEs presented 
in this study shows one of a growing number of of examples of this scenario. RNA 
interference by siRNAs is considered to have originally evolved to silence TEs (MATZKE 
et al. 2000; SLOTKIN et al. 2005; VASTENHOUW and PLASTERK 2004) and the primary 
function of siRNA sequence appears to be genome defense against genomic invaders 
while miRNAs are evolutionarily emergent regulators, and accordingly they function 
primarily to regulate host genes.  
 
 
          




SUPPLEMENTARY INFORMATION FOR CHAPTER 2 
 
Table A.1: Features of LRTS-derived protein coding exons 












































sequences in place 





internal protein coding exon 
 
          




protein interaction mediated 
by PDZ domains) 
AJ224748 N/A * GT/AG  
2 NM_198712* -/- 4/6* 70 400 265 MSTA MaLR1 prostaglandin E 
receptor 3 (subtype 
EP3) (PTGER3), 
transcript variant 2 
prostaglandin E receptor 
activity, ligand-dependent 
nuclear receptor activity, 
rhodopsin-like receptor 
activity  
D86097 N/A * donor (all = AT); 
acceptor (c & h = 
AG, r = TG)  
3 NM_198713* -/- 3/5* 76 393 265 MSTA MaLR1 prostaglandin E 
receptor 3 (subtype 
EP3) (PTGER3), 
transcript variant 3 
prostaglandin E receptor 
activity, ligand-dependent 




AY429108   
N/A * donor (all = GT); 
acceptor (c & h = 
AG, r = TG)  
4 NM_020161* -/- 2/3 73 150 382 MSTB2 MaLR1 hypothetical protein 
DKFZp547H025 
(DKFZp547H025) 
folic acid binding, reduced 
folate carrier activity  
AK055355, 
AL359944, 
CR749679   
DA513601 * donor (all = GT); 
acceptor (c & h = 
AG, r = GG)  










6 NM_001025468 +/+ 2/3 95 97 408 MSTA MaLR1 chromosome 3 open 









* GT/AG  
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Table A.1 continued            












































sequences in place 





7 NM_145027* -/+ 20/23 51(17) 814 361 MLT1A0 MaLR1 kinesin family 
member 6 (KIF6)  
ATP binding, nucleotide 
binding, microtubule motor 
activity, microtubule-based 











8 NM_052962* -/- 4/7* 96(32) 263 445 MSTB2 MaLR1 interleukin 22 











N/A * donor (c & h = 
GT, r = AT); 
acceptor (all = AG)
9 NM_024728* +/- 13/15 78(26) 434 519 MLT1E2 MaLR1 chromosome 7 open 
reading frame 10 
(C7orf10) 





10 NM_174930 +/+ 5/6 89 134 387 MSTA MaLR1 postmeiotic 
segregation increased 
2-like 5 (PMS2L5) 
ATP binding, damaged DNA 















* donor (c & h = 
GT, r = AT); 
acceptor (all = AG)
11 NM_002679 -/- 7/8 89 297 387 MSTA MaLR1 postmeiotic 
segregation increased 
2-like 2 (PMS2L2) 










* donor (c & h = 
GT, r = AT); 
acceptor (all = AG)
12 NM_002679 -/- 2/8 89 297 387 MSTA MaLR1 postmeiotic 
segregation increased 
2-like 2 (PMS2L2) 










* donor (c & h = 
GT, r = AT); 
acceptor (all = AG)
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sequences in place 





13 NM_002679 -/- 7/8 89 297 387 MSTA MaLR1 postmeiotic 
segregation increased 
2-like 2 (PMS2L2) 










* donor (c & h = 
GT, r = AT); 
acceptor (all = AG)
14 NM_002679 -/- 2/8 89 297 383 MSTA MaLR1 postmeiotic 
segregation increased 
2-like 2 (PMS2L2) 












* donor (c & h = 
GT, r = AT); 
acceptor (all = AG)




transcript variant 2 
DNA binding, transferase 
activity, protein dimerization 
activity, DNA-directed RNA 
polymerase activity (a subunit 

















* donor (c & h = 
GT, r = AT); 
acceptor (all = AG)
16 NM_001023564* +/- 4/5 94 218 419 MSTC MaLR1 cathepsin L-like 
protein  (HCTSL-s) 
cysteine-type peptidase 
activity  
AJ851862 N/A no orthologous 
exonic sequence in 
chimpanzee 
17 NM_017418* +/- 6/8 74 70 371 MSTD MaLR1 deleted in esophageal 
cancer 1 (DEC1) 
unknown (a candidate tumor 
suppressor gene for 
esophageal squamous cell 
carcinomas located in a region 







AB022761 N/A GT/AG 
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sequences in place 





18 NM_001010910* +/- 2/3 85 102 203 MLT1J MaLR1 hypothetical 
LOC399706 
(LOC399706) 
iron ion binding, electron 
transporter activity   
AK097673 DB045405 no orthologous 






19 NM_001548 +/+ 2/3* 109 41 402 MLT1B MaLR1 interferon-induced 
protein with 
tetratricopeptide 
repeats 1 (IFIT1), 
transcript variant 2 










donor (c & h = GT, 
r = AT); acceptor 
(all = AG) 




transcript variant 1 
trypsin activity, peptidase 
activity, calcium ion binding, 









21 NM_001001681* +/+ 3/7 104 129 395 MSTD MaLR1 FLJ45300 protein 
(FLJ45300) 
undefined AK127233 DA313959 * GT/AG 
22 NM_173580* +/- 2/3 107 122 133 MER21C ERV11 chromosome 11 open 
reading frame 44 
(C11orf44) 
undefined AK096377 DA748198  no orthologous 
exonic sequence in 
rhesus monkey 
23 NM_183378 -/+ 26/28 107 1134 436 MER34B ERV11 ovochymase 1 
(OVCH1) 
peptidase activity,serine-type 
endopeptidase activity   
BN000128 N/A * GT/AG 
24 NM_031915* +/- 5/15 36(12) 719 50 MER34 ERV11 SET domain, 
bifurcated 2 
(SETDB2) 




(likely a histone H3 
methyltransferase)   
AF334407 N/A GT/AG 
25 NM_145019* +/- 3/5 108(36) 582 675 LTR9 ERV11 hypothetical protein 
FLJ30707 
(FLJ30707) 
structural constituent of 
ribosome 
AK096364 DA745625  * donor (c & h & r 
= GT); acceptor (c 
& h = AG, r = 
deletion) 
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sequences in place 





26 NM_001014830 -/+ 3/5 75(25) 324 327 MLT1A0 MaLR1 hypothetical protein 
LOC196913 
(LOC196913) 









27 NM_033141* -/+ 11/13 42(14) 1118 589 MLT2B3 ERVL1 mitogen-activated 
protein kinase kinase 
kinase 9 (MAP3K9) 
ATP binding, nucleotide 
binding, transferase activity, 
MAP kinase kinase activity, 
protein-tyrosine kinase 
activity, JUN kinase kinase 
kinase activity, protein 
homodimerization activity, 
protein serine/ threonine 
kinase activity      
AF251442, 
BX648924 
N/A GT/AG  
28 NM_007319* +/- 8/11* 92 374 1701 MER52A ERV11 presenilin 1 
(Alzheimer disease 3) 
(PSEN1), transcript 
variant I-374 
protein binding, Notch 
receptor processing, amyloid 
precursor protein catabolism 
(regulation of amyloid 
precursor protein (APP) 
processing through their 
effects on a gamma-secretase, 
an enzyme that cleaves APP; 
involvement in the cleavage of 
the Notch receptor) 
U40380, 
AF416717 
N/A no orthologous 
exonic sequences in 
chimpanzee and 
rhesus monkey 
29 NM_020552* +/- 2/5 67 105 129 MLT1D MaLR1 T-cell leukemia/ 
lymphoma 6 (TCL6), 
transcript variant 
TCL6b1 
unknown (a candidate gene 
for leukemogenesis) 
AB035335 BX390485  donor (c & h = GT, 
r = GA); acceptor 
(all = AG) 
30 NM_020553* +/- 5/8 67 119 129 MLT1D MaLR1 T-cell leukemia/ 




unknown (a candidate gene 
for leukemogenesis) 
AB035337 BX390485  donor (c & h = GT, 
r = GA); acceptor 
(all = AG) 
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sequences in place 





31 NM_020554* +/- 5/8 67 163 129 MLT1D MaLR1 T-cell leukemia/ 
lymphoma 6 (TCL6), 
transcript variant 
TCL6d1 
unknown (a candidate gene 
for leukemogenesis) 
AB035338 BX390485  donor(c & h = GT, 
r = GA); acceptor 
(all = AG) 
32 NM_005624* +/- 4/5 120(40) 150 390 MLT1K MaLR1 chemokine (C-C 
motif) ligand 25 
(CCL25) 
hormone activity, chemokine 
activity, chemotaxis, sensory 
perception, inflammatory 
response, G-protein coupled 
receptor protein signaling 




33 NM_005867* -/- 2/3 102(34) 118 364 MLT2C1 ERVL1 Down syndrome 
critical region gene 4 
(DSCR4) 
unknown (contribution to the 
pathogenesis of many 
characteristics of Down 
syndrome, including 
morphological features, 
















ATP binding, nucleotide 
binding, transferase activity, 
protein-tyrosine kinase 
activity, protein serine/ 
threonine kinase activity, 
protein amino acid 
phosphorylation (association 





N/A no orthologous 
exonic sequence in 
chimpanzee 
35 NM_024332* +/- 8/12* 75(25) 316 528 MLT1J MaLR1 chromosome X open 







BU570969  no orthologous 
exonic sequences in 
chimpanzee and 
rhesus monkey 








donor (all = GT); 
acceptor  (c & h = 
AG, r = AT) 
37 NM_001004352* +/+ 4/7 187 141 5613 HERVL-A2 ERVL2 FLJ16323 protein 
(FLJ16323) 







N/A no orthologous 
exonic sequence in 
chimpanzee 
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sequences in place 





38 NM_004052* -/+ 3/6 85 194 87 HERV70 ERV12 BCL2/adenovirus 
E1B 19kDa 
interacting protein 3 

























position is not 
covered by 
HERV70) 
39 NM_004052* -/+ 2/6 151 194 154 HERV70 ERV12 BCL2/adenovirus 
E1B 19kDa 
interacting protein 3 
























GT/AG ( GT 
position is not 
covered by 
HERV70) 
40 NM_014317* +/+ 2/12 33(11) 415 1493 THE1D-int MaLR2 prenyl (decaprenyl) 
diphosphate synthase, 
subunit 1 (PDSS1) 
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sequences in place 






















exonic sequence in 
rhesus monkey 
42 NM_016488* +/+ 12/13* 225(75) 458 2904 HERVK22 ERVK2 periphilin 1 
(PPHLN1), transcript 
variant 1 
keratinization (may play a role 
in epithelial differentiation 
and contribute to epidermal 




N/A * GT/AG 


















GT/AG (T position 
is not covered by 
HERVIP10F) 
44 NM_015547* +/+ 16/17* 153 607 3404 MER9, 
HERVK9 
ERVK3 acyl-CoA thioesterase 
11 (ACOT11), 
transcript variant 1 
acyl-CoA thioesterase activity, 




N/A * GT/AG 
45 NM_016488* +/+ 11/13* 101 458 1356 LTR22A, 
HERVK22 
ERVK3 periphilin 1 
(PPHLN1), transcript 
variant 1 
keratinization (may play a role 
in epithelial differentiation 
and contribute to epidermal 







first CDS exon   
 
           
1 NM_144663* -/- 1/4 141(47) 217 580 LTR18B ERVL1 chromosome 11 open 
reading frame 40 
(C11orf40) 
undefined AF439154 N/A * donor (c & h = 
GT, r = GA), no 
flanking acceptor: 
first exon of gene 
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sequences in place 





2 NM_001012274* +/+ 2/3 106 117 998 MER61A, 
MER61A-int
ERV13 chromosome 1 open 
reading frame 99 
(C1orf99) 
undefined BC040856 BM452121 * GT/AG 
last CDS exon            
1 NM_013329* -/- 16/16* 114(38) 815 631 MER39B ERV11 chromosome 21 open 
reading frame 66 
(C21orf66), transcript 
variant 2 
DNA binding, regulation of 
DNA-dependent transcription
AY033904 N/A * acceptor (c & h & 
r = AG), no 
flanking donor: last 
exon of gene 
2 NM_015845* -/+ 14/14* 190 586 656 MLT2F ERVL1 methyl-CpG binding 
domain protein 1 
(MBD1), transcript 
variant 2 
metal ion binding, methyl-
CpG binding, transcription 
corepressor activity 
AF078831 N/A acceptor(c & h & r 
= AG), no flanking 
donor: last exon of 
gene 
3 NM_181538* -/- 2/2 59 279 491 LTR72B ERV11 gap junction protein, 
epsilon 1, 29kDa 
(GJE1) 
connexon channel activity AF503615, 
AY297109 
N/A * acceptor (c & h & 
r = AG), no 
flanking donor: last 
exon of gene 
4 NM_001015884 -/- 4/4 33(11) 115 384 MSTA MaLR1 RPB11b2alpha 
protein (POLR2J3) 
undefined AJ277741 BI223488, 
BE936699, 
DW433233  
* acceptor (c & h & 
r = AG), no 
flanking donor: last 
exon of gene 
single protein coding exon            
1 NM_001007236 -/- 1/1 5640 
(1880) 
1879 7536 HERVK ERVK2 endogenous retroviral 
sequence K, 6 
(ERVK6) 
aspartic-type endopeptidase 
activity, metal ion binding, 
nucleic acid binding, 
peptidase activity, zinc ion 
binding, DNA transposition, 






U87591,       
U87592    
N/A no orthologous 





location from the 
previous entry) 
-/- 1/1 5640 
(1880) 
1879 7535 HERVK ERVK2 endogenous retroviral 
sequence K, 6 
(ERVK6) 
aspartic-type endopeptidase 
activity, metal ion binding, 
nucleic acid binding, 
peptidase activity, zinc ion 
binding, DNA transposition, 






U87591,       
U87592    
N/A no orthologous 
exonic sequence in 
chimpanzee and 
rhesus monkey 
          
                                                                                                                                                                           
 
171 
Table A.1 continued            












































sequences in place 





3 NM_001007253 -/- 1/1 1696 564 8428 HERV3 ERV12 endogenous retroviral 
sequence 3 (includes 
zinc finger protein H-
plk/HPF9) (ERV3) 
unknown  N/A N/A no orthologous 




(1) RefSeq gene accession number. The entries marked with arterisk are known protein coding genes with the products listed in 
SWISS-PROT, TrEMBL, and TrEMBL-NEW and their corresponding mRNAs presented in the GenBank records. The adjacent 
entries in gray shading indicate the redundant exons, exons with exact or overlap boundaries participated in different alternative 
transcripts (derived from the same LRTS). Item 10-14 of internal protein coding exons could be the result of duplication of genes or 
gene regions, rather than direct LTR element insertion. 
(2) Orientation of gene and LRTS assigned as gene strand/ LRTS strand.  +, sense strand; -, antisense strand 
(3) The position of exon on a gene/ total number of exons. The arterisk indicates the alternatively spliced exon (exons which are not 
present in all transcript variants).  
(4) The length of LRTS-derived exon. In case of length divisible by three, the number in parenthesis shows the length of additional 
amino acid sequence provided by LRTS. 
(5) The length of LRTS fragment covering the exon. 
(6) Class/ family of LRTS. The superscript number refers to the part of LRTS covering an exon. 1, only LTR; 2, only internal 
sequence (sequence between flanking LTRs containing traditional viral genes); 3, both LTR and internal sequence. 
(7) Gene descriptions according to the Gene Ontology (GO). undefined: no match for the gene in GO. unknown: gene product whose 
process, function, or localization is not known or cannot be inferred.  
(8) GenBank mRNAs and (9) ESTs confirming the existence of LRTS-derived exon in human. Data were derived from the UCSC 
genome browser and the Entrez Gene. 
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(10) Sequences in place of splice sites flanking the LRTS-derived exon compared between human (May 2004, hg17), chimpanzee 
(Nov 2003, panTro1) and rhesus monkey (Jan 2006, rheMac2). h, human; c, chimpanzee; r, rhesus monkey. The data were derived 
from the multiple sequence alignment of the target exon of human and homologous sequences of chimpanzee and rhesus monkey 
retrieved from the UCSC genome browser. The entries marked with arterisk suggest possible primate-specific LTR element insertion 
(the homologous LRTS regions are present in chimpanzee and rhesus monkey but not in other vertebrates; mouse, rat, rabbit, dog, 





SUPPLEMENTARY INFORMATION FOR CHAPTER 3 
 
Table B.1: List of 124 TE-associated Pfam protein domains 
Table B.1 continued  
Accession ID Description 
PF00075 RnaseH RNase H 
PF00077 RVP Retroviral aspartyl protease 
PF00078 RVT_1 Reverse transcriptase (RNA-dependent DNA 
polymerase) 
PF00098 zf-CCHC Zinc knuckle 
PF00424 REV REV protein (anti-repression trans-activator 
protein) 
PF00429 TLV_coat ENV polyprotein (coat polyprotein) 
PF00469 F-protein Negative factor, (F-Protein) or Nef 
PF00516 GP120 Envelope glycoprotein GP120 
PF00517 GP41 Envelope Polyprotein GP41 
PF00522 VPR VPR/VPX protein 
PF00539 Tat Transactivating regulatory protein (Tat) 
PF00540 Gag_p17 gag gene protein p17 (matrix protein) 
PF00552 Integrase Integrase DNA binding domain 
PF00558 Vpu Vpu protein 
PF00559 Vif Retroviral Vif (Viral infectivity) protein 
PF00589 Phge_integrase Phage integrase family 
PF00607 Gag_p24 gag gene protein p24 (core nucleocapsid protein) 
PF00665 rve Integrase core domain 
PF00692 dUTPase dUTPase 
PF00872 Transposase_mut Transposase, Mutator family 
PF00906 Hepatitis_core Hepatitis core antigen 
PF00971 EIAV_GP90 EIAV coat protein, gp90 
PF00979 Reovirus_cap Reovirus outer capsid protein, Sigma 3 
PF01021 TYA TYA transposon protein 
PF01045 EIAV_GP45 EIAV glycoprotein, gp45 
PF01054 MMTV_SAg Mouse mammary tumour virus superantigen 
PF01140 Gag_MA Matrix protein (MA), p15 
PF01141 Gag_p12 Gag polyprotein, inner coat protein p12 
PF01359 Transposase_1 Transposase 
PF01385 Transposase_2 Probable transposase 
PF01498 Transposase_5 Transposase 
PF01526 Transposase_7 Transposase 
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Table B.1 continued  
Accession ID Description 
PF01527 Transposase_8 Transposase 
PF01548 Transposase_9 Transposase 
PF01609 Transposase_11 Transposase DDE domain 
PF01610 Transposase_12 Transposase 
PF01695 IstB IstB-like ATP binding protein 
PF01710 Transposase_14 Transposase 
PF01797 Transposase_17 Transposase IS200 like 
PF02022 Integrase_Zn Integrase Zinc binding domain 
PF02093 Gag_p30 Gag P30 core shell protein 
PF02228 Gag_p19 Major core protein p19 
PF02281 Transposase_Tn5 Transposase Tn5 dimerisation domain 
PF02316 Mu_DNA_bind Mu DNA-binding domain 
PF02337 Gag_p10 Retroviral GAG p10 protein 
PF02371 Transposase_20 Transposase IS116/IS110/IS902 family 
PF02411 MerT MerT mercuric transport protein 
PF02720 DUF222 Domain of unknown function DUF222 
PF02813 Retro_M Retroviral M domain 
PF02892 zf-BED BED zinc finger 
PF02914 Mu_transposase Bacteriophage Mu transposase 
PF02920 Integrase_DNA DNA binding domain of tn916 integrase 
PF02959 Tax HTLV Tax 
PF02992 Transposase_21 Transposase family tnp2 
PF02994 Transposase_22 L1 transposable element 
PF02998 Lentiviral_Tat Lentiviral Tat protein 
PF03004 Transposase_24 Plant transposase (Ptta/En/Spm family) 
PF03017 Transposase_23 TNP1/EN/SPM transposase 
PF03050 Transposase_25 Transposase IS66 family 
PF03056 GP36 Env gp36 protein (HERV/MMTV type) 
PF03078 ATHILA ATHILA ORF-1 family 
PF03108 MuDR MuDR family transposase 
PF03184 DDE DDE superfamily endonuclease 
PF03221 Transposase_Tc5 Tc5 transposase 
PF03274 Foamy_BEL Foamy virus BEL 1/2 protein 
PF03276 Gag_spuma Spumavirus gag protein 
PF03400 Transposase_27 IS1 transposase 
PF03408 Foamy_virus_ENV Foamy virus envelope protein 
PF03539 Spuma_A9PTase Spumavirus aspartic protease (A9) 
PF03708 Avian_gp85 Avian retrovirus envelope protein, gp85 
PF03716 WCCH WCCH motif 
PF03732 Retrotrans_gag Retrotransposon gag protein 
PF03811 Ins_element1 Insertion element protein 
PF04094 DUF390 Protein of unknown function (DUF390) 
PF04160 Borrelia_orfX Orf-X protein 
          
                                                                                                                                                                       
 175
Table B.1 continued  
Accession ID Description 
PF04195 Transposase_28 Putative gypsy type transposon 
PF04218 CENP-B_N CENP-B N-terminal DNA-binding domain 
PF04236 Transp_Tc5_C Tc5 transposase C-terminal domain 
PF04582 Reo_sigmaC Reovirus sigma C capsid protein 
PF04693 Transposase_29 Archaeal putative transposase ISC1217 
PF04740 Transposase_30 Bacillus transposase protein 
PF04754 Transposase_31 Putative transposase, YhgA-like 
PF04827 Plant_tran Plant transposon protein 
PF04937 DUF659 Protein of unknown function (DUF 659) 
PF04986 Transposase_32 Putative transposase 
PF05052 MerE MerE protein 
PF05344 DUF746 Domain of Unknown Function (DUF746) 
PF05380 Peptidase_A17 Pao retrotransposon peptidase 
PF05399 EVI2A Ectropic viral integration site 2A protein (EVI2A) 
PF05457 Transposase_33 Sulfolobus transposase 
PF05485 THAP THAP domain 
PF05598 DUF772 Sulfolobus solfataricus protein of unknown 
function (DUF772) 
PF05599 Deltaretro_Tax Deltaretrovirus Tax protein 
PF05621 TniB Bacterial TniB protein 
PF05699 hATC hAT family dimerisation domain 
PF05717 Transposase_34 IS66 Orf2 like protein 
PF05754 DUF834 Domain of unknown function (DUF834) 
PF05840 Phage_GPA Bacteriophage replication gene A protein (GPA) 
PF05851 Lentivirus_VIF Lentivirus virion infectivity factor (VIF) 
PF05858 BIV_Env Bovine immunodeficiency virus surface envelope 
protein (ENV) 
PF05928 Zea_mays_MuDR Zea mays MURB-like protein (MuDR) 
PF06527 TniQ TniQ 
PF06815 RVT_connect Reverse transcriptase connection domain 
PF06817 RVT_thumb Reverse transcriptase thumb domain 
PF07253 Gypsy Gypsy protein 
PF07282 Transposase_35 Putative transposase DNA-binding domain 
PF07567 zf-C2HC_plant Protein of unknown function, DUF1544 
PF07572 BCNT Bucentaur or craniofacial development 
PF07592 Transposase_36 Rhodopirellula transposase 
PF07727 RVT_2 Reverse transcriptase (RNA-dependent DNA 
polymerase) 
PF07999 RHSP Retrotransposon hot spot protein 
PF08284 RVP_2 Retroviral aspartyl protease 
PF08333 DUF1725 Protein of unknown function (DUF1725) 
PF08483 IstB_N IstB-like ATP binding N-terminal 
PF08705 Gag_p6 Gag protein p6 
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Table B.1 continued  
Accession ID Description 
PF08721 TnsA_C TnsA endonuclease C terminal 
PF08722 TnsA_N TnsA endonuclease N terminal 
PF08723 Gag_p15 Gag protein p15 
PF09035 Tn916-Xis Excisionase from transposon Tn916 
PF09039 Mu_I-gamma Mu DNA binding, I gamma subdomain 
PF09077 Phage-MuB_C Mu B transposition protein, C terminal 
PF09293 RNaseH_C T4 RNase H, C terminal 
PF09299 Mu-transpos_C Mu transposase, C-terminal 






Figure B.1: The GC composition of Alu-derived gene fragments. Scatter plots of 
%G+C of second (GC2) versus third (GC3) codon positions for Alu-derived gene 
fragments (pink), non Alu TE-derived gene fragments (red) and non TE-associated genes 















CCDS (w ithout TEs)
TE-derived fragments (not Alu)
Alu-derived fragments
Linear regression: CCDS (w ithout TEs)
95% confidence band: CCDS (w ithout TEs)
Linear regression: TE-derived fragments
          
                                                                                                                                                                       
 177
APPENDIX C 
SUPPLEMENTARY INFORMATION FOR CHAPTER 4 
 
 
Table C.1: mRNAs anticorrelated with hsa-mir-130b and their associated GO terms 
 
Table C.1 continued  
Namea GOb P-valuec 
A4GNT GO:0044237 cellular metabolism 0.0037 
BACH2 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
BRPF1 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
CAPN10 GO:0044237 cellular metabolism 0.0037 
CCNB1 GO:0050789 regulation of biological process 0.0017 
CCRN4L GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
COX7A2L GO:0044237 cellular metabolism 0.0037 
EEF1B2 GO:0044237 cellular metabolism 0.0037 
EPM2A GO:0031323 regulation of cellular metabolism 0.0008 
ERBB4 GO:0044237 cellular metabolism 0.0037 
EREG GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
GADD45A GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
GALR1 GO:0050789 regulation of biological process 0.0017 
GTF2H1 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
HOXD1 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
JARID2 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
KLF13 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
MAX GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
MBD4 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
MITF GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
MRPS30 GO:0044237 cellular metabolism 0.0037 
MYB GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
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Table C.1 continued  
Namea GOb P-valuec 
NOX1 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
PITPNM2 GO:0008152 metabolism 0.0068 
PPIG GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
PRKAA2 GO:0044237 cellular metabolism 0.0037 
PRMT7 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
PSMA8 GO:0044237 cellular metabolism 0.0037 
PTGER3 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
PTH GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
RPS2 GO:0044237 cellular metabolism 0.0037 
SIRT6 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
SIRT7 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
TGIF2 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
TP73L GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
UBE2W GO:0044237 cellular metabolism 0.0037 
VGLL2 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
WHSC1L1 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
ZNF430 GO:0006139 nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism 
5.96E-05 
 
aGene name for the anticorrelated mRNA 
bOver-represented biological process GO term and description 




Table C.2: Conserved RNA secondary structures that co-locate with human TE 
sequences 
 
Table C.2 continued  
Namea Coordsb TEc 
6597_0_+_74 chr1:6483733-6483759(+) Charlie8 
15086_0_-_78 chr1:15041842-15041859(-) HAL1 
24981_0_+_74 chr1:23415863-23415881(+) MIRb 
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Table C.2 continued  
Namea Coordsb TEc 
25288_0_-_83 chr1:23621848-23621877(-) MIRb 
25923_0_+_48 chr1:24115467-24115495(+) MIR3 
30647_0_+_38 chr1:27752374-27752433(+) MIRb 
30820.5_0_-_68 chr1:27791805-27791823(-) MIR3 
38333_0_+_77 chr1:34707582-34707607(+) Charlie7 
43475_0_+_88 chr1:38294035-38294051(+) L3 
46777_0_+_71 chr1:40440123-40440153(+) MER103 
48001_0_+_47 chr1:41214471-41214487(+) L2 
48998_0_-_51 chr1:41888110-41888146(-) L3 
51113_0_+_73 chr1:43734410-43734424(+) L1M5 
58555_0_+_65 chr1:49094515-49094531(+) L1ME4a 
60187_0_+_106 chr1:50667381-50667396(+) L1ME4a 
72612_0_-_79 chr1:61379203-61379221(-) L3 
73590_0_-_75 chr1:61923623-61923650(-) Charlie2 
82264_0_-_68 chr1:71707409-71707427(-) L3 
85615_0_+_83 chr1:76474930-76474947(+) MIRb 
92562_0_-_56 chr1:83112753-83112791(-) L2 
108307_0_+_78 chr1:97287966-97287983(+) L3b 
112207_0_+_95 chr1:101216647-101216665(+) MIR3 
120809_0_+_79 chr1:111021701-111021719(+) MIR 
122080_0_-_62 chr1:112177611-112177631(-) MIR 
124780_0_-_66 chr1:114214379-114214407(-) MIRb 
132990_0_-_73 chr1:142748623-142748637(-) MIR3 
148967_0_+_106 chr1:157421181-157421197(+) L2 
149463_0_+_61 chr1:157999850-157999872(+) L4 
154215_0_+_65 chr1:162123173-162123189(+) Tigger8 
161465_0_+_90 chr1:169013965-169013984(+) MER45A 
177588_0_-_76 chr1:182715187-182715207(-) MIRb 
184070_0_-_57 chr1:192397663-192397683(-) MER90 
188643_0_+_89 chr1:198985820-198985838(+) L2 
190021_0_+_47 chr1:199883257-199883273(+) MIRb 
199932_0_-_79 chr1:206789414-206789432(-) Charlie2 
228731_0_+_62 chr1:242250135-242250150(+) MER53 
230542_0_-_67 chr1:244286075-244286098(-) L1MB3 
1190052_0_-_69 chr2:26795482-26795520(-) L1ME4a 
1194893_0_+_73 chr2:29846946-29846960(+) HAL1 
1201447_0_+_65 chr2:37374164-37374180(+) L4 
1208495_0_+_83 chr2:44171423-44171440(+) LTR33 
1208526_0_-_109 chr2:44198198-44198220(-) MLT1J 
1222791_0_+_110 chr2:59759711-59759730(+) L1M5 
1228152_0_-_94 chr2:64565601-64565616(-) MIR3 
1229575_0_+_76 chr2:65898157-65898173(+) LTR33 
1239485_0_+_80 chr2:75090614-75090638(+) L1ME4a 
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Namea Coordsb TEc 
1239721_0_+_79 chr2:75407124-75407142(+) MARNA 
1239765_0_+_119 chr2:75520847-75520862(+) L1MC 
1243784_0_-_105 chr2:81417721-81417741(-) MIRb 
1245396_0_-_65 chr2:85055655-85055671(-) MER58B 
1247043_0_+_65 chr2:86563203-86563222(+) L3 
1250762_0_-_79 chr2:95726497-95726515(-) L2 
1257853_0_+_43 chr2:103875041-103875063(+) MIRm 
1258738_0_-_45 chr2:104657492-104657535(-) L1ME4a 
1265559_0_+_78 chr2:113813281-113813307(+) L2 
1280461_0_+_93 chr2:136964701-136964729(+) Tigger8 
1288189_0_+_138 chr2:145136397-145136417(+) L1MC5 
1304651_0_+_81 chr2:161680961-161680976(+) MIRb 
1307871_0_+_94 chr2:164440131-164440148(+) L3b 
1312547_0_+_65 chr2:169163008-169163024(+) Kanga2_a 
1318523_0_+_114 chr2:174053048-174053068(+) L2 
1319174_0_-_68 chr2:174641664-174641691(-) L1MC4a 
1320276_0_-_65 chr2:175480749-175480768(-) L1ME4a 
1344295_0_+_73 chr2:200120342-200120356(+) MIRm 
1346880_0_-_90 chr2:202119446-202119466(-) L1MB8 
1353436_0_-_43 chr2:206288743-206288763(-) MIRb 
1363676_0_-_76 chr2:215455658-215455686(-) MARNA 
1365045_0_+_67 chr2:216418189-216418209(+) MLT1K 
1371955_0_+_109 chr2:220595160-220595181(+) Arthur1 
1383146_0_-_65 chr2:232693947-232693963(-) L2 
1389370_0_-_70 chr2:240141186-240141212(-) L1M5 
1521839_0_+_74 chr3:10540626-10540652(+) Charlie8 
1525689_0_+_100 chr3:14249470-14249491(+) L3 
1530481_0_+_59 chr3:18526135-18526168(+) L2 
1542101_0_+_74 chr3:35354374-35354400(+) L1ME3A 
1558705_0_+_79 chr3:50643228-50643246(+) MIRb 
1572162_0_-_74 chr3:60630961-60630979(-) L1M5 
1584630_0_-_110 chr3:70684589-70684609(-) L1ME3A 
1590226_0_-_100 chr3:74756051-74756070(-) MER45B 
1593242_0_-_80 chr3:78065198-78065217(-) MIRb 
1595751_0_+_87 chr3:81453304-81453326(+) MIRb 
1605591_0_+_81 chr3:100984579-100984594(+) L3b 
1619386_0_-_86 chr3:115872816-115872837(-) MER69A 
1624711_0_+_126 chr3:120022139-120022157(+) L1ME4a 
1638166_0_-_65 chr3:133240374-133240390(-) MLT1J 
1651552_0_-_59 chr3:145681874-145681905(-) L2 
1664761_0_+_78 chr3:161388886-161388903(+) MER3 
1665104_0_-_61 chr3:161708071-161708106(-) L2 
1669125_0_+_65 chr3:169470145-169470170(+) L1ME4a 
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Namea Coordsb TEc 
1692753_0_+_65 chr3:194760060-194760076(+) MIRb 
1705626_0_-_63 chr4:12690588-12690606(-) L2 
1709742_0_-_82 chr4:17391442-17391474(-) L2 
1714124_0_-_124 chr4:23001557-23001573(-) L2 
1719629_0_+_105 chr4:27859462-27859480(+) LTR33 
1726312_0_-_63 chr4:39411734-39411760(-) MIRb 
1730972_0_-_56 chr4:46681709-46681733(-) L1ME3B 
1747758_0_-_63 chr4:74275595-74275629(-) L1M5 
1753586_0_-_83 chr4:81294838-81294860(-) MIRb 
1754111_0_+_88 chr4:81949213-81949228(+) L3 
1764240_0_-_76 chr4:95780967-95780983(-) MIR3 
1768888_0_-_54 chr4:101481090-101481113(-) LTR33 
1772239_0_+_73 chr4:106784430-106784444(+) MIR3 
1773181_0_+_100 chr4:108002087-108002108(+) LTR68 
1813460_0_-_96 chr4:158919215-158919239(-) MER5A 
1827139_0_+_83 chr4:181230274-181230297(+) MLT1C 
1827751_0_+_75 chr4:181988895-181988914(+) MIRb 
1829210_0_-_55 chr4:183054460-183054490(-) MIR3 
1830949_0_+_65 chr4:184054997-184055013(+) MIRm 
1842241_0_+_61 chr5:9629511-9629533(+) Charlie2 
1860397_0_+_94 chr5:38819321-38819337(+) MIR3 
1862891_0_+_55 chr5:42157514-42157542(+) LTR16A1 
1868925_0_+_75 chr5:53320758-53320785(+) MIRb 
1874290_0_-_110 chr5:59086690-59086709(-) MER113 
1876462_0_-_84 chr5:61101641-61101659(-) MIRb 
1900649_0_+_81 chr5:88600908-88600928(+) MARNA 
1904329_0_+_85 chr5:92449669-92449694(+) L3 
1912951_0_+_71 chr5:103360475-103360491(+) MIRb 
1919694_0_-_71 chr5:112530605-112530621(-) L3b 
1920501_0_+_72 chr5:113735156-113735173(+) L2 
1929047_0_+_75 chr5:124046980-124047023(+) HAL1 
1944753_0_+_72 chr5:139204106-139204134(+) Charlie7 
1944754_0_-_54 chr5:139204158-139204181(-) Charlie7 
1949916_0_-_74 chr5:141188281-141188299(-) L1MC 
1951254_0_-_65 chr5:142156112-142156128(-) MIR3 
1959488_0_-_87 chr5:149669722-149669736(-) L2 
1966281_0_+_83 chr5:156681824-156681841(+) MIR3 
1967253_0_+_52 chr5:157463563-157463620(+) L1ME4a 
1969951_0_+_79 chr5:159059780-159059812(+) L4 
1970767_0_+_67 chr5:159755119-159755139(+) Charlie11 
1973974_0_-_68 chr5:163838798-163838819(-) L2 
1980933_0_+_81 chr5:168747748-168747763(+) Charlie1a 
1987527_0_+_59 chr5:175727565-175727628(+) L2 
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Namea Coordsb TEc 
1988415_0_+_77 chr5:176255041-176255066(+) MIRb 
1874239_0_+_93 chr5:59035208-59035277(+) L3 
1999329_0_+_67 chr6:7450078-7450092(+) MIR3 
2006707_0_+_93 chr6:15110399-15110413(+) MIRb 
2012915_0_+_82 chr6:21665770-21665786(+) Charlie8 
2020947_0_+_75 chr6:31654313-31654336(+) LTR42 
2029187_0_+_46 chr6:37530191-37530227(+) L3b 
2029634_0_-_100 chr6:37784559-37784580(-) L1ME4a 
2032923_0_+_87 chr6:40857398-40857412(+) L1ME4a 
2037716_0_-_160 chr6:44077681-44077715(-) MER53 
2047183_0_+_78 chr6:54681376-54681393(+) L2 
2075048_0_-_91 chr6:94484941-94484963(-) ERVL-E 
2078828_0_-_111 chr6:99509678-99509696(-) MIRb 
2085959_0_+_73 chr6:107897109-107897123(+) MER5B 
2096533_0_+_62 chr6:119656124-119656165(+) L3 
2171717_0_+_110 chr7:34814854-34814873(+) HAL1b 
2177366_0_-_111 chr7:41288277-41288304(-) L1ME4a 
2195049_0_+_117 chr7:73161289-73161306(+) MIR3 
2203727_0_+_62 chr7:83830368-83830388(+) L3 
2214152_0_-_57 chr7:95381816-95381836(-) MIR 
2215010_0_-_104 chr7:95921415-95921438(-) L1ME3 
2216137_0_+_72 chr7:97120781-97120805(+) MIR3 
2229371_0_+_67 chr7:110280027-110280041(+) LTR40a 
2234441_0_+_52 chr7:115222951-115222981(+) L2 
2246941_0_+_73 chr7:128849628-128849649(+) L2 
2247695_0_+_119 chr7:129521829-129521855(+) L1ME4a 
2247695_1_+_65 chr7:129521966-129521985(+) L1ME4a 
2251058_0_-_95 chr7:131926833-131926869(-) Charlie7 
2277373_0_+_89 chr8:9268418-9268435(+) L1MD2 
2278817_0_+_62 chr8:10784215-10784248(+) MIRb 
2285985_0_+_74 chr8:20987404-20987426(+) L2 
2286909_0_+_87 chr8:21794450-21794464(+) MIRb 
2293775_0_+_77 chr8:28190662-28190683(+) L1MC4a 
2296966_0_-_112 chr8:31652907-31652946(-) MIRb 
2299343_0_+_68 chr8:33896886-33896904(+) L1MC4 
2299747_0_+_76 chr8:34293119-34293135(+) MIRb 
2301209_0_+_94 chr8:35801853-35801870(+) L3 
2306450_0_-_70 chr8:41798076-41798095(-) L2 
2317552_0_-_83 chr8:64247707-64247729(-) MIRb 
2322741_0_+_67 chr8:69743160-69743177(+) L3 
2330830_0_-_81 chr8:78984234-78984259(-) MER5B 
2337143_0_+_72 chr8:89013976-89013993(+) L2 
2339739_0_+_72 chr8:92822152-92822176(+) L3 
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2339740_0_-_87 chr8:92822207-92822229(-) L3 
2348773_0_+_51 chr8:102229956-102230022(+) Charlie9 
2356873_0_+_100 chr8:110789279-110789300(+) L3 
2363824_0_-_100 chr8:119852398-119852414(-) L4 
2369557_0_+_74 chr8:125994973-125994991(+) MIRb 
2373181_0_+_76 chr8:130158434-130158450(+) L2 
2376487_0_+_73 chr8:134299648-134299669(+) MIRb 
2378900_0_-_81 chr8:138418970-138418990(-) MER91B 
2380602_0_-_97 chr8:141811863-141811931(-) L2 
2389613_0_+_87 chr9:3936317-3936331(+) L2 
2393693_0_+_78 chr9:8804094-8804111(+) L2 
2394223_0_+_76 chr9:9267671-9267699(+) L1M4 
2401146_0_-_96 chr9:16787222-16787246(-) MIR 
2401571_0_+_67 chr9:17060609-17060626(+) L1ME4a 
2412879_0_+_68 chr9:29844233-29844254(+) L3 
2421368_0_-_79 chr9:37811135-37811158(-) L1MC4a 
2426661_0_+_64 chr9:70297285-70297306(+) MER91A 
2431307_1_+_89 chr9:75353184-75353201(+) L4 
2442499_0_+_85 chr9:88825569-88825595(+) L4 
2447361_0_+_94 chr9:97429994-97430011(+) MLT1K 
2452438_0_-_120 chr9:101754094-101754108(-) L4 
2452597_0_+_91 chr9:101776189-101776211(+) L4 
2452602_0_-_68 chr9:101776449-101776467(-) L4 
2455634_0_-_64 chr9:105918396-105918420(-) MER5A 
2468629_0_+_104 chr9:117452580-117452603(+) L2 
2472869_0_+_76 chr9:121613122-121613138(+) L2 
2479521_0_+_75 chr9:126607543-126607574(+) L1ME4a 
2500550_0_-_83 chrX:10899595-10899617(-) L4 
2507070_0_-_85 chrX:15944486-15944505(-) L1ME4a 
2509218_0_-_95 chrX:17351726-17351746(-) MIRb 
2513321_0_+_81 chrX:19783471-19783486(+) MER58A 
2514009_0_+_54 chrX:20163518-20163543(+) L1ME4a 
2514011_0_+_147 chrX:20164132-20164161(+) L1ME4a 
2514641_0_+_84 chrX:20436611-20436629(+) L2 
2519737_0_+_67 chrX:24557155-24557175(+) L1ME4a 
2527121_0_+_47 chrX:32060447-32060480(+) MIRb 
2537738_0_-_61 chrX:43454292-43454314(-) MIRb 
2557941_0_+_75 chrX:71069003-71069018(+) L2 
2571697_0_+_73 chrX:97698707-97698728(+) Charlie1a 
2573092_0_-_86 chrX:99503268-99503289(-) MIR 
2576468_0_-_59 chrX:102471559-102471585(-) L1MC4a 
2583739_0_+_63 chrX:108529599-108529617(+) L2 
2584535_0_+_91 chrX:109185224-109185300(+) MER91C 
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2585968_0_-_86 chrX:110177627-110177654(-) L2 
2598315_0_+_62 chrX:123586235-123586255(+) MIRb 
2604008_0_-_88 chrX:129506265-129506281(-) HAL1b 
2604832_0_-_51 chrX:129994594-129994630(-) L3 
2607024_0_-_68 chrX:131689852-131689873(-) L1MB5 
2613374_0_-_71 chrX:135974107-135974123(-) MIR 
2613853_0_+_60 chrX:136377304-136377323(+) L1MC4 
2625375_0_+_86 chrX:152562536-152562556(+) L2 
241830_0_-_89 chr10:13315027-13315044(-) MIR 
246588_0_-_100 chr10:18657192-18657208(-) MER5B 
251147_0_+_94 chr10:24324839-24324855(+) MIRb 
276291_0_+_66 chr10:62836157-62836220(+) L1M5 
278579_0_+_157 chr10:64671753-64671775(+) L2 
279306_0_-_71 chr10:65568421-65568437(-) MLT1L 
292265_0_+_95 chr10:77784926-77784944(+) L2 
295318_0_-_86 chr10:80133480-80133500(-) L3b 
296055_0_+_79 chr10:80679702-80679720(+) MIRb 
299725_0_+_88 chr10:86569717-86569742(+) L1ME4a 
333376_0_-_70 chr10:115808231-115808257(-) MER46C 
334961_0_+_78 chr10:117579937-117579954(+) L2 
341781_0_+_89 chr10:123290268-123290285(+) L3 
361933_0_+_88 chr11:6635631-6635654(+) Kanga2_a 
368338_0_-_100 chr11:11787492-11787508(-) L3 
370306_0_-_88 chr11:13416460-13416476(-) L3 
377681_0_+_96 chr11:19331037-19331062(+) L3 
394814_0_-_79 chr11:40886992-40887015(-) L2 
395263_0_+_46 chr11:41605707-41605732(+) FordPrefect_a 
397099_0_+_71 chr11:43869396-43869412(+) MIRb 
408823_0_+_73 chr11:59187569-59187590(+) MIR 
425555_0_+_71 chr11:71985685-71985701(+) MIR 
438440_0_-_74 chr11:83316345-83316367(-) L2 
438439_0_+_83 chr11:83316376-83316398(+) L2 
440997_0_+_81 chr11:85937263-85937278(+) L4 
444101_0_+_100 chr11:91430989-91431005(+) MIR 
466625_0_+_110 chr11:116956700-116956719(+) MIR 
471849_0_+_90 chr11:119880617-119880636(+) L3 
486187_0_+_68 chr11:130861130-130861151(+) MIRb 
492576_0_-_95 chr12:2125422-2125443(-) MIRb 
498153_0_+_67 chr12:6658215-6658235(+) MIRm 
522947_0_+_70 chr12:40826566-40826585(+) L2 
533638.0_0_-_122 chr12:50492331-50492353(-) MIRb 
542148_0_-_83 chr12:55246557-55246574(-) LTR37B 
569483_0_+_39 chr12:87985382-87985425(+) L2 
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570380_0_-_86 chr12:88718407-88718434(-) MIRb 
571837_0_+_78 chr12:90583073-90583090(+) MER58B 
578709_0_+_108 chr12:96992583-96992607(+) L1ME3B 
637241_0_+_66 chr13:52383235-52383263(+) L3b 
645204_0_-_94 chr13:62341135-62341150(-) MIR 
648567_0_+_59 chr13:67872860-67872891(+) MIRb 
650887_0_+_68 chr13:71623788-71623824(+) L3b 
654127_0_+_82 chr13:74685170-74685186(+) MER5A 
710673_0_+_58 chr14:49857372-49857390(+) MIR 
731341_0_+_70 chr14:67762102-67762121(+) L3b 
737958_0_-_62 chr14:72903436-72903456(-) MIRb 
740946_0_-_72 chr14:74763371-74763399(-) L2 
746350_0_-_81 chr14:78670822-78670842(-) MIRm 
766865_0_+_57 chr14:100584767-100584820(+) MER5A1 
775713_0_+_77 chr15:25703141-25703162(+) L1MCc 
783373_0_+_94 chr15:33592451-33592467(+) L1ME4a 
795825_0_+_111 chr15:41875416-41875434(+) MIRb 
804788_0_-_75 chr15:50144808-50144835(-) L1M1 
823849_0_+_52 chr15:65945171-65945195(+) L1ME4a 
830936_0_-_60 chr15:71924252-71924271(-) L4 
842223_0_+_71 chr15:81565655-81565678(+) MIR3 
844067_0_+_100 chr15:83150156-83150175(+) L1ME4a 
851769_0_+_126 chr15:89250081-89250099(+) L4 
854345_0_+_71 chr15:91631904-91631924(+) MIRb 
857021_0_+_68 chr15:94257983-94258001(+) MIRb 
858814_3_-_112 chr15:95403622-95403655(-) L4 
872420_0_-_70 chr16:6175415-6175434(-) MIRb 
896537_0_+_81 chr16:30749660-30749680(+) MIR 
904577_0_+_91 chr16:49653282-49653304(+) MER99 
905411_0_+_74 chr16:50290185-50290231(+) L3 
909177_0_+_82 chr16:53170182-53170198(+) MIRb 
914771_0_+_81 chr16:57783182-57783208(+) MIRb 
918945_0_+_64 chr16:63576155-63576179(+) L1M5 
924692_0_-_70 chr16:67025377-67025409(-) L1ME4a 
928869_0_+_74 chr16:70304015-70304037(+) MIR3 
929116_0_-_165 chr16:70444938-70444954(-) MIR 
933812_0_-_89 chr16:74025554-74025571(-) Tigger2 
976169_0_+_86 chr17:24040248-24040268(+) L1ME4a 
989909_0_+_100 chr17:34009010-34009024(+) MIR3 
993737_0_+_67 chr17:36057125-36057139(+) MIRb 
1000039.8_0_+_109 chr17:39468501-39468532(+) L1MC4 
1015457_0_+_67 chr17:50377318-50377332(+) MLT1C 
1018093_0_+_74 chr17:52576474-52576492(+) MIR3 
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1027140_0_-_109 chr17:58956205-58956226(-) MER5A 
1029871_0_+_79 chr17:60844235-60844253(+) MIR 
1044595_0_+_71 chr17:73614287-73614307(+) L1MDa 
1054900_0_-_75 chr18:6426001-6426016(-) L1M5 
1062229_0_+_73 chr18:18029737-18029751(+) L1ME4a 
1067853_0_+_86 chr18:22989505-22989533(+) L3 
1072891_0_+_61 chr18:29462119-29462141(+) MIRb 
1073425_0_+_104 chr18:30062939-30062963(+) L2 
1076640_0_-_90 chr18:33541894-33541913(-) L2 
1077026_0_-_100 chr18:33875539-33875554(-) MIRb 
1077028_0_-_58 chr18:33875730-33875789(-) MIRb 
1079884_0_-_53 chr18:37167167-37167185(-) L3 
1083125_0_+_82 chr18:41077120-41077141(+) L2 
1083586_0_-_71 chr18:41429464-41429484(-) MIR 
1084952_0_-_69 chr18:42863307-42863338(-) L1ME4a 
1085381_0_+_105 chr18:43238379-43238399(+) MIR 
1085682_0_-_76 chr18:43568621-43568637(-) MER113 
1100012_0_-_81 chr18:59852148-59852168(-) L3 
1105949_0_+_73 chr18:71397854-71397883(+) L3b 
1139206_0_-_87 chr19:37294434-37294456(-) L2 
1394080_0_-_52 chr20:2927811-2927835(-) L1ME3B 
1397189_0_+_110 chr20:6163591-6163611(+) L2 
1401791_0_+_119 chr20:10612937-10612952(+) L2 
1405784_0_-_100 chr20:14549750-14549770(-) MIRb 
1405783_1_+_46 chr20:14549818-14549865(+) MIRb 
1412553_0_+_87 chr20:20910851-20910873(+) L1P4 
1416308_0_-_95 chr20:29589818-29589838(-) MIRb 
1434998_0_-_100 chr20:44089910-44089928(-) MIR 
1435354_0_-_79 chr20:44235903-44235921(-) MIR 
1453725_0_+_67 chr21:14966802-14966816(+) MIR3 
1466070_0_-_70 chr21:33853177-33853203(-) L2 
1489729_0_+_59 chr22:28457760-28457800(+) L1ME4a 
1496941_0_+_79 chr22:35289947-35289989(+) L1MC4 
1498291_0_+_153 chr22:36325294-36325312(+) L3b 
1509614_0_-_55 chr22:48049650-48049680(-) L1ME4a 
3715_0_+_61 chr1:3131597-3131629(+) MER121 
52664_0_-_50 chr1:44571346-44571464(-) Eulor9A 
52940_0_-_77 chr1:44674828-44674849(-) MER121 
67625_0_+_68 chr1:57127369-57127387(+) Eulor1 
67626_0_-_76 chr1:57127400-57127465(-) Eulor1 
75315_0_+_61 chr1:63495303-63495320(+) UCON8 
82063_0_+_72 chr1:71463300-71463317(+) MER133A 
88341_0_+_95 chr1:79596295-79596315(+) UCON15 
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88403_0_+_60 chr1:79660341-79660380(+) UCON30 
88624_0_-_75 chr1:80015139-80015158(-) X6A_LINE 
93362.2_0_-_68 chr1:83766400-83766418(-) MER131 
112743_0_+_87 chr1:101723969-101723998(+) MER133A 
130308_0_-_77 chr1:118651361-118651382(-) MER121 
130734_0_-_76 chr1:119254356-119254388(-) MER121 
154446_0_-_100 chr1:162492879-162492895(-) UCON18 
154818_0_-_64 chr1:162825371-162825437(-) MER135 
161005_0_+_64 chr1:168646670-168646694(+) UCON26 
187011_0_+_89 chr1:197245358-197245395(+) MER121 
188052_1_-_92 chr1:198460508-198460590(-) Eulor3 
198813_0_+_90 chr1:206237185-206237204(+) MER136 
204532_0_-_104 chr1:211522027-211522054(-) UCON31 
211312_0_-_76 chr1:217555499-217555519(-) MER121 
1171004_0_-_83 chr2:6568368-6568396(-) MER121 
1184389_0_+_73 chr2:22111720-22111741(+) MER136 
1221529_0_+_96 chr2:58895995-58896019(+) X7C_LINE 
1223513_0_+_97 chr2:60171167-60171200(+) Eulor10 
1231302_0_-_88 chr2:66979970-66979994(-) Eulor3 
1231553_0_+_75 chr2:67238894-67239028(+) Eulor4 
1241102_0_-_78 chr2:77353762-77353793(-) MER123 
1258257_0_+_85 chr2:104314401-104314489(+) MER134 
1258569_0_+_76 chr2:104524897-104524954(+) Eulor1 
1260469_0_+_45 chr2:107079289-107079332(+) Eulor10 
1260520_0_-_81 chr2:107258693-107258740(-) UCON23 
1285391_0_+_90 chr2:143702983-143703011(+) MER136 
1285391_1_+_129 chr2:143703042-143703075(+) MER136 
1285392_0_-_87 chr2:143703144-143703181(-) MER136 
1286513_0_+_57 chr2:144311903-144311946(+) MER125 
1288297_0_+_88 chr2:145186813-145186838(+) Eulor4 
1288651_0_+_86 chr2:145417357-145417378(+) LmeSINE1b 
1305099_0_+_74 chr2:161974382-161974408(+) AmnSINE1_GG 
1307386_0_-_85 chr2:164117565-164117584(-) Eulor6D 
1321435_0_+_100 chr2:176377724-176377743(+) MER133A 
1329277_0_+_76 chr2:181280870-181280886(+) MER135 
1343221_0_+_43 chr2:199281672-199281699(+) X6A_LINE 
1344357_0_+_95 chr2:200156156-200156174(+) MER131 
1344453_0_+_48 chr2:200237188-200237216(+) MER121 
1357076_0_-_85 chr2:208527969-208528001(-) MER134 
1361323_0_+_57 chr2:213067475-213067509(+) Eulor5A 
1372257_0_+_56 chr2:220785460-220785507(+) UCON11 
1373497_0_+_65 chr2:221709145-221709161(+) MER121 
1512259_0_+_84 chr3:886207-886231(+) Eulor3 
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1529073_0_+_51 chr3:17512755-17512791(+) UCON17 
1537363_0_+_82 chr3:28861055-28861082(+) Eulor4 
1570585_0_+_100 chr3:59401515-59401529(+) UCON17 
1573547_0_+_44 chr3:61643441-61643518(+) MER126 
1573643_0_+_95 chr3:61718341-61718381(+) MER134 
1583919_0_+_136 chr3:70159597-70159621(+) Eulor3 
1584125_0_+_85 chr3:70282197-70282216(+) MER121 
1587903_0_+_63 chr3:72770417-72770435(+) MER121 
1589951_0_+_75 chr3:74512342-74512357(+) MER129 
1613192_0_-_38 chr3:109671038-109671090(-) MER127 
1619194_0_-_81 chr3:115772653-115772683(-) UCON9 
1620066_0_-_64 chr3:116298434-116298458(-) Eulor1 
1631238_0_-_62 chr3:125850420-125850440(-) X7B_LINE 
1644004_0_-_55 chr3:138650699-138650738(-) UCON4 
1651767_0_+_52 chr3:146074810-146074873(+) Eulor3 
1662217_0_+_62 chr3:159045808-159045847(+) MER121 
1668216_0_-_58 chr3:168436231-168436447(-) MER126 
1670278_0_-_120 chr3:170405686-170405715(-) MER131 
1678363_0_+_67 chr3:179445164-179445181(+) X6B_LINE 
1680024_0_-_54 chr3:181521306-181521359(-) UCON29 
1688359_0_+_58 chr3:189369310-189369328(+) UCON7 
1689205_1_+_86 chr3:190161865-190161886(+) UCON7 
1705501_0_+_62 chr4:12551247-12551267(+) MER121 
1705501_1_+_80 chr4:12551274-12551293(+) MER121 
1706954_0_-_78 chr4:14392438-14392473(-) MER121 
1710470_0_-_75 chr4:18287096-18287119(-) X6B_LINE 
1713985_0_+_114 chr4:22907781-22907802(+) MER132 
1713986_1_-_100 chr4:22907805-22907826(-) MER132 
1714957_0_+_71 chr4:23573735-23573758(+) UCON2 
1715903_0_+_88 chr4:24017990-24018005(+) UCON2 
1743298_0_-_89 chr4:67215793-67215838(-) Eulor8 
1743393_0_+_92 chr4:67394199-67394235(+) Eulor5B 
1757379_0_+_70 chr4:85466757-85466855(+) MER134 
1798767_0_+_50 chr4:142921647-142921690(+) UCON9 
1802422_0_-_75 chr4:147467073-147467100(-) LF-SINE 
1803203_0_+_84 chr4:148224139-148224169(+) X7C_LINE 
1828955_0_+_104 chr4:182906948-182906974(+) Eulor6A 
1829383_0_+_100 chr4:183149701-183149718(+) LF-SINE 
1830405_0_+_49 chr4:183690755-183690850(+) MER135 
1846135_0_+_73 chr5:15474550-15474564(+) MER121 
1850975_0_+_96 chr5:27214825-27214847(+) Eulor3 
1851065_0_+_102 chr5:27505032-27505076(+) Eulor4 
1864187_0_+_85 chr5:44037377-44037402(+) MER121 
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1864730_0_-_92 chr5:44649544-44649567(-) MER121 
1866169_0_+_73 chr5:50392064-50392078(+) MER127 
1873731_0_+_53 chr5:58495675-58495729(+) UCON9 
1876134_0_-_86 chr5:60931589-60931609(-) MER121 
1890599_0_+_79 chr5:77309961-77309998(+) Eulor6B 
1895055_0_+_87 chr5:81671505-81671527(+) MER121 
1900625.5_0_+_72 chr5:88585797-88585825(+) MER121 
1902777_0_+_53 chr5:90643387-90643420(+) AmnSINE1_GG 
1903538_0_-_79 chr5:91723955-91723983(-) MER125 
1913159_0_+_89 chr5:103795810-103795856(+) UCON31 
1929440_0_-_73 chr5:124269753-124269778(-) Eulor5B 
1930433_1_+_82 chr5:125337043-125337092(+) Eulor4 
1955119_0_+_44 chr5:145869978-145870018(+) LF-SINE 
1955395_0_+_81 chr5:146094979-146094999(+) X5A_LINE 
1975838_0_-_80 chr5:165688874-165688944(-) Eulor5A 
1979031_0_+_61 chr5:167506770-167506888(+) Eulor9A 
2000476_0_-_85 chr6:8499794-8499914(-) Eulor6C 
2001968_0_-_145 chr6:10178396-10178424(-) MER131 
2008557_0_+_81 chr6:16949073-16949103(+) UCON26 
2031067_0_+_44 chr6:39048083-39048162(+) Eulor5A 
2047829_0_+_41 chr6:55761992-55762018(+) MER121 
2066390_0_-_81 chr6:85075854-85075874(-) MER121 
2078773_0_+_88 chr6:99459607-99459623(+) UCON9 
2080615_0_+_60 chr6:101110199-101110218(+) MER131 
2103549_0_+_93 chr6:128809103-128809145(+) UCON16 
2110337_0_+_44 chr6:136398344-136398375(+) UCON26 
2114503.0_0_+_80 chr6:140364809-140364828(+) MER121 
2115069.5_0_+_82 chr6:141179709-141179763(+) Eulor5B 
2121113_0_+_55 chr6:148347371-148347399(+) LF-SINE 
2122492_0_-_129 chr6:149575272-149575305(-) SacSINE1 
2124929_0_+_75 chr6:152368090-152368109(+) MER121 
2127747_0_+_66 chr6:155834738-155834778(+) UCON9 
2129448_0_-_71 chr6:157252755-157252771(-) X7B_LINE 
2164946_0_-_47 chr7:28364896-28364929(-) AmnSINE1_GG 
2165103_0_+_104 chr7:28447122-28447144(+) MER121 
2177946_0_-_48 chr7:41927983-41928013(-) MER121 
2199161_0_+_76 chr7:78029611-78029627(+) UCON25 
2232211_0_+_45 chr7:113190696-113190791(+) Eulor6B 
2233748_0_-_181 chr7:114618868-114618893(-) Eulor6B 
2265159_0_+_85 chr7:146833245-146833271(+) UCON4 
2289857_0_+_81 chr8:24066738-24066758(+) MER121 
2298526_0_-_61 chr8:33038256-33038278(-) MER121 
2302531_0_+_170 chr8:37341837-37341883(+) Eulor5B 
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2328941_0_+_120 chr8:76879838-76879852(+) Eulor4 
2330918_0_-_108 chr8:79081399-79081462(-) Eulor3 
2339767_0_+_82 chr8:92837069-92837101(+) MER121 
2339841_0_+_84 chr8:92935042-92935090(+) MER121 
2344217_0_+_65 chr8:97188471-97188580(+) MER135 
2354838_0_-_72 chr8:108773965-108774000(-) UCON26 
2379473_0_+_97 chr8:139630131-139630160(+) Eulor1 
2394293_0_+_95 chr9:9338370-9338389(+) Eulor2A 
2397055_0_+_80 chr9:13796837-13796866(+) Eulor6A 
2397055_1_+_73 chr9:13796922-13796943(+) Eulor6A 
2409235_0_+_142 chr9:25589526-25589549(+) Eulor3 
2431229_0_+_103 chr9:75174932-75174961(+) Eulor6B 
2439460_0_-_71 chr9:84169407-84169440(-) Eulor10 
2451401_0_+_100 chr9:101409466-101409483(+) UCON27 
2469220_0_-_74 chr9:118053225-118053243(-) MER121 
2469999_0_+_79 chr9:118715772-118715795(+) UCON11 
2521976_0_-_97 chrX:26365641-26365669(-) MER131 
2551760_0_-_64 chrX:65934376-65934400(-) MER121 
2572113_0_+_91 chrX:98425536-98425558(+) MER124 
2598753_0_+_171 chrX:123865376-123865447(+) Eulor11 
2615332_2_-_77 chrX:137769424-137769462(-) Eulor5A 
236504_0_-_113 chr10:7164642-7164680(-) MER134 
256849_0_+_114 chr10:31429075-31429102(+) MER131 
276892.3_0_-_76 chr10:63322047-63322080(-) Eulor9A 
276891.4_0_+_88 chr10:63322163-63322186(+) Eulor9A 
285555_0_+_63 chr10:72980870-72980944(+) MER125 
292625_0_+_200 chr10:78081072-78081104(+) Eulor3 
292626_0_-_70 chr10:78081151-78081173(-) Eulor3 
295479_0_+_56 chr10:80319880-80319927(+) MER125 
318452_0_-_79 chr10:103288332-103288350(-) AmnSINE1_GG,
AmnSINE1_HS 
327752_0_-_82 chr10:111678355-111678382(-) MER121 
330818_0_-_148 chr10:114305414-114305436(-) MER134 
335779_0_+_54 chr10:118027456-118027512(+) Eulor6D 
337561_0_+_69 chr10:119614151-119614186(+) MER121 
338610_0_-_64 chr10:120269645-120269680(-) Eulor2A 
369668_0_-_112 chr11:12893042-12893058(-) UCON31 
373787_0_+_88 chr11:16322974-16322989(+) MER131 
487071_1_+_53 chr11:131453807-131453846(+) MER121 
487071_2_+_103 chr11:131453921-131453949(+) MER121 
512063_0_+_83 chr12:23491193-23491210(+) LF-SINE 
513095_0_+_110 chr12:24372647-24372676(+) UCON15 
516227_0_+_65 chr12:27866363-27866396(+) AmnSINE1_HS 
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551096_0_-_85 chr12:64538090-64538148(-) Eulor5A 
596281_0_+_59 chr12:114732788-114732836(+) MER121 
596947_0_+_93 chr12:115505370-115505426(+) MER123 
622745_0_+_100 chr13:35243065-35243085(+) MER131 
645738_0_-_105 chr13:63899169-63899187(-) UCON7 
645910_0_-_48 chr13:64241844-64241876(-) MER131 
646225_0_+_88 chr13:65068325-65068348(+) Eulor6B 
647102_0_-_48 chr13:66105298-66105320(-) LF-SINE 
648333_0_+_100 chr13:67341863-67341891(+) Eulor5B 
649736_0_-_74 chr13:70683133-70683151(-) UCON15 
651061_0_+_58 chr13:71771123-71771160(+) Eulor8 
651179.1_0_+_60 chr13:71904255-71904296(+) Eulor6B 
653822_0_-_62 chr13:74296760-74296798(-) Eulor5A 
677411_0_+_89 chr13:106457940-106457957(+) UCON9 
677411_1_+_76 chr13:106457967-106457999(+) UCON9 
677411_2_+_85 chr13:106458051-106458083(+) UCON9 
677677_0_+_73 chr13:106991355-106991369(+) MER123 
692404_0_-_138 chr14:28918314-28918337(-) MER133B 
693415_0_+_104 chr14:29848578-29848603(+) Eulor6A 
697653_0_+_69 chr14:33093444-33093479(+) UCON11 
700890_0_-_65 chr14:35855217-35855366(-) Eulor6A 
714186_0_-_107 chr14:53128581-53128608(-) MER121 
751714_0_-_85 chr14:84779620-84779653(-) UCON30 
753005_0_+_40 chr14:86595882-86595921(+) UCON30 
783832_0_-_73 chr15:33865137-33865158(-) MER133A 
785532_1_-_63 chr15:34979215-34979241(-) MER121 
785532_0_-_103 chr15:34979391-34979424(-) MER121 
786420_0_-_57 chr15:35436668-35436697(-) MER133A 
787092_0_-_65 chr15:35993736-35993832(-) Eulor5A 
798275_0_+_115 chr15:43865498-43865524(+) X7C_LINE 
821528_0_-_96 chr15:64357134-64357156(-) UCON3 
853348_0_-_69 chr15:90707731-90707784(-) UCON7 
861597_0_+_94 chr15:98233883-98233900(+) Eulor1 
872174_0_-_78 chr16:5965366-5965388(-) Eulor3 
881780_0_-_82 chr16:17002623-17002644(-) Eulor6A 
905560_0_-_64 chr16:50405915-50405939(-) MER121 
905867_0_+_68 chr16:50695398-50695444(+) MER121 
917018_0_-_100 chr16:60639392-60639413(-) MER121 
920401_0_+_83 chr16:64684847-64684892(+) Eulor10 
931567_0_+_51 chr16:72032498-72032534(+) MER135 
984571_0_+_105 chr17:30189303-30189321(+) MER123 
1015325_0_+_70 chr17:50225698-50225730(+) Eulor8 
1024163_0_+_84 chr17:56744693-56744735(+) UCON8 
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1036020_0_-_69 chr17:66781338-66781363(-) MER121 
1038462_1_-_124 chr17:68911481-68911497(-) UCON7 
1066259_0_+_153 chr18:21498030-21498080(+) Eulor8 
1068544_0_-_89 chr18:23659572-23659590(-) Eulor2A 
1083195_0_+_73 chr18:41146705-41146745(+) UCON21 
1084969_0_+_97 chr18:42888291-42888326(+) MER123 
1091966_0_-_67 chr18:51316122-51316169(-) MER125 
1092513_0_+_129 chr18:51746153-51746176(+) MER121 
1105916_0_-_78 chr18:71369451-71369514(-) UCON11 
1106836_0_-_55 chr18:72345054-72345073(-) Eulor9C 
1107891_0_+_101 chr18:74472718-74472919(+) MER123 
1136689_2_+_91 chr19:35356712-35356733(+) Eulor5B 
1136695_0_+_93 chr19:35387180-35387194(+) UCON28 
1137640_0_-_88 chr19:35962919-35962951(-) MER121 
1137668_1_-_133 chr19:35986024-35986041(-) UCON18 
1137917_0_+_156 chr19:36199466-36199483(+) Eulor1 
1138452_0_-_84 chr19:36589246-36589288(-) Eulor10 
1139164_0_-_65 chr19:37257771-37257787(-) UCON18 
1427009_0_+_75 chr20:37524951-37524982(+) MER121 
1427160_0_-_120 chr20:37678080-37678099(-) MER125 
1427182_0_-_100 chr20:37689430-37689447(-) MER125 
1431929_0_+_129 chr20:41294085-41294112(+) MER128 
1443968_0_-_61 chr20:53838763-53838824(-) UCON29 
1462483_0_+_84 chr21:29777827-29777864(+) MER127 
1463946_0_-_55 chr21:31573085-31573124(-) Eulor10 
1504557_0_+_88 chr22:41047017-41047040(+) Eulor9A 
 
aName of the EvoFold locus from the hg18 UCSC Genome Browser annotation 
bGenome coordinates and strand of the EvoFold locus 
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>>> 1 hsa-mir-552 MI0003557 - 1 34907787 34907882 96 61:81, L1MD2 L1 21/96(21.88)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      L1MD2 (L1, LINE) 
 
 
>>> 2 hsa-mir-553 MI0003558 + 1 100519385 100519452 68 16:36, MIR3, MIR3 MIR, MIR





XXXXXXXXXXXX--------------------------------------------------------      MIR3 (MIR, SINE) 
-----------------------------------------------------------------XXX      MIR3 (MIR, SINE) 
 
 
>>> 3 hsa-mir-558 MI0003564 + 2 32610724 32610817 94 61:79, MLT1C MaLR 19/94(20.21)









Figure C.2: Genomic structure of TE-derived human miRNAs. Schematics representing the relationships between human miRNA 
and TE sequences are shown. The first line of each entry summarizes the genomic location of the miRNA along with its association 
with TEs. The following fields are shown: entry number, miRNA name and accession number, human genome strand, chromosome, 
start coordinate, end coordinate, miRNA gene length, start and end positions of the mature miRNA sequence, associated TE name and 
family, the fraction of the mature miRNA sequence, the fraction of TE-derived positions in the miRNA gene, the fraction of TE-
derived positions in the mature miRNA sequence. For each entry, a line diagram displays the relationship (overlap) between the 
miRNA and TE sequences. The miRNA gene, with mature sequence marked as “O”, is compared with the locations of TE-derived 
residues at the same genomic position. The corresponding TE sequences along with their name (family, class) are shown below the 
composite sequence used for the comparison. The orientation of the TE in the same and opposite strand relative to the miRNA 
sequences is represented by “X” and “Y”, respectively. 
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>>> 4 hsa-mir-562 MI0003568 + 2 232745607 232745701 95 61:80, L1MB7 L1 20/95(21.05)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L1MB7 (L1, LINE) 
 
 
>>> 5 hsa-mir-566 MI0003572 + 3 50185763 50185856 94 16:34, AluSg Alu 19/94(20.21)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      AluSg (Alu, SINE) 
 
 
>>> 6 hsa-mir-28 MI0000086 + 3 189889263 189889348 86 14:35, L2, L2 L2, L2 22/86(25.58)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY---------------------------------------------------      L2 (L2, LINE) 
-----------------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      L2 (L2, LINE) 
 
 
>>> 7 hsa-mir-570 MI0003577 + 3 196911452 196911548 97 61:82, MADE1 Mariner 22/97(22.68)





-----------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX------      MADE1 (Mariner, DNA) 
 
 






YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY-----------------------------------------------------------------      L1MA9 (L1, LINE) 
----------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L1MA9 (L1, LINE) 
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YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY--------------------------------------      L2 (L2, LINE) 
----------------------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX-      L2 (L2, LINE) 
 
 
>>> 10 hsa-mir-575 MI0003582 - 4 83893514 83893607 94 61:79, MIR MIR 19/94(20.21)





------------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      MIR (MIR, SINE) 
 
 
>>> 11 hsa-mir-576 MI0003583 + 4 110629303 110629400 98 16:38, L1MB7 L1 23/98(23.47)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L1MB7 (L1, LINE) 
 
 
>>> 12 hsa-mir-578 MI0003585 + 4 166526844 166526939 96 61:81, L2 L2 21/96(21.88)





-----------------------------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      L2 (L2, LINE) 
 
 
>>> 13 hsa-mir-579 MI0003586 - 5 32430241 32430338 98 61:83, MADE1, L1MB8 Mariner, L1





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY----      MADE1 (Mariner, DNA) 
---------------------------------------------------------------------------------------------YYYYY      L1MB8 (L1, LINE) 
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>>> 14 hsa-mir-581 MI0003588 - 5 53283091 53283186 96 16:36, Charlie10 MER1_type





XXXX--------------------------------------------------------------------------------------------      Charlie10 (MER1_type, DNA) 
 
 
>>> 15 hsa-mir-582 MI0003589 - 5 59035189 59035286 98 16:38, L3, L3 CR1, CR1 23/98(23.47)





--------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX----------------------------------------------------      L3 (CR1, LINE) 
---------------------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L3 (CR1, LINE) 
 
 
>>> 16 hsa-mir-584 MI0003591 - 5 148422069 148422165 97 16:37, MER81 AcHobo 22/97(22.68)





-------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      MER81 (AcHobo, DNA) 
 
 
>>> 17 hsa-mir-378 MI0000786 + 5 149092581 149092646 66 5:26,44:65, MIRb, MIRb MIR, MIR





YYYYYYYYYYYYYYYYYYYYYYYYY-----------------------------------------      MIRb (MIR, SINE) 
-------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      MIRb (MIR, SINE) 
 
 
>>> 18 hsa-mir-585 MI0003592 - 5 168623183 168623276 94 61:79, MLT1C MaLR 19/94(20.21)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYY-----------------------------------------------------------------      MLT1C (MaLR, LTR) 
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>>> 19 hsa-mir-340 MI0000802 - 5 179374909 179375003 95 58:80, MARNA Mariner 23/95(24.21)





------------------------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY--------      MARNA (Mariner, DNA) 
 
 
>>> 20 hsa-mir-548a-1 MI0003593 + 6 18679994 18680090 97 61:82, MADE1 Mariner 22/97(22.68)





-----------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY----------      MADE1 (Mariner, DNA) 
 
 
>>> 21 hsa-mir-587 MI0003595 + 6 107338693 107338788 96 16:36, MER115 Tip100 21/96(21.88)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      MER115 (Tip100, DNA) 
 
 
>>> 22 hsa-mir-548b MI0003596 - 6 119431911 119432007 97 61:82, MADE1 Mariner 22/97(22.68)





----XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX------------      MADE1 (Mariner, DNA) 
 
 
>>> 23 hsa-mir-588 MI0003597 + 6 126847470 126847552 83 16:36, L1MA3, L1MA3 L1, L1 21/83(25.30)





XX---------------------------------------------------------------------------------      L1MA3 (L1, LINE) 
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      L1MA3 (L1, LINE) 
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>>> 24 hsa-mir-548a-2 MI0003598 + 6 135601991 135602087 97 61:82, LTR16A1, MADE1, LTR16A1 ERVL, 





YYYYYYYYYYY--------------------------------------------------------------------------------------      LTR16A1 (ERVL, LTR) 
----------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY-----      MADE1 (Mariner, DNA) 
-------------------------------------------------------------------------------------------YYYYYY      LTR16A1 (ERVL, LTR) 
 
 
>>> 25 hsa-mir-591 MI0003603 - 7 95686910 95687004 95 16:35, MER5A MER1_type 20/95(21.05)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX-------------------------------------------------------      MER5A (MER1_type, DNA) 
 
 
>>> 26 hsa-mir-335 MI0000816 + 7 129923188 129923281 94 16:38, MIRb MIR 23/94(24.47)





YY--------------------------------------------------------------------------------------------      MIRb (MIR, SINE) 
 
 
>>> 27 hsa-mir-548a-3 MI0003612 - 8 105565773 105565869 97 61:82, MLT1G1, MADE1, MLT1G1 MaLR, Mariner, 





YYYYY--------------------------------------------------------------------------------------------      MLT1G1 (MaLR, LTR) 
----XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX------------      MADE1 (Mariner, DNA) 
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>>> 28 hsa-mir-548d-1 MI0003668 - 8 124429455 124429551 97 61:82, MADE1 Mariner 22/97(22.68)





----YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY------------      MADE1 (Mariner, DNA) 
 
 
>>> 29 hsa-mir-151 MI0000809 - 8 141811845 141811934 90 46:67, L2, L2 L2, L2 22/90(24.44)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX---      L2 (L2, LINE) 
----------------------------------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L2 (L2, LINE) 
 
 
>>> 30 hsa-mir-421 MI0003685 - X 73354937 73355021 85 48:70, L2, L2 L2, L2 23/85(27.06)





----YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY------------------------------------------------      L2 (L2, LINE) 
------------------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      L2 (L2, LINE) 
 
 
>>> 31 hsa-mir-545 MI0003516 - X 73423664 73423769 106 62:83, L2, L2 L2, L2 22/106(20.75)





---------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY---------------------------------------------------------      L2 (L2, LINE) 
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>>> 32 hsa-mir-374 MI0000782 - X 73423846 73423917 72 12:33, L2 L2 22/72(30.56)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX---------------------------------      L2 (L2, LINE) 
 
 
>>> 33 hsa-mir-325 MI0000824 - X 76142220 76142317 98 16:38, L2, L2 L2, L2 23/98(23.47)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY-----------------------------------------------------      L2 (L2, LINE) 
-------------------------------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      L2 (L2, LINE) 
 
 
>>> 34 hsa-mir-361 MI0000760 - X 85045297 85045368 72 6:27, MER5A MER1_type 22/72(30.56)





------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX-------      MER5A (MER1_type, DNA) 
 
 
>>> 35 hsa-mir-652 MI0003667 + X 109185213 109185310 98 61:83, MER91C Tip100 23/98(23.47)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      MER91C (Tip100, DNA) 
 
 
>>> 36 hsa-mir-513-1 MI0003191 - X 146102673 146102801 129 37:58, MER91C Tip100 22/129(17.05)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      
MER91C (Tip100, DNA) 
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>>> 37 hsa-mir-513-2 MI0003192 - X 146115036 146115162 127 36:57, MER91C Tip100 22/127(17.32)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      
MER91C (Tip100, DNA) 
 
 
>>> 38 hsa-mir-603 MI0003616 + 10 24604620 24604716 97 61:82, MADE1 Mariner 22/97(22.68)





----------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY-----      MADE1 (Mariner, DNA) 
 
 
>>> 39 hsa-mir-606 MI0003619 + 10 76982222 76982317 96 61:81, L1MCc L1 21/96(21.88)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L1MCc (L1, LINE) 
 
 
>>> 40 hsa-mir-607 MI0003620 - 10 98578416 98578511 96 61:81, MIR, MIR MIR, MIR





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX-------------------------------------------      MIR (MIR, SINE) 
-------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      MIR (MIR, SINE) 
 
 
>>> 41 hsa-mir-608 MI0003621 + 10 102724732 102724831 100 16:40, L2 L2 25/100(25.00)





---------------------------------------------------------------------------------------------YYYYYYY      L2 (L2, LINE) 
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>>> 42 hsa-mir-612 MI0003625 + 11 64968505 64968604 100 16:40, MIRb MIR 25/100(25.00)





XXXXXXXXX-------------------------------------------------------------------------------------------      MIRb (MIR, SINE) 
 
 
>>> 43 hsa-mir-326 MI0000808 - 11 74723784 74723878 95 60:79, Arthur1 Tip100 20/95(21.05)





XXXXXXXXXXXX-----------------------------------------------------------------------------------      Arthur1 (Tip100, DNA) 
 
 
>>> 44 hsa-mir-616 MI0003629 - 12 56199213 56199309 97 16:37, L2 L2 22/97(22.68)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L2 (L2, LINE) 
 
 
>>> 45 hsa-mir-548c MI0003630 + 12 63302556 63302652 97 61:82, MADE1 Mariner 22/97(22.68)





-----------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX-----      MADE1 (Mariner, DNA) 
 
 
>>> 46 hsa-mir-619 MI0003633 - 12 107754813 107754911 99 61:84, L1MC4, AluSx L1, Alu 24/99(24.24)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY----------------------------------------------------------      L1MC4 (L1, LINE) 
----------------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      AluSx (Alu, SINE) 
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>>> 47 hsa-mir-625 MI0003639 + 14 65007573 65007657 85 15:36, L1MCa L1 22/85(25.88)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L1MCa (L1, LINE) 
 
 
>>> 48 hsa-mir-345 MI0000825 + 14 99843949 99844046 98 17:37, MIR MIR 21/98(21.43)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY-----------------------------------------------------------      MIR (MIR, SINE) 
 
 
>>> 49 hsa-mir-493 MI0003132 + 14 100405150 100405238 89 16:37,57:77, L2 L2 43/89(48.31)





------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L2 (L2, LINE) 
 
 
>>> 50 hsa-mir-370 MI0000778 + 14 100447229 100447303 75 48:68, MIRm MIR 21/75(28.00)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      MIRm (MIR, SINE) 
 
 
>>> 51 hsa-mir-487b MI0003530 + 14 100582545 100582628 84 51:72, MIR MIR 22/84(26.19)
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>>> 52 hsa-mir-544 MI0003515 + 14 100584748 100584838 91 55:74, MER5A1 MER1_type 20/91(21.98)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      MER5A1 (MER1_type, DNA) 
 
 
>>> 53 hsa-mir-626 MI0003640 + 15 39771075 39771168 94 61:79, L1MB8, L1MCa L1, L1 19/94(20.21)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY------------------------------------------------------------      L1MB8 (L1, LINE) 
---------------------------------------------------------------------------YYYYYYYYYYYYYYYYYYY      L1MCa (L1, LINE) 
 
 
>>> 54 hsa-mir-422a MI0001444 - 15 61950182 61950271 90 11:32, MIR3 MIR 22/90(24.44)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      MIR3 (MIR, SINE) 
 
 
>>> 55 hsa-mir-549 MI0003679 - 15 78921374 78921469 96 61:81, MIRb MIR 21/96(21.88)














Figure C.2 continued 
          
                                                                                                                                                                           
 
206 
>>> 56 hsa-mir-633 MI0003648 + 17 58375308 58375405 98 61:83, MIRb MIR 23/98(23.47)





XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      MIRb (MIR, SINE) 
 
 
>>> 57 hsa-mir-634 MI0003649 + 17 62213652 62213748 97 61:82, L1ME3A L1 22/97(22.68)





--------------------------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L1ME3A (L1, LINE) 
 
 
>>> 58 hsa-mir-548d-2 MI0003671 - 17 62898067 62898163 97 61:82, MADE1 Mariner 22/97(22.68)





----YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY------------      MADE1 (Mariner, DNA) 
 
 






------------------------------------------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      L1MC4a (L1, LINE) 
 
 
>>> 60 hsa-mir-640 MI0003655 + 19 19406872 19406967 96 61:81, MIRb MIR 21/96(21.88)
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>>> 61 hsa-mir-641 MI0003656 - 19 45480290 45480388 99 16:39, MIR3 MIR 24/99(24.24)





------------------------------------------------------------------------------------------------YYY      MIR3 (MIR, SINE) 
 
 
>>> 62 hsa-mir-330 MI0000803 - 19 50834092 50834185 94 57:79, MIRm MIR 23/94(24.47)





--------------------------------------------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX      MIRm (MIR, SINE) 
 
 
>>> 63 hsa-mir-644 MI0003659 + 20 32517791 32517884 94 61:79, L1MB3 L1 19/94(20.21)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY------------------------------------      L1MB3 (L1, LINE) 
 
 
>>> 64 hsa-mir-645 MI0003660 + 20 48635730 48635823 94 61:79, MER1B MER1_type 19/94(20.21)





YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY-----------------------------------      MER1B (MER1_type, DNA) 
 
 
>>> 65 hsa-mir-648 MI0003663 - 22 16843634 16843727 94 16:34, L2 L2 19/94(20.21)
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>>> 66 hsa-mir-649 MI0003664 - 22 19718465 19718561 97 61:82, L1M4, MER8, AluSx L1, MER2_type, 





YYYYYYYYYY---------------------------------------------------------------------------------------      L1M4 (L1, LINE) 
---------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY----------      MER8 (MER2_type, DNA) 
---------------------------------------------------------------------------------------YYYYYYYYYY      AluSx (Alu, SINE) 
 
 
>>> 67 hsa-mir-130b MI0000748 + 22 20337593 20337674 82 51:72, MIRm MIR 22/82(26.83)





----------------------------YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY      MIRm (MIR, SINE) 
 
 
>>> 68 hsa-mir-659 MI0003683 - 22 36573631 36573727 97 61:82, Arthur1 Tip100 22/97(22.68)




























Figure C.3: Gene Ontology (GO) biological process directed acyclic graph 
showing over-represented GO terms (P<0.01; red) associated with mRNA targets of 
hsa-mir-130b. Targets were identified based on target site complementarity in 3’ UTRs 
and miRNA-mRNA anti-correlated expression patterns. 
 
          





Figure C.4: Rate of increase in the number of miRNA gene entries reported in 
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APPENDIX D 
SUPPLEMENTARY INFORMATION FOR CHAPTER 5 
 
 
Table D.1: Made1 homologous human expressed sequence tags (ESTs)1 
 
Table D.1 continued          
Hit  identifiers % 
identity 












gi|23517262|gb|BU674347.1| 94.81 77 4 0 4 80 59 135 7.00E-26 121 
gi|11450750|gb|BF438233.1| 93.42 76 5 0 1 76 311 386 7.00E-23 111 
gi|18976268|gb|BM668437.1| 93.42 76 5 0 1 76 330 405 7.00E-23 111 
gi|19006458|gb|BM693200.1| 93.42 76 5 0 1 76 282 207 7.00E-23 111 
gi|19721538|gb|BM996637.1| 93.42 76 5 0 1 76 321 396 7.00E-23 111 
gi|23274374|gb|BU608159.1| 93.42 76 5 0 1 76 326 401 7.00E-23 111 
gi|2784598|gb|AA743782.1| 93.42 76 5 0 1 76 110 185 7.00E-23 111 
gi|2876039|gb|AA804638.1| 93.42 76 5 0 1 76 318 393 7.00E-23 111 
gi|3933745|gb|AI290971.1| 93.42 76 5 0 1 76 311 386 7.00E-23 111 
gi|4990875|gb|AI702975.1| 93.42 76 5 0 1 76 307 382 7.00E-23 111 
gi|5454573|gb|AI832593.1| 93.42 76 5 0 1 76 309 384 7.00E-23 111 
gi|7320253|gb|AW615067.1| 93.42 76 5 0 1 76 313 388 7.00E-23 111 
gi|8167811|gb|AW976581.1| 93.42 76 5 0 1 76 307 382 7.00E-23 111 
gi|8359944|gb|BE042891.1| 93.42 76 5 0 1 76 307 382 7.00E-23 111 
gi|52721466|gb|CV371411.1| 95.52 67 3 0 14 80 236 170 3.00E-22 109 
gi|32004424|emb|BX492684.1| 92.41 79 6 0 2 80 382 304 3.00E-22 109 
gi|2907387|gb|AA833659.1| 93.24 74 5 0 3 76 199 126 1.00E-21 107 
gi|52700258|gb|CV350203.1| 93.24 74 5 0 2 75 551 624 1.00E-21 107 
gi|6837361|gb|AW340735.1| 93.24 74 5 0 3 76 216 143 1.00E-21 107 
gi|7039615|gb|AW469509.1| 93.24 74 5 0 3 76 216 143 1.00E-21 107 
gi|3400022|gb|AI073378.1| 91.25 80 7 0 1 80 241 320 2.00E-20 103 
gi|46547768|gb|CN478769.1| 91.25 80 7 0 1 80 255 334 2.00E-20 103 
gi|20494289|gb|BQ269223.1| 92 75 6 0 1 75 483 409 6.00E-20 101 
gi|44842622|gb|CK825697.1| 92 75 6 0 1 75 470 396 6.00E-20 101 
gi|45695156|emb|AL519606.3| 94.12 68 3 1 13 80 747 681 3.00E-19 99.6 
gi|52811228|gb|CV415725.1| 90.91 77 7 0 4 80 190 266 1.00E-18 97.6 
gi|2908283|gb|AA834684.1| 94.12 68 3 1 5 72 137 203 4.00E-18 95.6 
gi|13292606|gb|BG399158.1| 90.79 76 7 0 5 80 232 157 4.00E-18 95.6 
gi|52653216|gb|CV330002.1| 90.79 76 7 0 5 80 163 88 4.00E-18 95.6 
gi|8061011|gb|AW896806.1| 90.79 76 7 0 1 76 289 214 4.00E-18 95.6 
gi|52667308|gb|CV344094.1| 92.11 76 5 1 1 76 280 206 4.00E-18 95.6 
gi|5438416|gb|AI819337.1| 90 80 8 0 1 80 241 320 4.00E-18 95.6 
gi|7946376|gb|AW850859.1| 90 80 8 0 1 80 170 249 4.00E-18 95.6 
gi|12766146|gb|BG256330.1| 92.5 80 4 2 1 80 385 308 4.00E-18 95.6 
gi|27846682|emb|BX105680.1| 91.55 71 6 0 8 78 364 434 2.00E-17 93.7 
gi|3837536|gb|AI242139.1| 91.55 71 6 0 8 78 269 199 2.00E-17 93.7 
gi|58568449|dbj|BP395858.1| 90.54 74 7 0 7 80 284 211 6.00E-17 91.7 
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gi|6602709|emb|AL134522.1| 93.24 74 3 2 4 77 28 99 6.00E-17 91.7 
gi|91749404|gb|EB386059.1| 91.3 69 6 0 11 79 162 94 2.00E-16 89.7 
gi|32005544|emb|BX493226.1| 92.75 69 4 1 7 75 216 149 2.00E-16 89.7 
gi|14321058|gb|BG926535.1| 90.41 73 7 0 2 74 661 589 2.00E-16 89.7 
gi|52707894|gb|CV357839.1| 90.41 73 7 0 2 74 127 55 2.00E-16 89.7 
gi|82333517|dbj|DA902558.1| 90.91 77 6 1 1 77 193 118 2.00E-16 89.7 
gi|12120877|gb|BF772977.1| 90.12 81 7 1 1 80 235 155 2.00E-16 89.7 
gi|12120883|gb|BF772983.1| 90.12 81 7 1 1 80 236 156 2.00E-16 89.7 
gi|5110886|gb|AI742598.1| 90.12 81 7 1 1 80 241 321 2.00E-16 89.7 
gi|1885842|gb|AA250882.1| 92.19 64 5 0 1 64 41 104 1.00E-15 87.7 
gi|82341158|dbj|DB016887.1| 92.19 64 5 0 1 64 188 251 1.00E-15 87.7 
gi|10200151|gb|BE778953.1| 90.28 72 7 0 9 80 149 220 1.00E-15 87.7 
gi|13339103|gb|BG432597.1| 89.47 76 8 0 5 80 516 441 1.00E-15 87.7 
gi|13343062|gb|BG436556.1| 89.47 76 8 0 1 76 300 375 1.00E-15 87.7 
gi|15164200|emb|AL600694.1| 89.47 76 8 0 1 76 324 399 1.00E-15 87.7 
gi|18983536|gb|BM673638.1| 89.47 76 8 0 5 80 116 41 1.00E-15 87.7 
gi|19005651|gb|BM692393.1| 89.47 76 8 0 5 80 185 260 1.00E-15 87.7 
gi|2834284|gb|AA774950.1| 89.47 76 8 0 1 76 221 146 1.00E-15 87.7 
gi|11977833|gb|BF692425.1| 90.79 76 6 1 1 76 386 460 1.00E-15 87.7 
gi|13452873|gb|BG491361.1| 90.79 76 6 1 1 76 8 82 1.00E-15 87.7 
gi|13580923|gb|BG573270.1| 90.79 76 6 1 1 76 290 364 1.00E-15 87.7 
gi|19727271|gb|BQ002371.1| 90.79 76 6 1 1 76 400 326 1.00E-15 87.7 
gi|24776874|gb|CA414223.1| 90.79 76 6 1 1 76 400 326 1.00E-15 87.7 
gi|27932373|gb|CB106566.1| 90.79 76 6 1 1 76 13 87 1.00E-15 87.7 
gi|28365225|gb|CB243581.1| 90.79 76 6 1 1 76 29 103 1.00E-15 87.7 
gi|43429246|emb|BX952415.1| 90.79 76 6 1 5 80 89 163 1.00E-15 87.7 
gi|43425548|emb|BX951140.1| 88.75 80 9 0 1 80 136 57 1.00E-15 87.7 
gi|3038959|gb|AA903836.1| 90 80 7 1 1 80 74 152 1.00E-15 87.7 
gi|5543963|gb|AI869995.1| 90 80 7 1 1 80 450 372 1.00E-15 87.7 
gi|7668921|gb|AW753989.1| 91.04 67 6 0 12 78 421 487 4.00E-15 85.7 
gi|7668972|gb|AW754040.1| 91.04 67 6 0 12 78 421 487 4.00E-15 85.7 
gi|8046501|gb|AW884489.1| 88.61 79 9 0 2 80 132 210 4.00E-15 85.7 
gi|14466558|gb|BI059028.1| 90 70 7 0 3 72 129 198 1.00E-14 83.8 
gi|81125345|dbj|DA460339.1| 90 70 7 0 3 72 349 280 1.00E-14 83.8 
gi|27845181|emb|BX102210.1| 89.74 78 7 1 1 77 407 330 1.00E-14 83.8 
gi|31915369|emb|BX479525.1| 89.04 73 8 0 4 76 130 202 6.00E-14 81.8 
gi|66791763|dbj|BP425510.1| 89.04 73 8 0 4 76 184 256 6.00E-14 81.8 
gi|685935|gb|T71414.1| 88.16 76 9 0 1 76 11 86 6.00E-14 81.8 
gi|711241|gb|T82953.1| 88.16 76 9 0 1 76 11 86 6.00E-14 81.8 
gi|1404173|gb|W88623.1| 87.5 80 10 0 1 80 146 67 6.00E-14 81.8 
gi|1891141|gb|AA257012.1| 88.89 81 8 1 1 80 248 168 6.00E-14 81.8 
gi|81181343|dbj|DA639796.1| 90.62 64 6 0 1 64 16 79 2.00E-13 79.8 
gi|8058080|gb|AW893875.1| 92.19 64 4 1 1 64 471 409 2.00E-13 79.8 
gi|14372680|gb|BG954509.1| 90.28 72 6 1 9 80 238 168 2.00E-13 79.8 
gi|79163886|dbj|DA105807.1| 90.28 72 6 1 9 80 387 317 2.00E-13 79.8 
gi|8623066|gb|BE160345.1| 90.28 72 6 1 9 80 94 164 2.00E-13 79.8 
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gi|8623148|gb|BE160427.1| 90.28 72 6 1 9 80 94 164 2.00E-13 79.8 
gi|2162267|gb|AA448597.1| 88.16 76 9 0 1 76 343 418 2.00E-13 79.8 
gi|80799866|dbj|DA505931.1| 88.16 76 9 0 1 76 121 196 2.00E-13 79.8 
gi|21855046|gb|BQ716149.1| 89.47 76 7 1 1 76 119 193 2.00E-13 79.8 
gi|24805094|gb|CA440674.1| 89.47 76 7 1 1 76 400 326 2.00E-13 79.8 
gi|83480277|dbj|DB358036.1| 89.47 76 7 1 1 76 382 308 2.00E-13 79.8 
gi|3056341|gb|AA916949.1| 87.5 80 10 0 1 80 230 309 2.00E-13 79.8 
gi|1764951|gb|AA181484.1| 88.75 80 8 1 2 80 360 281 2.00E-13 79.8 
gi|8054117|gb|AW889912.1| 88.75 80 8 1 1 80 149 227 2.00E-13 79.8 
gi|83532058|dbj|DB333866.1| 88.75 80 8 1 1 80 65 143 2.00E-13 79.8 
gi|10107714|gb|BE719449.1| 88.73 71 8 0 1 71 623 553 9.00E-13 77.8 
gi|504666|dbj|D20846.1| 90.14 71 6 1 1 70 191 121 9.00E-13 77.8 
gi|14393270|gb|BG989200.1| 89.33 75 7 1 6 80 304 231 9.00E-13 77.8 
gi|31446439|gb|CD514721.1| 89.33 75 7 1 6 80 13 86 9.00E-13 77.8 
gi|2617003|gb|AA663012.1| 88.46 78 7 1 5 80 105 28 9.00E-13 77.8 
gi|90847359|dbj|DB577513.1| 87.65 81 7 1 1 78 52 132 9.00E-13 77.8 
gi|83241952|dbj|DB315742.1| 90 70 6 1 11 79 73 142 4.00E-12 75.8 
gi|91749668|gb|EB386323.1| 90 70 6 1 9 77 226 157 4.00E-12 75.8 
gi|10918992|dbj|AV761144.1| 88.46 78 8 1 3 79 236 313 4.00E-12 75.8 
gi|78737823|dbj|DA326471.1| 88.46 78 8 1 3 80 82 6 4.00E-12 75.8 
gi|83199537|dbj|DB235269.1| 85.88 85 6 1 2 80 480 396 4.00E-12 75.8 
gi|7668920|gb|AW753988.1| 89.23 65 7 0 14 78 91 27 1.00E-11 73.8 
gi|7668971|gb|AW754039.1| 89.23 65 7 0 14 78 91 27 1.00E-11 73.8 
gi|83486421|dbj|DB358889.1| 89.23 65 7 0 16 80 329 393 1.00E-11 73.8 
gi|2328991|gb|AA558514.1| 87.67 73 9 0 4 76 115 43 1.00E-11 73.8 
gi|81156387|dbj|DA383600.1| 87.67 73 9 0 4 76 516 588 1.00E-11 73.8 
gi|8165082|gb|AW973998.1| 87.67 73 9 0 4 76 244 172 1.00E-11 73.8 
gi|23373989|gb|BU661807.1| 88.16 76 7 1 5 80 85 158 1.00E-11 73.8 
gi|3896467|gb|AI274199.1| 88.16 76 7 1 1 74 74 149 1.00E-11 73.8 
gi|5054918|gb|AI733805.1| 88.16 76 7 1 1 74 72 147 1.00E-11 73.8 
gi|82136433|dbj|DB047679.1| 88.31 77 8 1 1 76 152 228 1.00E-11 73.8 
gi|33252132|gb|CF136688.1| 90.62 64 5 1 1 64 30 92 6.00E-11 71.9 
gi|46922787|emb|BX405577.2| 87.5 80 9 1 1 80 146 224 6.00E-11 71.9 
gi|46233530|emb|AL566894.3| 86.3 73 9 1 1 73 526 455 2.00E-10 69.9 
gi|3872647|gb|AI264444.1| 86.84 76 8 1 1 74 72 147 2.00E-10 69.9 
gi|33258518|gb|CF143074.1| 86.25 80 7 1 1 80 184 259 2.00E-10 69.9 
gi|7111293|gb|AW499536.1| 86.25 80 7 1 1 80 184 259 2.00E-10 69.9 
gi|7111295|gb|AW499537.1| 86.25 80 7 1 1 80 184 259 2.00E-10 69.9 
gi|7111327|gb|AW499553.1| 86.25 80 7 1 1 80 184 259 2.00E-10 69.9 
gi|7116331|gb|AW502136.1| 86.25 80 7 1 1 80 184 259 2.00E-10 69.9 
gi|7116335|gb|AW502138.1| 86.25 80 7 1 1 80 184 259 2.00E-10 69.9 
gi|3214298|gb|AI004788.1| 85.71 84 8 1 1 80 128 45 2.00E-10 69.9 
gi|90648194|dbj|BY797461.2| 85.71 84 8 1 1 80 347 430 2.00E-10 69.9 
gi|1486755|gb|AA022674.1| 84.88 86 7 1 1 80 283 198 2.00E-10 69.9 
gi|1486863|gb|AA022709.1| 84.88 86 7 1 1 80 101 186 2.00E-10 69.9 
gi|83124689|dbj|DB343577.1| 86.49 74 10 0 4 77 405 478 9.00E-10 67.9 
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gi|90938918|dbj|DB507251.1| 87.84 74 8 1 1 74 74 2 9.00E-10 67.9 
gi|694186|gb|T76983.1| 86.84 76 7 1 5 80 204 132 9.00E-10 67.9 
gi|83078449|dbj|DB106337.1| 85.9 78 7 1 1 78 458 385 9.00E-10 67.9 
gi|83237080|dbj|DB354909.1| 86.25 80 8 1 1 80 218 294 9.00E-10 67.9 
gi|12189868|gb|BF837652.1| 88.41 69 7 1 1 69 148 215 4.00E-09 65.9 
gi|8167508|gb|AW976282.1| 87.67 73 8 1 5 76 495 423 4.00E-09 65.9 
gi|14399447|gb|BG995377.1| 85.71 77 11 0 4 80 227 151 4.00E-09 65.9 
gi|81108769|dbj|DA381665.1| 85.9 78 7 1 1 78 487 414 4.00E-09 65.9 
gi|83190413|dbj|DB352537.1| 87.65 81 8 2 1 80 312 391 4.00E-09 65.9 
gi|83517488|dbj|DB143470.1| 86.84 76 9 1 1 76 116 42 1.00E-08 63.9 
gi|82338292|dbj|DB049879.1| 85 80 12 0 1 80 166 87 1.00E-08 63.9 
gi|80933029|dbj|DA523524.1| 86.25 80 10 1 1 80 468 390 1.00E-08 63.9 
1BLASTN was used to search the human EST database with a full length Made1 element 
query sequence. Only hits that were ≥80% identical over ≥80% of the length of the 
element are reported. Hit identifiers (Genbank identification numbers and accessions) are 




Table D.2: Over-represented GO biological process categories among genes with 
Made1-derived hsa-mir-548 target sites 
GO IDa Descriptionb Gene accc Obsd Expe P-valuef 





3 0.44 9.42E-03 
GO:0007067 mitosis ENSG00000130177 
ENSG00000086827*
ENSG00000004897*
3 0.43 9.06E-03 
GO:0007088 regulation of mitosis ENSG00000130177 
ENSG00000086827*
2 0.12 6.39E-03 





3 0.44 9.42E-03 






3 0.44 9.42E-03 











2 0.11 5.17E-03 
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aGO biological process category ID 
bFunctional description for the GO category 
cThe list of Ensembl gene accessions in the GO category, * indicates genes that are 
down-regulated in colorectal cancer tissue 
dObserved gene number in the GO category 
eExpected gene number in the GO category 





Table D.3: Over-represented GO biological process categories among genes with 
miRanda predicted hsa-mir-548 target sites that map to colorectal cancer down-
regulated co-expression clusters (i.e. 12, 15 & 20 in Figure 5.6). 
  
Table D.3 continued     
GO IDa Descriptionb Gene accc Obsd Expe P-valuef 



























27 10.05 2.61E-06 





10 3.45 2.48E-03 
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7 2.16 5.99E-03 





5 0.9 2.03E-03 





5 0.9 2.03E-03 


























76 51.71 1.01E-04 
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Table D.3 continued     
GO IDa Descriptionb Gene accc Obsd Expe P-valuef 
ENSG00000198929 




















20 8.45 3.13E-04 














12 3.79 4.30E-04 












12 3.64 3.02E-04 





4 0.73 5.84E-03 
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Table D.3 continued     
GO IDa Descriptionb Gene accc Obsd Expe P-valuef 
ENSG00000198929 
















































65 47.47 2.90E-03 
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Table D.3 continued     
























3 0.27 2.38E-03 





2 0.06 1.52E-03 





3 0.39 6.51E-03 











9 3.31 6.04E-03 






4 0.82 9.08E-03 
GO:0009250 glucan biosynthesis ENSG00000111713 
ENSG00000056998 
2 0.15 8.65E-03 
GO:0005978 glycogen biosynthesis ENSG00000111713 
ENSG00000056998 
2 0.15 8.65E-03 







6 1.82 9.91E-03 
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GO IDa Descriptionb Gene accc Obsd Expe P-valuef 
ENSG00000043355 










2 0.15 8.65E-03 



































3 0.03 1.41E-06 
GO:0050966 detection of 
mechanical stimulus 
during sensory 









2 0.06 1.52E-03 
GO:0050999 regulation of nitric-
oxide synthase activity 
ENSG00000146648 
ENSG00000198929 
2 0.06 1.52E-03 
 
aGO biological process category ID 
bFunctional description for the GO category 
cThe list of Ensembl gene accessions in the GO category 
dObserved gene number in the GO category 
eExpected gene number in the GO category 
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Table D.4: Putative hsa-mir-548 target genes previously implicated as being 
involved in colorectal cancer by microarray expression profiling 
 
Table D.4 continued     
Accna Refb Namec Statusd Targete P-valuef
ENST00000282050 (TAKEMASA 
et al. 2001) 
ATP synthase alpha chain, 




et al. 2001) 
Aquaporin-8 (AQP-8) down b 0.0050 
ENST00000262825 (KITAHARA 
et al. 2001) 
 
Cytokine receptor common beta 
chain precursor (GM-CSF/IL-
3/IL-5 receptor common beta-
chain) (CD131 antigen) 
(CDw131) 
down b 0.0006 
ENST00000201031 (KITAHARA 
et al. 2001) 
Transcription factor AP-2 
gamma (AP2-gamma) 
(Activating enhancer- binding 
protein 2 gamma) 
(Transcription factor ERF-1) 
down a,b,c,d 0.0006 
 
ENST00000241261 (KITAHARA 
et al. 2001) 
Tumor necrosis factor ligand 
superfamily member 10 (TNF-
related apoptosis-inducing 
ligand) (TRAIL protein) (Apo-2 
ligand) (Apo-2L) (CD253 
antigen) 
down a 0.0315 
ENST00000360121 (KITAHARA 





(GALGP) (CD43 antigen) 
down a,c 0.0018 
 
ENST00000360876 (KITAHARA 
et al. 2001) 
Eukaryotic translation initiation 
factor 3 subunit 9 (eIF-3 eta) 
(eIF3 p116) (eIF3 p110) 
(eIF3b) (Prt1 homolog) (hPrt1) 
up a 0.0176 
ENST00000368083 (BERTUCCI et 
al. 2004) 
Arginase-1 (EC 3.5.3.1) (Type I 
arginase) (Liver-type arginase) 
down c 0.0308 
ENST00000344548 (BERTUCCI et 
al. 2004) 
Cell division control protein 42 
homolog precursor (G25K 
GTP-binding protein) 
down c 0.0455 
ENST00000379328 (BERTUCCI et 
al. 2004) 
Trans-acting T-cell-specific 
transcription factor GATA-3 
(GATA-binding factor 3) 
down a 0.0012 
ENST00000285900 (BERTUCCI et 
al. 2004) 
Glutamate receptor 1 precursor 
(GluR-1) (GluR-A) (GluR-K1) 
(Glutamate receptor ionotropic, 
AMPA 1) (AMPA-selective 
glutamate receptor 1) 
down d 0.0058 
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Accna Refb Namec Statusd Targete P-valuef
ENST00000328245 (BERTUCCI et 
al. 2004) 
Heat shock factor protein 1 
(HSF 1) (Heat shock 
transcription factor 1) (HSTF 1)
down c 1.03E-05
ENST00000227752 (BERTUCCI et 
al. 2004) 
Interleukin-10 receptor alpha 
chain precursor (IL-10R-A) 
(IL-10R1) (CDw210a antigen) 
down d 0.0206 
ENST00000371794 (BERTUCCI et 
al. 2004) 




down d 0.0410 




delta 1 (EC 3.1.4.11) 
(Phosphoinositide 
phospholipase C) (PLC-delta-1) 
(Phospholipase C-delta-1) 
(PLC-III) 
down c 0.0198 
ENST00000229390 (BERTUCCI et 
al. 2004) 
Splicing factor, arginine/serine-
rich 9 (Pre-mRNA-splicing 
factor SRp30C) 
down a 0.0005 
ENST00000340600 (BERTUCCI et 
al. 2004) 
Suppressor of cytokine 
signaling 2 (SOCS-2) 
(Cytokine-inducible SH2 
protein 2) (CIS-2) (STAT-
induced STAT inhibitor 2) 
(SSI-2) 
down b 0.0056 
ENST00000288207 (BERTUCCI et 
al. 2004) 
G2/mitotic-specific cyclin-B2 up a,b,c,d 0.0010 
ENST00000264161 (BERTUCCI et 
al. 2004) 
Aspartyl-tRNA synthetase (EC 
6.1.1.12) (Aspartate--tRNA 
ligase) (AspRS) 
up c 0.0121 
ENST00000309268 (BERTUCCI et 
al. 2004) 
Elongation factor 1-alpha 1 
(EF-1-alpha-1) (Elongation 
factor 1 A-1) (eEF1A-1) 
(Elongation factor Tu) (EF-Tu)
up a 0.0252 
ENST00000319974 (BERTUCCI et 
al. 2004) 
no description (ets variant gene 
4 (E1A enhancer binding 
protein, E1AF)) 
up a 0.0025 
ENST00000302068 (BERTUCCI et 
al. 2004) 
Fibrinogen beta chain precursor 
[Contains: Fibrinopeptide B] 
up a,c 0.0053  
ENST00000341048 (BERTUCCI et 
al. 2004) 
no description (interleukin 6 
signal transducer (gp130, 
oncostatin M receptor)) 
up a 0.0004 
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Table D.4 continued     
Accna Refb Namec Statusd Targete P-valuef
ENST00000296585 (BERTUCCI et 
al. 2004) 
Integrin alpha-2 precursor 
(Platelet membrane 
glycoprotein Ia) (GPIa) 
(Collagen receptor) (VLA-2 
alpha chain) (CD49b antigen) 
up d 0.0088 
ENST00000260302 (BERTUCCI et 
al. 2004) 




up b 0.0197 




B23) (Numatrin) (Nucleolar 
protein NO38) 
up a 0.0015 
ENST00000216392 (BERTUCCI et 
al. 2004) 
Glycogen phosphorylase, liver 
form (EC 2.4.1.1) 
up b,c,d 0.0467 
ENST00000370321 (BERTUCCI et 
al. 2004) 
60S ribosomal protein L5 up c 0.0032 
ENST00000265361 (BERTUCCI et 
al. 2004) 
Semaphorin-3C precursor 
(Semaphorin E) (Sema E) 
up d 8.05E-05
ENST00000244520 (BERTUCCI et 
al. 2004) 
U1 small nuclear 
ribonucleoprotein C (U1 snRNP 
protein C) (U1C protein) (U1-
C) 
up a 0.0001 




PRA1 family protein 3 (ARL-6-
interacting protein 5) (ADP-
ribosylation- like factor 6-
interacting protein 5) (Aip-5) 
(Glutamate transporter EAAC1-
interacting protein) (GTRAP3-
18) (Prenylated Rab acceptor 
protein 2) (Protein JWa) 
(Dermal papilla-derived protein 
11) 
down b 0.0014 
ENST00000323456 (KWON et al. 
2004) 
myotubularin related protein 4 down b 0.0011 
ENST00000258428 (KWON et al. 
2004) 
DNA repair protein REV1 (EC 
2.7.7.-) (Rev1-like terminal 
deoxycytidyl transferase) 
(Alpha integrin-binding protein 
80) (AIBP80) 
down c 0.0011 
ENST00000326361 (KWON et al. 
2004) 
Zinc finger protein 639 (Zinc 
finger protein ZASC1) (Zinc 
finger protein ANC_2H01) 
up a 0.0015 






up b,c,d 7.5E-05 
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Accna Refb Namec Statusd Targete P-valuef
ENST00000262462 (KWON et al. 
2004) 
Long-chain fatty acid transport 
protein 6 (Fatty acid transport 
protein 6) (FATP-6) (Very 
long-chain acyl-CoA synthetase 
homolog 1) (VLCSH1) 
(hVLCS-H1) (Fatty-acid-
coenzyme A ligase, very long-
chain 2) (Solute carrier family 
27 member 6) 
up a,c 6.4E-05 
 
ENST00000307633 (KWON et al. 
2004) 
Histidyl-tRNA synthetase (EC 
6.1.1.21) (Histidine--tRNA 
ligase) (HisRS) 
up c 0.0001 
ENST00000327304 (KWON et al. 
2004) 
Exosome complex exonuclease 
RRP40 (EC 3.1.13.-) 
(Ribosomal RNA- processing 
protein 40) (Exosome 
component 3) (p10) 
up b,c,d 0.0001 
 
ENST00000370986 (KWON et al. 
2004) 
Growth arrest and DNA-
damage-inducible protein 
GADD45 alpha (DNA- 
damage-inducible transcript 1) 
(DDIT1) 
up a 0.0013 
ENST00000160827 (KWON et al. 
2004) 
Kinesin-like protein KIF22 
(Kinesin-like DNA-binding 
protein) (Kinesin-like protein 4)
up a 0.0031 
ENST00000230588 (NOTTERMAN
et al. 2001) 
 
Meprin A subunit alpha 
precursor (EC 3.4.24.18) 
(Endopeptidase-2) (N- benzoyl-
L-tyrosyl-P-amino-benzoic acid 
hydrolase subunit alpha) 
(PABA peptide hydrolase) 
(PPH alpha) 
down a 0.0012 
ENST00000162749 (NOTTERMAN
et al. 2001) 
Tumor necrosis factor receptor 
superfamily member 1A 
precursor (p60) (TNF-R1) 
(TNF-RI) (TNFR-I) (p55) 
(CD120a antigen) [Contains: 
Tumor necrosis factor receptor 
superfamily member 1A, 
membrane form; Tumor 
necrosis factor-binding protein 
1 (TBPI)] 
down b 0.0023 
ENST00000314355 (NOTTERMAN
et al. 2001) 
Cyclin-dependent kinases 
regulatory subunit 2 (CKS-2) 
up a 0.0136 






down a 4.2E-05 
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Table D.4 continued     
Accna Refb Namec Statusd Targete P-valuef
ENST00000356245 (SHIH et al. 
2005) 
Ras-GTPase-activating protein-
binding protein 1 (EC 3.6.1.-) 
(ATP- dependent DNA helicase 
VIII) (GAP SH3-domain-




aEnsembl transcript accession for putative hsa-mir-548 target genes 
bPublication where the genes involvement in colorectal cancer was originally reported 
cName and brief description of the gene 
dExpression status of the gene (up- or down-regulated) in colorectal cancer relative to 
normal tissue  
eParalog-specific hsa-mir-548 target site 
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Figure D.1: Dendogram showing relationships among tissues from the Novartis 
Foundation Symatlas microarray dataset. Cancer tissues are indicated with the red bar. 
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Figure D.2: Over-represented GO biological process categories among genes with miRanda predicted hsa-mir-548 target sites 
that map to colorectal cancer down-regulated co-expression clusters (i.e. 12, 15 & 20 in Figure 5.6). The portion of the directed 
acyclic graph (DAG) containing all paths from the root biological process term to the over-represented functional category terms is 
shown. Over-represented functional categories are indicated in red. 
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Figure D.3: Made1-derived miRNA genes are primate-specific. Human genomic 
regions corresponding to Made1-derived miRNA genes are shown: (A) hsa-mir-548a-1, 
(B) hsa-mir-548a-2, (C) hsa-mir-548a-3, (D) hsa-mir-548b, (E) hsa-mir-548c, (F) hsa-
mir-548d-1, (G) hsa-mir-548d-2. The UCSC Genome Browser is used to show the 
location of the Made1 elements (DNA) in the RepeatMasker track. Evolutionary 
comparisons between the human genome and the corresponding regions in the chimp, 
rhesus, mouse, rat, dog and cow genomes are shown using the species-specific Net tracks 
of the Genome Browser. Corresponding Made1 orthologous regions that are present in 
another species are indicated with a broad line, while regions that are missing in another 
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Figure D.3 continued 
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APPENDIX E 
SUPPLEMENTARY INFORMATION FOR CHAPTER 6 
 
 
Table E.1: TE-derived miRNAs 
 
Table E.1 continued    
Namea Accnb Coordsc TEd Overlape
ath-MIR414 MI0001425 chr1:25141119-25141226(-) ATCopia24I 
(LTR/Copia) 
57.41 
ath-MIR855 MI0005411 chr2:4681509-4681780(+) Athila4B_LTR 
(LTR/Gypsy) 
100.00 
ath-MIR416 MI0001427 chr2:7015602-7015681(+) Vandal1 (DNA/MuDR) 100.00 
ath-MIR405a MI0001074 chr2:9642037-9642193(-) SIMPLEHAT2 
(DNA/hAT) 
100.00 
ath-MIR407 MI0001079 chr2:13873282-13873544(+) ATMU9 (DNA/MuDR) 93.16 
ath-MIR405d MI0001077 chr4:2789653-2789738(-) SIMPLEHAT2 
(DNA/hAT) 
100.00 
ath-MIR401  MI0001070 chr4:5020234-5020483(-) Athila4B_LTR 
(LTR/Gypsy) 
100.00 
ath-MIR854b  MI0005413 chr5:11341600-11341820(-) Athila6A_I 
(LTR/Gypsy) 
100.00 
ath-MIR854d  MI0005415 chr5:11707091-11707311(-) Athila6A_I 
(LTR/Gypsy) 
100.00 
ath-MIR854c  MI0005414 chr5:11855326-11855546(+) Athila6A_I 
(LTR/Gypsy) 
100.00 
ath-MIR854a  MI0005412 chr5:11864949-11865169(+) Athila6A_I 
(LTR/Gypsy) 
100.00 
ath-MIR405b  MI0001075 chr5:20649740-20649863 (+) SIMPLEHAT2 
(DNA/hAT) 
100.00 
osa-MIR439a MI0001691 chr1:20206990-20207082(+) MuDR4_OS 
(DNA/MuDR) 
100.00 
osa-MIR814a MI0005239 chr1:22701877-22701973(+) STOWAWAY47_OS 
(DNA/Stowaway) 
100.00 
osa-MIR441c MI0001706 chr1:32522492-32522645(+) STOWAWAY1_OS 
(DNA/Stowaway) 
97.40 
osa-MIR812a MI0005233 chr1:34273999-34274232(+) STOWAWAY51_OS 
(DNA/Stowaway) 
100.00 
osa-MIR807a MI0005209 chr1:39312844-39313095(+) ECR (DNA/Tourist) 98.41 
osa-MIR818a MI0005247 chr1:40742271-40742414(+) STOWAWAY15-2_OS 
(DNA/Stowaway) 
98.61 
osa-MIR819a MI0005252 chr1:41534243-41534367(+) STOWAWAY1_OS 
(DNA/Stowaway) 
100.00 
osa-MIR806a MI0005210 chr1:43254846-43255097(-) TREP215 
(DNA/Stowaway) 
94.44 
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Table E.1 continued    
Namea Accnb Coordsc TEd Overlape
osa-MIR812b MI0005234 chr2:1936324-1936493(-) STOWAWAY51_OS 
(DNA/Stowaway) 
100.00 
osa-MIR818b MI0005248 chr2:4007187-4007299(+) STOWAWAY15-2_OS 
(DNA/Stowaway) 
100.00 
osa-MIR806b MI0005211 chr2:5044109-5044323(-) TREP215 
(DNA/Stowaway) 
100.00 
osa-MIR814c MI0005241 chr2:10889670-10889752(-) STOWAWAY47_OS 
(DNA/Stowaway) 
100.00 
osa-MIR817 MI0005246 chr2:12276361-12276443(-) ENSPM3_OS 
(DNA/En-Spm) 
100.00 
osa-MIR437 MI0001688 chr2:17044466-17044678(-) STOWAWAY41_OS 
(DNA/Stowaway) 
37.09 
osa-MIR807b MI0005218 chr2:24481931-24482076(-) ECR (DNA/Tourist) 100.00 
osa-MIR814b MI0005240 chr2:26335342-26335415(+) STOWAWAY47_OS 
(DNA/Stowaway) 
100.00 
osa-MIR819c MI0005254 chr2:33750674-33750827(+) STOWAWAY1_OS 
(DNA/Stowaway) 
97.40 





osa-MIR818c MI0005249 chr2:35922869-35923044(+) STOWAWAY46_OS 
(DNA/Stowaway) 
89.77 
osa-MIR808 MI0005220 chr3:8847036-8847187(+) STOWAWAY1_OS 
(DNA/Stowaway) 
98.68 





osa-MIR439d MI0001694 chr3:13677143-13677240(+) MuDR4_OS 
(DNA/MuDR) 
89.80 
osa-MIR435 MI0001687 chr3:18164352-18164483(+) MERMITEH (DNA) 39.39 




osa-MIR809a MI0005221 chr3:26735515-26735675(-) STOWAWAY1_OS 
(DNA/Stowaway) 
94.41 
osa-MIR441a MI0001704 chr3:28876745-28876897(-) STOWAWAY1_OS 
(DNA/Stowaway) 
79.74 
osa-MIR443 MI0001708 chr3:29972009-29972156(+) STOWAWAY47_OS 
(DNA/Stowaway) 
100.00 
osa-MIR806c MI0005212 chr3:36133235-36133504(-) TREP215 
(DNA/Stowaway) 
88.52 
osa-MIR819e MI0005256 chr3:36206839-36206992(-) STOWAWAY1_OS 
(DNA/Stowaway) 
97.40 
osa-MIR420 MI0001440 chr4:6098543-6098697(+) TRUNCATOR2_OS 
(LTR/Gypsy) 
100.00 
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Table E.1 continued    
Namea Accnb Coordsc TEd Overlape
osa-MIR416 MI0001436 chr4:17268776-17268884(+) CPSC3_LTR 
(LTR/Copia) 
100.00 
osa-MIR807c MI0005219 chr4:23886344-23886527(+) ECR (DNA/Tourist) 100.00 
osa-MIR442 MI0001707 chr4:32149607-32149839(+) OLO24B 
(DNA/Tourist) 
100.00 
osa-MIR806d MI0005213 chr4:33568288-33568558(-) TREP215 
(DNA/Stowaway) 
87.82 
osa-MIR818d MI0005250 chr4:34750094-34750232(-) TREP220 
(DNA/Stowaway) 
81.29 
osa-MIR819f MI0005257 chr4:35070636-35070779(-) STOWAWAY50_OS 
(DNA/Stowaway) 
100.00 
osa-MIR815b MI0005243 chr5:14914142-14914271(+) WANDERER_OS 
(DNA/Tourist) 
54.62 
osa-MIR445d MI0001712 chr5:18245235-18245546(-) NDNA2TNA_OS 
(DNA/Tourist) 
96.15 
osa-MIR809b MI0005222 chr5:26781125-26781276(-) STOWAWAY1_OS 
(DNA/Stowaway) 
86.18 
osa-MIR819g MI0005258 chr5:28003948-28004094(+) STOWAWAY1_OS 
(DNA/Stowaway) 
100.00 
osa-MIR815a MI0005242 chr5:29663360-29663442(+) WANDERER_OS 
(DNA/Tourist) 
26.51 
osa-MIR439h MI0001698 chr6:1552120-1552218(-) MuDR4_OS 
(DNA/MuDR) 
88.89 
osa-MIR819h MI0005259 chr6:10052973-10053127(-) STOWAWAY50_OS 








osa-MIR811a MI0005230 chr6:13901553-13901742(+) TAMI2 (DNA) 100.00 
osa-MIR438 MI0001689 chr6:20744968-20745153(+) OSTE1 (DNA) 1.61 
osa-MIR812c MI0005235 chr6:26259310-26259473(+) STOWAWAY9_OS 
(DNA/Stowaway) 
100.00 





osa-MIR815c MI0005244 chr7:5425185-5425287(-) DITTO-2 
(DNA/Tourist) 
58.25 
osa-MIR439c MI0001693 chr7:8232129-8232221(+) MuDR4_OS 
(DNA/MuDR) 
96.77 
osa-MIR820b MI0005264 chr7:13118845-13119035(-) ENSPM2_OS 
(DNA/En-Spm) 
16.75 
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Table E.1 continued    
Namea Accnb Coordsc TEd Overlape




osa-MIR441b MI0001705 chr7:17310115-17310266(-) STOWAWAY1_OS 
(DNA/Stowaway) 
87.50 
osa-MIR812d MI0005236 chr7:22393529-22393681(+) STOWAWAY44_OS 
(DNA/Stowaway) 
100.00 
osa-MIR819i MI0005260 chr7:27791376-27791573(+) STOWAWAY1_OS 
(DNA/Stowaway) 
75.76 
osa-MIR445a MI0001709 chr7:28117531-28117798(+) NDNA2TNA_OS 
(DNA/Tourist) 
100.00 
osa-MIR818e MI0005251 chr7:28152738-28152962(-) STOWAWAY21_OS 
(DNA/Stowaway) 
100.00 
osa-MIR806e MI0005214 chr7:29167591-29167845(+) TREP215 
(DNA/Stowaway) 
93.33 
osa-MIR531 MI0003204 chr8:1214013-1214093(-) SC-1_int-int 
(LTR/Copia) 
100.00 
osa-MIR439g MI0001697 chr8:3657884-3657971(+) MuDR4_OS 
(DNA/MuDR) 
96.59 
osa-MIR439e MI0001695 chr8:14924726-14924823(-) MuDR4_OS 
(DNA/MuDR) 
91.84 
osa-MIR809e MI0005225 chr8:15317880-15318040(-) STOWAWAY1_OS 
(DNA/Stowaway) 
97.52 
osa-MIR812e MI0005237 chr8:16268303-16268472(+) STOWAWAY44_OS 
(DNA/Stowaway) 
100.00 




osa-MIR806f MI0005215 chr8:27832638-27832878(+) TREP215 
(DNA/Stowaway) 
99.17 
osa-MIR819j MI0005261 chr8:28081183-28081357(+) STOWAWAY1_OS 
(DNA/Stowaway) 
85.71 
osa-MIR809f MI0005226 chr9:12000642-12000795(+) STOWAWAY1_OS 
(DNA/Stowaway) 
97.40 
osa-MIR439f MI0001696 chr9:16962023-16962118(+) MuDR4_OS 
(DNA/MuDR) 
93.75 
osa-MIR811b MI0005231 chr10:2372014-2372203(+) TAMI2 (DNA) 100.00 
osa-MIR439b MI0001692 chr10:5338996-5339055(+) MuDR4_OS 
(DNA/MuDR) 
100.00 
osa-MIR820c MI0005265 chr10:6693845-6694025(+) ENSPM2_OS 
(DNA/En-Spm) 
14.92 
osa-MIR439j MI0001700 chr10:15479858-15479982(-) MuDR4_OS 
(DNA/MuDR) 
26.40 
osa-MIR819k MI0005262 chr10:18374459-18374614(-) STOWAWAY50_OS 
(DNA/Stowaway) 
98.72 
osa-MIR816 MI0005245 chr10:21478646-21478722(+) STOWAWAY47_OS 
(DNA/Stowaway) 
100.00 
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Table E.1 continued    
Namea Accnb Coordsc TEd Overlape
osa-MIR806g MI0005216 chr10:22588399-22588638(+) TREP215 
(DNA/Stowaway) 
100.00 
osa-MIR811c MI0005232 chr11:5200383-5200541(-) TAMI2 (DNA) 100.00 
osa-MIR813 MI0005238 chr11:23113437-23113639(+) NDNA1TNA_OS 
(DNA/Tourist) 
100.00 
osa-MIR809g MI0005227 chr11:25437945-25438096(-) STOWAWAY1_OS 
(DNA/Stowaway) 
98.68 
osa-MIR531 MI0003204 chr11:26423868-26423948(+) SC-1_int-int 
(LTR/Copia) 
100.00 
osa-MIR806h MI0005217 chr11:28361967-28362237(-) TREP215 
(DNA/Stowaway) 
88.19 
osa-MIR809h MI0005228 chr12:5776955-5777088(+) STOWAWAY1_OS 
(DNA/Stowaway) 
100.00 




amiRNA name (from miRBase) 
bmiRBase accession number 
cGenomic coordinates of the miRNA 
dName of co-located TE 





          







Figure E.1: RNA secondary structures of siRNA-miRNA encoding TE sequences.  
The predicted secondary structures of TE sequence transcripts encoding both siRNA and 
miRNA are shown for (A) ath-MIR855 (B) ath-MIR401 (C) ath-MIR416 (D) ath-
MIR405b (E) ath-MIR854a (F) osa-MIR439a (G) osa-MIR814a (H) osa-MIR812b (I) 
osa-MIR814b (J) osa-MIR821a (K) osa-MIR443 (L) osa-MIR420 (M) osa-MIR442 (N) 
osa-MIR531 (O) osa-MIR821c (P) osa-MIR439b (Q) osa-MIR531 (R) osa-MIR821b.  
The miRNA stem-loop region, miRNA mature sequence, miRNA signature sequence and 
siRNA signature sequence are shown in red, blue, pink and green, respectively. 
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Figure E.1 continued 
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